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SUMMARY 
 
Amyloid fibrils are associated with a large number of diseases in which proteins and 
peptides abnormally assemble to form insoluble amyloid that deposit in the tissues. 
However, oxidative stress has been implicated in the pathogenesis of a number of 
neurodegenerative diseases and is believed to play an important role in the amyloid 
deposition through protein cross-linkings. Under oxidative stress conditions, tyrosyl 
radicals can be formed and coupled to form dityrosine cross-linkage. The formation of 
dityrosine cross-linked oligomers is one of the oxidative modifications that may 
mediate the toxicity of amyloid β (Aβ) and α-synuclein (α-syn) in Alzheimer’s disease 
(AD) and Parkinson’s disease (PD) respectively. In this thesis, I explored the oxidative 
modification of two short peptides, HYFNIF and VIYKI, using a Cu2+/H2O2 oxidation 
system, and studied the morphological and conformational changes of these amyloid 
fibrils during the oxidation process. These peptides were selected as simple amyloid 
model systems that have been previously structurally characterised, to better understand 
the dityrosine formation at a structural level and to optimise the oxidation conditions.  
 
Oxidative stress has been implicated in AD. Here, I have explored the formation of 
dityrosine cross-linked Aβ42 in vitro. We have shown that dityrosine is generated in 
internalised Aβ in cell cultures. Results also revealed the prevalence of dityrosine 
crosslinks in amyloid plaques in brain tissue and cerebrospinal fluid from AD patients, 
indicating that dityrosine could be used as a biomarker of oxidative stress in AD.   
 
The ability of the Cu2+ ion to promote the formation of in vitro dityrosine cross-linked 
α-syn was also explored and the effect on α-syn fibrillogenesis and conformation 
induced by Cu2+ was investigated. The results revealed the possibility of involvement 
the dityrosine cross-linked α-syn dimer as a nucleus to initiate the polymerisation 
process of α-syn to form amyloid fibrils. 
 
Dityrosine cross-linkages can be generated in vitro using oxidation system of 
Cu2+/H2O2, and might play an important role in the solubility and assembly of 
amyloidogenic peptides and proteins that are associated in the pathogenesis of many 
neurodegenerative disease including AD and PD. Dityrosine cross-linkages can lend a 
further stability to the already stable amyloid fibrils, and this may explain their protease 
resistance. Dityrosine cross-links formation represents one of the possible pathways by 
which oligomers can be formed. Dityrosine cross-linked oligomers represent a good 
bio-index of oxidatively coupled tyrosine-contained proteins due to their high stability.  
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1 Introduction 
 Amyloid((an(over(view)(1.1
Rudolf Virchow first used "amyloid" term in 1854 to describe a structure observed in 
human brain tissue (Cohen 1986; Virchow 1854; Westermark 2005). Virchow observed 
that wax-like deposits in brain tissue displayed a starch-like reaction with iodine and 
subsequently concluded that these inclusions were composed of carbohydrate and called 
them amyloid which is derived from the Latin amylum, meaning starch. Later, Friedrich 
and Kekule refuted the hypothesis of the cellulose nature of amyloid by discovering that 
these wax-like deposits were mainly composed of protein, and this was further 
confirmed by Hanssen, who revealed that amyloid is digestible with pepsin 
(Westermark 2005). Using electron microscopy (EM), Cohen and Calkins were able to 
identify the ultrastructure of amyloid in vivo, which has characteristic fine fibrillar 
morphology (Cohen and Calkins 1959). This was followed by ex-vivo EM study of 
amyloid fibres (Cohen 1982), showing that amyloid fibres have a width of 75 − 100 Å 
and indeterminate length. Connors et al. revealed the formation of in vitro amyloid 
fibrils from intact β-microglobulin, demonstrating that they are non-branching fibrils of 
indeterminate length with 8 − 10 nm in diameter by EM (Connors et al. 1985). These 
findings contributed early insights toward an understanding of amyloid structure. 
 
The knowledge of the biochemical and structural nature of amyloid fibrils has increased 
over the time. By definition, amyloids are in vivo filamentous protein deposits, which 
are composed of self-assembled peptides formed of β-sheets that showed a typical 
cross-β X-ray diffraction pattern arising from cross-β structure (Harrison et al. 2007; 
Serpell et al. 1997; Westermark et al. 2007). Also, amyloid fibrils display an apple-
green birefringence under cross-polarised lighted when binding to Congo red dye 
(Figure 1-1, A), and are found to be long, straight and unbranched by EM (Figure 1-1, 
B) (Rambaran and Serpell 2008; Serpell et al. 1997). Although amyloid proteins are 
biochemically different, they share distinct features: the ability to bind Congo red dye, 
fibril ultrastructure and typical cross-β X-ray diffraction pattern. 
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Figure 1-1: Characterisation of amyloid fibrils. A) Glomerulus from renal biopsy stained with Congo red 
and visualised by polarisation microscopy showing the classic apple-green birefringence characteristic 
of amyloid, adapted from (http://www.pathology.vcu.edu/education/). B) Negative stain electron 
micrograph of synthetic amyloid fibrils made from Aβ peptide that displays long, straight unbranched 
fibrils. 
 
Although amyloid fibrils can be formed from many pathogenic precursor proteins 
implicated in a wide range of diseases, many non-pathogenic proteins including those 
that are naturally occurring or designed can produce amyloid fibrils, and this 
consequently added more criteria to define amyloid. A recent amyloid definition states: 
" to be included in the list, the protein has to be a major fibril protein in extracellular 
deposits, which have the characteristics of amyloid, including affinity for Congo Red 
with resulting green birefringence. Synthetic fibrils with amyloid properties are best 
named 'amyloid-like' " (Westermark 2005). Later on, it has been found that many 
proteins can form intracellular inclusions with typical amyloid structure (Westermark et 
al. 2007). Thus, the definition of amyloid has expanded to involve these intracellular 
amyloids, and also exclude any extracellular and intracellular deposits that do not fulfill 
the criteria of amyloid identity such as binding with Congo red dye and showing the 
typical green birefringence. Additional criteria have been added, including the ability 
bind Thioflavin T (ThT) dye giving enhanced fluorescence, although this is not 
necessarily fundamental (Pepys 2006). However, one criterion that has been accepted is 
that fibrils must display a cross-β structure to be called amyloid or amyloid-like 
(Meinhardt and Fandrich 2009; Sunde et al. 1997). 
 
A diverse group of diseases of acquired or hereditary origin are associated with 
insoluble amyloid fibril deposition in the affected organs and are called "amyloidoses" 
(Westermark et al. 2007). The main component of amyloid deposits is the amyloid 
fibril, where a specific precursor protein is deposited in each kind of amyloidosis 
0.2 µm 
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(Westermark 2005). It has been revealed that amyloid toxicity is independent of 
polypeptide amino acid sequence, length and chirality (Pastor et al. 2008). However, it 
is clear that amyloid deposits in tissue contain other common components including 
glycosaminoglycans, apolipoprotein E and serum amyloid P-component (Uversky et al. 
2006b; Westermark 2005). Amyloidoses are discussed in more detail below. 
 
In contrast to their pathogenic role, it has been found that some amyloids have a 
functional role in many organisms, from bacteria to mammals, without observable toxic 
effect (Fowler et al. 2006; Maji et al. 2009; Maury 2009). Furthermore, amyloid fibres 
have recently been applied for industrial purpose, and this due to their high stability and 
strength (Sawada et al. 2013; Smith et al. 2006b). 
 
 Protein(folding(and(misfolding(1.2
Proteins represent one of the most important biological molecules in the cells due to 
their biological role in controlling and regulating the majority of cellular processes. 
Proteins are synthesised on ribosomes where a linear sequence of amino acids can be 
produced through a specific translation process. For each newly synthesised protein to 
be functionally active, it needs to fold into a three-dimensional structure (Figure 1-2), 
which is a unique complex structure called the native state.  
 
 
Figure 1-2: Folding of a linear amino acid sequence into a three-dimension structure. Reproduced from 
(http://physics.stackexchange.com). 
 
Essentially, there are 20 different native amino acids that can be combined via peptide 
bonds to form an enormous number of different sized proteins. However, the native 
proteins consist of a specific amino acid sequences that encoded to fold into a native 
protein state. In 1973, Anfinsen had observed that ribonuclease A folded spontaneously 
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into its native state in vitro, concluding that all required information for the native fold 
are contained within the primary amino acid sequence (Anfinsen 1973). Many 
experimental and theoretical studies have been designed to investigate the protein 
folding mechanism (Anfinsen 1973; Bartlett and Radford 2009; Dobson 2004; Lee et al. 
2006; Radford and Dobson 1999; Vabulas et al. 2010). The Levinthal paradox 
highlighted that the folding of any polypeptide chain into its native state can not occur 
by a random search of all possible conformations, as this would take an unrealistic time 
compared with that actually observed for protein folding (Lenvinthal 1968). It has been 
suggested that protein folding is driven initially by hydrophobic collapse followed by 
formation of secondary structure forms within a polypeptide, and then formation of 
covalent bonds, such as S-S bond under oxidising conditions, that help to stabilise the 
final native state (Gething and Sambrook 1992). 
 
Intermediate formation has observed to accompany the folding mechanism, and 
considered as the rule for larger proteins (> 100 amino acid), which have a high 
tendency to rapidly collapse in aqueous solution into compact non-native conformations 
(Bartlett and Radford 2009; Brockwell and Radford 2007). The polypeptide chain may 
fold by many routes, likely adopting multiple folded intermediates on-path to the native 
state (Onuchic and Wolynes 2004). A multidimensional energy landscape has been used 
to describe the protein folding pathway (Dobson 2003; Radford 2000), explaining that 
there are likely an enormous number of pathways to reach the native state and the 
pathway will depend on the details of the protein being studied, such as the amino acid 
sequence and the experimental conditions. Generally, proteins fold either on a relatively 
smooth landscape or a rough, rugged landscape (Bartlett and Radford 2009). A 
relatively smooth landscape (Figure 1-3, A), can be produced when a protein folds via a 
two-state transition (from denatured state to native state), and this transition is rare 
(Brockwell and Radford 2007). By contrast, when a protein is funneled to the native 
state through multiple routes that might be involved intermediate formation, a rugged 
landscape is produced (Figure 1-3, B).  
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Figure 1-3: Schematic representation of energy folding funnels. Two different types of folding funnels can 
be occupied by proteins: (A) smooth energy landscape, in which a protein is effectively funneled to the 
native structure via a two-state transition, (B) rough, rugged landscape, through which the protein has to 
navigate, possibly via one or more populated intermediates, to the native state. In both types, the 
denatured state occupies several structures containing elements of both native and non-native 
interactions. Adapted with permission from (Bartlett and Radford 2009). 
 
Recently, it has been demonstrated that even small proteins that fold on a subsecond 
timescale may pass through structural intermediates on their way toward native state 
(Bartlett and Radford 2009), explaining that such intermediates are either ‘stepping 
stones’ on-pathway toward the native state, or kinetically stable, misfolded 
intermediates that may need fundamental reorganisation to reach the final native state. 
However, incorrectly folded protein can result in a wide range of protein misfolding 
diseases (Dobson 2003). Many of these diseases display pathologies in which insoluble 
amyloid fibrils are formed from soluble and often functional proteins. It has been shown 
that partially folded or misfolded intermediates, that formed en route to the native state, 
often tend to aggregate, especially when they represent major kinetic traps in the folding 
route (Bartlett and Radford 2009). In these conformational forms, the hydrophobic 
amino acid residues and regions of unstructured polypeptide backbone are exposed, 
whereas in native state they are mostly buried. Like intramolecular folding, aggregation, 
which represents intermolecular interaction between two or more non-native protein 
molecules, is highly driven by hydrophobic interactions and leads to formation of either 
amorphous structures or amyloid fibrils that are thermodynamically highly stable, 
ordered forms and show a common structural feature of cross-β structure (Figure 1-4) 
(Bartlett and Radford 2009; Hartl and Hayer-Hartl 2009; Relini et al. 2014). It has been 
illustrated that amyloid formation is an inherent feature of the polypeptide chain, and 
can be enhanced using an appropriate in vitro denatured conditions (Chiti and Dobson 
2006; Dobson 2003). 
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Figure 1-4: Schematic diagram showing protein folding and aggregation funnel landscape. Protein 
folding occurs when intermediate fold into more ordered native state via intramolecular interactions and 
this is showed by the purple surface. The pink area shows the multitude conformations moving toward 
amorphous aggregates or amyloid fibrils via intermolecular interactions. Cell-toxic oligomers may 
represent on or off-pathway intermediates of amyloid fibril formation. Reused with permission from 
(Hartl and Hayer-Hartl 2009). 
 
Amyloid fibrils are extremely stable and exhibit a resistance to many denaturation 
agents such as urea, SDS and formic acid compared to native state globular proteins. 
However, they can be dissolved using very strong chaotropic agents or organic solvents 
such as phenol (Masters et al. 1985). Furthermore, the core is highly protease resistant, 
a common characteristic of amyloid fibres (Hartley et al. 2008; Hill et al. 1999). These 
observations together indicate that amyloid fibres are the lowest energy state that a 
protein can adopt, and have the lowest energy minima in the folding funnel landscape 
(Chiti and Dobson 2006; Hartl and Hayer-Hartl 2009) as shown in Figure 1-4. 
 
Oxidative modifications of protein have been reported to promote protein misfolding 
both in vivo and in vitro, and eventually aggregation formation (Campioni et al. 2010; 
Scheinost et al. 2010). Reactive oxygen species (ROS) are generated as a by-product of 
normal metabolism and/or by exogenous stimuli such as ultraviolet light (Andreyev et 
al. 2005). ROS can attack all biological macromolecules, including proteins and causing 
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oxidative damage (Campioni et al. 2010). Oxidation of a protein in vitro can induce its 
aggregation via multiple mechanisms such as destabilisation of the native state (Granata 
et al. 2007). Similarly, in vivo protein oxidation can also promote aggregation by 
additional mechanisms, such as protein cross-linking (Atwood et al. 2004; Zhang et al. 
2004).  
 
 Amyloid(fibril(structure(1.3
The structure of amyloid fibrils can not usually be determined using commonly used 
structural techniques due to the insolubility and heterogeneity of amyloid fibrils. 
Instead, structural techniques including X-ray fibre diffraction (XRFD), solid-state 
nuclear magnetic resonance (ssNMR) and electron microscopy are often used to 
determine amyloid fibril structure. Many morphological and macromolecular structural 
analyses have been carried out using both electron and atomic force microscopy, 
revealing that amyloid fibrils are long, straight and unbranched (Goldsbury et al. 1999; 
Makin and Serpell 2005; Stromer and Serpell 2005; Sunde et al. 1997) (Figure 1-6, A). 
Moreover, it has been demonstrated that amyloid fibrils are made up of twisted 
individual subunits called “protofilaments” that can vary in number in different fibrils 
(Rambaran and Serpell 2008; Serpell et al. 2000b). Synthetic amyloid fibrils that are 
formed by amyloid β (Aβ), insulin and lysozyme were analysed using cryo-electron 
microscopy and showed to be composed of several protofilaments (2-6) twisted around 
one another (Figure 1-5, K) (Jimenez et al. 2001; Jimenez et al. 2002).  
 
Amyloid fibrils that are generated from the same amyloidogenic protein are reported to 
show different fibril morphologies, i.e structural polymorphism (Figure 1-5, L) 
(Meinhardt et al. 2009), and this is attributed to different factors including different 
numbers of protofilaments (Goldsbury et al. 2000; Jimenez et al. 2002), different 
protofilament arrangements (Chamberlain et al. 2000), or different peptide 
conformations (Petkova et al. 2005). The structure of Aβ40 fibrils that were formed 
under agitation or quiescent conditions have been analysed using ssNMR, and a high-
resolution structural model was constructed (Figure 1-5, H) (Paravastu et al. 2008; 
Petkova et al. 2006). More structural details for amyloid fibrils obtained using different 
structural techniques are shown in Figure 1-5. 
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Figure 1-5: Diversity of cross-β structures that are characterised using X-ray crystallography, ssNMR, 
and cryo-EM.  (A) The atomic structure of Aβ (35-40) segment with amino acid sequence of MVGGVV 
has been identified using X-ray microcrystallography and showed steric zipper conformation (Sawaya et 
al. 2007). (B) Crystal structure of β2-microglobulin (β2m) dimer cross linked via disulfide linkages and 
formed in three-dimensional domain-swapped amyloid fibrils (Liu et al. 2011). (C) Crystal structure 
stefin B in a domain-swapped dimer conformation implicated as pre-fibril oligomers in amyloid 
formation (Jenko Kokalj et al. 2007). (D, E) Three-dimensional structures of cross-β parallel and anti 
parallel in-register protein fibrils of the K3 (β2m20-41) and NFGAIL peptide respectively, which are 
identified using ssNMR (Iwata et al. 2006; Nielsen et al. 2009). (F) Structure model of Aβ42 fibrils 
obtained using hydrogen exchange, pairwise mutagenesis, and solution NMR (Luhrs et al. 2005). (G and 
H) High-resolution structural model of Aβ40 fibrils formed under agitation or quiescent conditions, 
respectively, obtained using ssNMR (Paravastu et al. 2008; Petkova et al. 2006). (I) High-resolution 
structural model of Het-s (218-289) prion fibrils determined using ssNMR (Wasmer et al. 2008). (J) Low-
resolution three-dimensional structural model of amyloid fibrils formed from full-length β2m obtained by 
cryo-EM (White et al. 2009). (K) Low-resolution three-dimensional structures of fibrils assembled from 
the polypeptide hormone insulin consisting of 2, 4, or 6 protofilaments based on cryo-EM (Jimenez et al. 
2002). (L) Low-resolution three-dimensional structures of Aβ40 fibrils polymorphism revealed by cryo-
EM (Meinhardt et al. 2009). Reused with permission from (Eichner and Radford 2011). 
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ssNMR has been used to analyse amyloid fibrils formed from various peptides 
corresponding to different regions of Aβ, and shown to have parallel and antiparallel β-
sheet structures depending on the properties of the precursor polypeptide and assembly 
conditions (Balbach et al. 2002; Lu et al. 2013; Petkova et al. 2004; Petkova et al. 
2005). A full length Aβ40 has been found to form fibrils that have an in-register β-
structure (Luhrs et al. 2005; Petkova et al. 2002), in which the peptide molecules fold 
into a β-bend structure and then associate together to form parallel β-sheets (Figure 1-6, 
C).  
 
The XRFD patterns from many different synthetic amyloid fibrils showed a cross-β 
structure (Figure 1-6, B). The cross-β diffraction pattern was first identified for silk 
from the egg stalk of the lacewing (Geddes et al. 1968). The typical cross-β diffraction 
patterns consist of “two major reflections at 4.7 Å and 10 Å found on orthogonal axes 
and arising from the hydrogen bonding distances between β-strands and side chain 
packing between the sheets respectively” (Makin et al. 2006; Rambaran and Serpell 
2008; Sunde et al. 1997). 
 
As some short amyloidogenic peptide can form crystals, their atomic structure has been 
elucidated by X-ray crystallography. In turn, considerable structural information has 
been gained, revealing the role of side chain interactions in the association of β-sheet 
ribbons. Atomic structure of Aβ(35−40) segment with amino acid sequence of 
MVGGVV obtained using X-ray microcrystallography (Figure 1-5, A) revealed a steric 
zipper conformation (Sawaya et al. 2007). The amyloidogenic peptide GNNQQNY, a 
fragment of the yeast prion, Sup35, has been characterised structurally by X-ray 
crystallography and recently, aromatic side chain packing of tyrosine residues have 
been reported to play a curial role in the fibre-crystal switching (Gazit 2002; Marshall et 
al. 2010; Nelson et al. 2005). 
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Figure 1-6: Synthetic Aβ fibrils structure based on XRFD, ssNMR and TEM. (A) Aβ fibrils are long, 
straight, unbranching fibrils under TEM. (B) X-ray fibre diffraction pattern from Aβ fibrils showing a 
typical cross-β diffraction, characteristic feature of amyloid fibrils. (C) The structural model of amyloid 
fibrils assembled from Aβ40 based on ssNMR data, (i and ii) the top view of the fiber with side chains and 
as a cartoon respectively, revealing the importance of side chain packing with in the fiber. The side view 
(iii) showing the β-strands running perpendicular to the fiber axis. Adapted from (Rambaran and Serpell 
2008). 
 
 Mechanism(of(amyloid(assembly(1.4
Many proteins and peptides with very different sequences have the ability to assemble 
into amyloid fibrils that share a cross-β core. Thus, it is very important to study and 
understand the mechanism underlying amyloid assembly, as this will contribute 
significantly to therapeutic approaches to halting and avoiding many amyloidoses. It is 
accepted that amyloid assembly mechanism involves formation of partially folded 
intermediates (Jahn et al. 2006; McParland et al. 2000). Ferrone et al. revealed a 
nucleation dependant mechanism of amyloid assembly (Ferrone 1999). Generally, the 
mechanism shows the conversion of unfolded monomeric species into partially folded 
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intermediates that then undergo nucleation to form protofibrils that then lengthen into 
mature fibrils (Figure 1-7) (Harper et al. 1997; Serpell 2000). This mechanism has been 
shown for α-synuclein (α-syn)(Conway et al. 2000).  
 
 
Figure 1-7: Schematic diagram showing amyloid assembly mechanism. The amyloidogenic 
protein/peptide undergo a multi step misfolding process in which the monomeric species aggregate into 
oligomeric species, which then form protofibrils which come together to form fibrils, which have very 
ordered cross β -structure. Provided by Prof. Louise Serpell. 
 
Many biophysical and biochemical techniques, such as light scattering, size exclusion 
chromatography, fluorimetry and ultracentrifugation, have been used to study the 
kinetics of amyloid assembly in vitro. Thioflavin T fluorescence is often used to 
monitor amyloid fibril formation (see section 1.11.2.3), and the conventional ThT 
graphs reveal three phases; lag, growth and plateau phase (Figure 1-8).  
 
 
Figure 1-8: ThT graph showing amyloid fibril formation kinetics. Two distinct stages are observed in the 
amyloid fibril formation: a lag phase corresponds to the formation of thermodynamically disfavored 
nucleation events, and secondly, an elongation phase which is rapid and thermodynamically favored 
(black line). The lag phase can be significantly shortened using preformed fibrils as seeds (red line). 
Adapted with permission from (Eichner and Radford 2011). 
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Generally, the different species that are involved in amyloid assembly are classified as 
fibrillar and non-fibrillar species (Murphy 2007). The non-fibrillar species may be 
intermediates, i.e. monomers and oligomers, on-pathway to fibrillar species. Monomers 
can be folded or unfolded. When amyloid precursors proteins are natively folded, such 
as Transthyretin (TTR) and Prion protein (PrP), the folded monomers undergo a 
conformational switch to form amyloid fibrils (Colon and Kelly 1992; Kelly 1996). For 
example, some natively folded precursors proteins have α-helical structure that is 
converted into β-sheet rich fibrils, whereas, others have β-sheet structure that becomes 
rearranged into an amyloid architecture. On the other hand, monomers may be natively 
unfolded such as Aβ and α-syn (Uversky et al. 2006a), which undergo a structural 
transition from an unfolded state into β-sheet rich fibrils.  
 
Oligomers, a second type of non-fibrillar species, are multimeric states and do not have 
a well-defined structure. For example, in vitro some Aβ oligomers display a spherical 
structure with diameters of 5 – 15 nm. Oligomers can serve as nuclei that are needed to 
initiate the nucleation of protein to form amyloid fibrils (Lee et al. 2011b). However, 
fibril fragmentation represents an alternative pathway for nucleation of fibril formation 
(Xue et al. 2008).   
 
There are three types of fibrillar states; protofibrils, protofilaments and mature fibrils 
(Morris and Serpell 2013). Protofibrils, also called “bead-like structures” represent early 
intermediates in amyloid fibril formation. Generally, protofibrils are < 200 nm in length 
with diameter of up to 11 nm (Murphy 2007). They appear to have a repeating 
monomer structure that makes them more structurally defined than non-fibrillar species 
(Harper et al. 1999). Whereas, protofilaments are well defined filamentous species that 
laterally associated to form a mature amyloid fibril. Cryo-EM studies showed that 
protofilaments have a β-sheet rich core (Serpell and Smith 2000; Serpell et al. 2000b; 
Tattum et al. 2006). Mature fibrils are structurally defined using TEM and shown to be 
long and unbranched fibrils with a diameter of 7-12 nm and an indeterminate length 
(Makin and Serpell 2005; Morris and Serpell 2013). They are composed of a number of 
protofilaments with β-sheet structure (Eichner and Radford 2011). 
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 Amyloid(in(diseases((amyloidosis)(1.5
Amyloid fibril formation is associated with protein misfolding (Dobson 2003, 2013). 
The natively folded or unfolded polypeptide chain undergoes conformational change 
resulting in the formation of amyloid structure. However, exactly how amyloid fibrils 
form in vivo is yet unknown. Amyloid fibrils may deposit at one or several sites in the 
body. Thus, amyloidosis can be classified very broadly into either localised or systemtic 
amyloidosis, based on the location of the amyloid deposits (Westermark et al. 2007). 
Generally, amyloid appearing at one site or in one type of tissue is called “localised” 
such as Alzheimer’s disease, which is characterised by deposition of Aβ into amyloid 
plaques in the brain. By contrast, deposition of amyloid in peripheral organs is called 
systemic amyloidosis such as AL-amyloidosis that affects many organs including heart, 
liver and kidneys and associated with deposition of fibrils that are derived from 
monoclonal immunoglobulin light chains. Apparently, this classification seems to be an 
easy and logical definition. However, one essential criterion to define systemic 
amyloidosis correctly is that the precursor protein has to be expressed in at least one 
site, and then released to plasma and eventually deposited from the blood stream at 
another site (Westermark et al. 2007). Thus, according to the definition systemic 
amyloids are derived from a plasma protein. On the other hand, the typical localised 
amyloid is formed in close proximity to the site of deposition, in other words it is 
derived from protein expressed by cells at the deposition site (Westermark et al. 2007). 
Some examples of amyloidoeses and their corresponding aggregated protein or peptide 
are summarised in Table 1-1.  
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Table 1-1: Some human diseases associated with protein misfolding and the formation of extracellular 
amyloid deposits or intracellular inclusions that are showing amyloid-like characteristics. Adapted from 
(Dobson 2013). Diseases may be predominantly sporadic such as Alzheimer’s disease, or hereditary such 
as Huntington’s disease. * Intracellular misfolding diseases.  
Disease Aggregated peptide or protein 
(no. of residues) 
Structure of precursor 
peptide or protein 
Neurodegenerative diseases 
Alzheimer’s disease Amyloid β peptide (40 or 42) Natively unfolded 
Spongiform encephalopathies Prion protein or fragments thereof 
(253) 
Natively unfolded (1-120) and 
α-helical (121-230) 
Parkinson’s disease* α-synuclein (140) Natively unfolded 
Amyotrophic lateral sclerosis Superoxide dismutase 1 (153) All β 
Huntington’s disease* Huntingtin with long polyQ 
stretches (3144) 
Largely natively unfolded or 
unknown 
Familial amyloidotic 
polyneuropathy 
Mutants of transthyretin (127) Mostly β 
Non-neuropathic systemic amyloidoses 
AL amyloidosis Immunoglobulin light chains or 
fragments thereof (~ 90) 
All β 
AA amyloidosis Fragments of serum amyloid A 
protein (76-104) 
All α 
Senile systematic amyloidosis Wild type transthyretin (127) Mostly β 
Hemodialysis-related 
amyloidosis 
β-Microglobulin (99) All β 
Finnish hereditary amyloidosis Fragments of gelsolin mutants (71) Natively unfolded 
Lysozyme amyloidosis Mutants of lysozyme (130) α and β 
Non-neuropathic localized amyloidosis 
ApoAI amyloidosis Fragments of apolipoprotein AI (80-
93) 
Natively unfolded/ α-helical 
Type II diabetes  Amylin (37) Natively unfolded 
Medullary carcinoma of the 
thyroid 
Calcitonin (32) Natively unfolded 
Hereditary cerebral hemorrhage 
with amyloidosis 
Mutants of amyloid β peptide (40 or 
42) 
Natively unfolded 
Injection-localised amyloidosis Insulin chains A (21) and B (30) All α 
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 Alzheimer’s disease and Aβ  1.5.1
Alzheimer's disease (AD) is a neurodegenerative disease that results from neuronal 
dysfunction and represents the most common cause of dementia (Selkoe 2000), 
affecting around 496,000 people in the UK (http://www.alzheimers.org.uk). Currently, 
over 35 million people worldwide are affected with dementia and this number is 
expected to double by 2030 and more than triple by 2050 to 115 million 
(http://www.alz.co.uk/research/world-report-2013). In 1904, AD was identified for the 
first time by the German neurologist Alois Alzheimer, describing it as a physical 
disease affecting the brain (Alzheimer 1904). Alzheimer carried out a postmortem 
examination of brain tissue from a 55-year old woman who had suffered from a 
progressive behavioral and cognitive disorder. The results revealed the presence of two 
distinctive pathological features: neurofibrillary tangles and neuritic plaques (Alzheimer 
et al. 1995) (Figure 1-9). In 1984, Glenner and Wang were able to isolate and purify 
these neuritic plaques and showed that they were consistent with a peptide that is 
primarily 40 or 42 amino acid in length with molecular weight of 4.2 kDa, assuming it 
was derived from cleavage of a large precursor protein (Glenner and Wong 1984).  
 
 
Figure 1-9: Healthy brain verses Alzheimer's affected brain. The cell death in AD brain leads to severe 
changes in the whole brain including shriveling of the cortex, tissue shrinkage especially in the 
hippocampus and increased ventricles. As a consequence, many fundamental living activities involving 
thinking, planning and remembering are excessively affected. AD is associated with deposition of 
extracellular amyloid plaques and intracellular neurofibrillary tangles of hyper-phosphorylated tau 
protein. Reproduced from (http://www.hopkinsmedicine.org/).  
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AD is clinically characterised by global cognitive decline, associated with brain 
pathology involving deposition of extracellular Aβ fibrils as senile plaques and 
intracellular neurofibrillary tangles of hyper-phosphorylated tau protein (Bothwell and 
Giniger 2000). Aβ plaque formation is accompanied by astrogliosis and microgliosis 
(Gupta and Pansari 2003). The neocortex and hippocampus are the most affected brain 
areas (Figure 1-9) (Sisodia and Gallagher 1998).  
 
The Aβ is an amyloidogenic peptide and cleaved from the large, transmembrane 
amyloid precursor protein (APP) (Selkoe 1991). APP is proteolytically hydrolysed 
through two distinct amyloidogenic and non-amyloidogenic pathways (Figure 1-10). 
The non-amyloidogenic pathway refers to the sequential enzymatic cleavage of APP by 
α- and γ-secretases (Figure 1-10, B) and leads to production of transcriptional regulator 
APP intracellular domain (AICD) and p3 fragment whose functions are not well known 
(Hicks et al. 2012; O'Brien and Wong 2011). By contrast, amyloidogenic processing 
refers to the sequential cleavage of APP by the action of membrane-bounded β- and γ-
secretases (Figure 1-10, C) (Zhang et al. 2012). In this process, APP is first cleaved by 
β-secretase and released as a soluble ectodomain (sAPPβ) and the C-terminal fragment 
CTF99. The latter is then cleaved by γ-secretase, releasing the 39 – 42 amino acid Aβ 
peptide, and also producing the AICD (Zhang et al. 2012). Soluble ectodomains, sAPPβ 
and sAPPα that are released from both amyloidogenic and non-amyloidogenic pathways 
respectively, have been reported to have neuroprotective properties (Turner et al. 2003; 
Zhang et al. 2012). 
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Figure 1-10: Schematic presentation showing proteolytic processing of amyloid precursor protein (APP). 
(A) The Aβ peptide, which is shaded in red color, starts within the ectodomain and continues into the 
transmembrane region. The major sites of cleavage by α-, β-, and γ-secretases are indicated with black 
arrows. Sequential cleavage of the APP occurs by two distinct pathways: nonamyloidogenic and 
amyloidogenic processing (B and C respectively). Nonamyloidogenic processing of APP is carried out by 
the action of α-secretase followed by γ-secretase, whereas amyloidogenic processing of APP refers to 
sequential action of membrane-bound β- and followed by γ-secretase. Both processes produce soluble 
ectodomains (sAPPα and sAPPβ) and identical intracellular C-terminal fragments (AICD). Reused with 
permission from (O'Brien and Wong 2011). 
 
It is hypothesised that accumulation of Aβ peptide into amyloid plaques is the cause of 
AD. This accumulation is attributed to an imbalance between Aβ production and 
clearance which triggers a sequence of pathogenic events leading to AD (Selkoe 2000). 
This is known as the "amyloid cascade hypothesis of AD " which is assumed based on a 
large body of evidence showing that Aβ production is strongly correlated with AD 
A 
B C 
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(Hardy and Selkoe 2002; Karran et al. 2011; Selkoe 2000). However, it is important to 
mention that Aβ fibrils are not necessarily the toxic species. The main evidence for 
amyloid hypothesis is the accumulation of amyloid fibrils, which are formed from Aβ 
peptide, into amyloid plaques in the brain, the characteristic pathological feature of AD. 
The presence of intracellular neurofibrillary tangles that consist of tau protein is also 
correlated with Aβ. It has been suggested that these neurofibrillary tangles are formed 
after and likely as a consequence of APP processing to release Aβ (Hardy and Selkoe 
2002; Lewis et al. 2001). Moreover, genetic evidence has been reported to strongly 
support that Aβ is responsible for AD. It has been demonstrated that the epsilon4 allele 
of apolipoprotein E (APOE) represents the major genetic risk factor for AD, and can 
affect Aβ metabolism (Kim et al. 2009). Support for the amyloid hypothesis has been 
provided by the identification of APP mutants that leads to either over production of Aβ 
or increase Aβ inherent propensity to aggregate (Kim and Hecht 2008). In addition, 
mutations in the presenilin proteins PS1 and PS2, part of the γ-secretase complex that 
cleaves APP in a typical site to form Aβ, can also cause AD (Cruts and Van 
Broeckhoven 1998; De Strooper 2007; Xia et al. 2000). The majority of AD cases are 
sporadic with onset of symptoms correlating with increasing age (Chiti and Dobson 
2006). However, in early-onset cases, AD can be hereditary and is due to mutations that 
lead to either over production of Aβ by APP or produce a higher ratio of Aβ42 to Aβ40 
(Walsh and Selkoe 2007), where Aβ42 found to be much more fibrillogenic (Jarrett et 
al. 1993). 
 
The Aβ peptide is normally formed in all individuals although it is found to be 
responsible in large part for the pathogenesis of AD due to its ability to aggregate and 
form oligomeric species, i.e. dimers, trimers and higher level oligomers, which are 
neurotoxic and cause neuronal death (Lesné et al. 2013; Roher et al. 1996; Walsh et al. 
2002; Zhang et al. 2012). The oligomeric Aβ is further aggregated into amyloid plaques, 
the common pathogenic hallmark of AD, and this process is considered as a scavenging 
process (Zhang et al. 2012). 
 
According to the amyloid cascade hypothesis, Aβ is principally responsible for many of 
the pathological characteristic of the disease (Hardy and Higgins 1992; Sakono and 
Zako 2010). Over recent years it has become widely accepted that oligomeric Aβ 
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species are neurotoxic rather than Aβ fibrils (Hayden and Teplow 2013; Kayed and 
Lasagna-Reeves 2013; Klein 2006; Lesné et al. 2013). The classic amyloid cascade 
hypothesis for AD (Hardy and Selkoe 2002) was updated to a new "oligomer-driven" 
amyloid hypothesis (Figure 1-11) (Klein 2006). This hypothesis is strongly supported 
by many observations. Many Aβ oligomers have been extracted and isolated from brain 
tissue of both human AD and animal AD models (Shankar et al. 2008; Walsh et al. 
2002; Walsh and Selkoe 2007). Also, it has been shown that Aβ oligomers that are 
prepared in vitro are neurotoxic (Atwood et al. 2004). However, the identity and 
structural composition of these in vivo oligomeric species and what is making them 
stable has not yet determined. One hypotheses is that Aβ monomers may interact by 
covalent cross-linkage or strong ionic interactions to form these oligomers (Atwood et 
al. 2004; Drew et al. 2013; Naylor et al. 2008), and this is central to the work in this 
thesis.  
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Figure 1-11: A new oligomer-driven amyloid cascade hypothesis for AD. Adapted from (Klein 2006). 
 
 Parkinson’s disease and α-syn 1.5.2
Parkinson’s disease (PD) is the most common neurodegenerative motor disorder, and 
the second most common progressive neurodegenerative brain disorder of humans, after 
AD. Clinically, PD is characterised by severe movement symptoms including 
uncontrollable resting tremor, muscular rigidity, impaired postural reflexes, and 
bradykinesia, which vary from patient to patient (Recchia et al. 2004). The pathological 
hallmark of PD is degeneration of dopaminergic neurons in the substantia nigra and this 
is accompanied by intracellular accumulation of filamentous α-syn protein into Lewy 
bodies in the surviving dopaminergic neurons and other affected regions of the central 
nervous system as shown in Figure 1-12 (Davie 2008; Recchia et al. 2004). However, 
the mechanism underlying the deposition of α-syn fibrils into Lewy bodies is not fully 
Oligomer-initiated Amyloid Cascade Hypothesis 
Increased Aβ42 production and accumulation 
Aβ42 oligomerisation and accumulation in a 
regionally-specific manner 
Oligomers as ligands attack synapses critical for 
memory formation (diffuse plaques) 
Impact on synapse signaling , shape, and stability 
Neuronal/neuritic dysfunction; Memory loss/Mild 
cognitive impairment 
Microglial and astrocytic activation 
(complement factors, cytokines, etc.) 
Restructuring oligomers into fibrils 
(dense core plaques) 
Altered neuronal ionic homeostasis; oxidative injury 
Altered kinase/phosphatase activities  tangles  
Widespread cell death with transmitter deficits 
 
 
 
 
 
 
 
 
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defined. It has been revealed that familiar or inherited forms of PD are linked to the 
mutation of genes coding α-syn, i.e. SNCA (Hardy et al. 2009; Stefanis 2012).  
 
 
Figure 1-12: Immunohistochemical image showing neuron containing a Lewy body found within the 
substantia nigra, the pathological hallmark of PD. Reproduced from 
(http://www.virtualmedstudent.com/links/neurological/parkinsons.html). 
 
α-syn is a soluble and predominantly neuronal protein that is abundantly expressed at 
presynaptic terminals in the central nervous system (Stefanis 2012). α-syn consists of 
140 amino acids with molecular weight of 14.5 kDa and has three distinct regions 
(Figure 1-13): the highly conserved N-terminal domain of α-syn (1−65), the central 
hydrophobic domain of α-syn (61−95) is known as the non-Aβ component of plaques 
(NAC) and the acidic negatively charged C-terminal domain (96−140) (Recchia et al. 
2004; Stefanis 2012).  
 
 
 
Figure 1-13: Schematic showing structure of α-syn showing the three distinct domains. 
 
 
 
1 140 
95 61 
Acidic C-terminal 
NAC domain necessary for aggregation 
Repeat 1 Repeat 2 Repeat 3 Repeat 4 Repeat 5 Repeat 6 
(Apolipoprotein motifs) 
Amphipathic α-helical domain 
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The N-terminal domain of α-syn contains six apolipoprotein motifs that may bind lipids 
to form amphipathic α-helices (Stefanis 2012). It has been demonstrated that lipid 
environments enhance the ability of α-syn to form an α-helical conformation by the 
interaction with negatively charged phospholipids, indicating that α-syn may normally 
be membrane associated (Davidson et al. 1998; Eliezer et al. 2001). It has been 
demonstrated that mutations in the N-terminal domain at position 53 (A53T) and 30 
(A30P) are associated with early-onset, familial PD.  Mutant α-syn has been shown to 
adopt a random coil state that facilitates self-assembly (Clayton and George 1999; 
Kruger et al. 1998). Moreover, these mutations have been found to increase the rate of 
α-syn oligomerisation and make it more prone to aggregation and fibril formation 
(Rochet et al. 2000). 
 
The hydrophobic NAC domain, which is the second main component of amyloid 
plaques in AD, represents the amyloidogenic region of α-syn that is responsible for 
amyloid fibril formation (Giasson et al. 2001). It has been shown that deletion or 
disruption of this domain blocks the ability of α-syn to form amyloid fibrils (Giasson et 
al. 2001). 
 
The acidic C-terminal domain consists primarily of acidic amino acids and exhibits a 
strong negative charge and does not show any distinct structural conformation (George 
2002). Unlike N-terminal and NAC domains, C-terminal domain is highly variable in 
size and in sequence (Lavedan 1998). Several phosphorylation sites have been 
identified in the C-terminal domain including Tyr125, -133, and -136, and on Ser129 
(Negro et al. 2002). It has been reported that Tyr125 residue can undergo 
phosphorylation by two Src family protein tyrosine kinases, c-Src and Fyn (Ellis et al. 
2001; Nakamura et al. 2001), although it has been shown that phosphorylation by Src 
family of kinases does not suppress or promote the propensity of α-syn to aggregate.  
 
A cascade of events involving misfolding or α-syn dysfunction can be triggered by 
various environmental and genetic factors, and this in turn may lead to dopaminergic 
cell loss and PD. It is believed that the α-syn toxic species are responsible for neuronal 
dysfunction and death and ultimately PD. Many studies have been carried out to 
Chapter 1 
 
23 
identify these species. However, the mechanism by which α-syn induces neuronal cell 
toxicity is not well understood. Like AD, soluble oligomeric α-syn species are 
suggested to be the toxic species rather than fibrillar α-syn. Moreover, it has been 
suggested that amyloid aggregates may serve as a reservoir for these oligomeric forms 
(Marques and Outeiro 2012). The neurotoxicity of oligomeric α-syn species has been 
assessed in vivo using animal models of PD (Karpinar et al. 2009; Winner et al. 2011). 
Variants of α-syn that enhance oligomer formation were designed and tested for their 
toxicity in vivo. For example, it has been shown that over-expression of α-syn mutants 
that are less fibrillogenic leads to increased toxicity in Caenorhabditis elegans and 
Drosophila models (Karpinar et al. 2009).  
 
 Metal(ions(and(neurodegenerative(diseases(1.6
 Introduction 1.6.1
An enormous number of biochemical reactions in the brain utilise metal ions, such as 
copper, zinc and iron. Similarly, redox-active metal ions are essential for antioxidant 
defences such as cytochrome c oxidase and superoxide dismutase 1 (Cu), haemoglobin 
(Fe), and superoxide dismutase 2 (Mn) (Kozlowski et al. 2012; Strozyk and Bush 2006). 
However, abnormal interactions of proteins with metal ions mediate different 
neurodegenerative diseases such as AD and PD. Two basic mechanisms have been 
described to explain abnormalities in metal ion biochemistry in the brain (Strozyk and 
Bush 2006). First, “protein aggregation mediated by metal ions”, and second, “oxidative 
reactions catalysed by redox-active metals” (Strozyk and Bush 2006). Inappropriate 
electron transfer from redox-active metals, such as copper and iron to a protein can lead 
to generation of reactive oxygen species (ROS), free radicals and nitrogen species 
(Strozyk and Bush 2006). The metallobiology of neurodegenerative diseases have been 
extensively studied and reviewed (Bush 2003b; Kozlowski et al. 2006; Kozlowski et al. 
2012; Roberts et al. 2012; Viles 2012). The transfer of metal ions through the blood-
brain barrier is tightly regulated. Many transporters, enzymes and chaperones strictly 
control metal uptake and delivery to its correct site in the brain, regulating the metal 
content and preventing a passive metal fluctuation from the environment to the brain 
(Outten and O'Halloran 2001). Thus, the homeostatic failures of the endogenous content 
of metals in the brain are associated with many neurodegenerative diseases. It is well 
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known that the brain has the highest metabolic rate of any tissue and requires oxygen 
for aerobic metabolism (Strozyk and Bush 2006). Several proteins are involved in the 
maintenance of copper homeostasis, including copper transporters and metal chaperones 
(Cerpa et al. 2005). If metal chaperones do not work effectively, the concentrations of 
free redox-active metal ions will increase in the brain, and this may increase the 
vulnerability of brain tissue to radical attack. ROS generation by redox-active metals 
and its consequences are shown in Figure 1-14. 
 
 
Figure 1-14: Simplified diagram showing ROS generation by redox-active metals. Redox-active metal 
ions such as Cu and Fe ions in their reduced state (Mx−1) can reduce dissolved molecular oxygen (O2) to 
superoxide O2 −, which is then enzymatically converted to H2O2. H2O2 is freely permeable across lipid 
membranes and can react with encountered Mx−1 to generate the highly reactive hydroxyl radical (OH •), 
which reacts with the adjacent substrates and generates a variety of oxidative damage species that has 
been observed in neurodegenerative disorders such as AD and PD. Adapted from (Strozyk and Bush 
2006). 
 
ROS and free radicals can be generated through sequential processes that involve 
reduction of molecular oxygen (O2) by redox-active metals in their reducing state 
(Mx−1) to form superoxide (O−2 ), which is then converted to H2O2 (Figure 1-14). The 
metal catalysed generation of H2O2 has been considered to play a role in 
neurodegenerative diseases characterised by protein aggregation such as AD and PD 
(Strozyk and Bush 2006). The protein oxidation and oxidative stress in 
neurodegenerative diseases has been studied and reviewed extensively (Eskici and 
Axelsen 2012; Jomova et al. 2010; Mariani et al. 2005; Moreira et al. 2007; Pennathur 
et al. 1999b; Smith et al. 1996; Souza et al. 2000), highlighting that oxidative protein 
modification is implicated in the pathogenesis of AD and PD. 
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 Alzheimer’s disease  1.6.2
Transition metal ions have been frequently reported to be involved in the pathogenesis 
of AD, PD and prion diseases (Bush 2003b; Huang et al. 2004a; Kozlowski et al. 2006; 
Strozyk and Bush 2006; Viles 2012). High concentrations of zinc, copper and iron have 
been observed in amyloid plaques from AD brains (1 mM, 400 µM and 1 mM, 
respectively) (Lovell et al. 1998). Also, it has been found that levels of copper and zinc 
in the cerebrospinal fluid (CSF) of patients affected by both AD and PD are two or three 
fold higher than control levels (Hozumi et al. 2010). Accumulation of iron is also 
reported in the brain of both AD and PD (Barnham and Bush 2008; Stankiewicz et al. 
2007). It has been revealed that Aβ is a metalloprotein and appears to have both low and 
high affinity for copper and zinc (Atwood et al. 1998; Atwood et al. 2000; Bush et al. 
1994a). 
 
Induction of Aβ accumulation by zinc in AD has been reported by Bush et al. (Bush et 
al. 1994b). AD studies using Tg2576 transgenic mice as a model for AD showed that 
genetic ablation of zinc transporter 3 (ZnT3), the protein required for transporting and 
concentrating zinc into synaptic vesicles, leads to significant reduction in Aβ deposition 
(Friedlich et al. 2004; Lee et al. 2002). Recently, it has been found that zinc transport 
capacity is modulated by the dimeric state of ZnT3 (Salazar et al. 2009), explaining that 
dityrosine cross-linked ZnT3 dimeric species, which are formed in response to H2O2, 
are the likely ZnT3 functional states, indicating the important role of oxidative stress in 
the pathogenesis of AD. 
 
Bush suggested a sequence of biochemical processes leading to AD as shown in Figure 
1-15: (1) Copper and iron cellular levels increase with increasing age in the brain cortex 
(Maynard et al. 2002), and this will result in overproduction of APP and Aβ in order to 
suppress the cellular elevation of metal ion levels (Rogers et al. 2002). Under slightly 
acidic conditions Aβ becomes hypermetalled (Bush 2003b), copper and iron bind Aβ 
and Aβ-chelated zinc is totally displaced by copper and iron (Atwood et al. 1998; 
Atwood et al. 2000; Nair et al. 2010). (2) Some hypermetallated Aβ species can 
catalytically generate H2O2 from O2 in the presence of biological reducing agents that 
help to recycle metal ions (Opazo et al. 2002). (3) The resulting H2O2 can oxidise Aβ-
copper complexes and form oxidised and cross-linked Aβ species that are liberated 
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from the membrane and also exhibit protease resistance (Atwood et al. 2004). (4) These 
oxidised Aβ species represent the major components of amyloid plaque deposits (Al-
Hilaly et al. 2013; Head et al. 2001). The soluble Aβ can be precipitated in the presence 
of high concentration of zinc, which is released close to the synapses. Thus, plaques 
contain a mixture of Aβ complexes with zinc, copper and iron. (5) Microglial activation 
can be initiated by oxidised Aβ. It has been revealed that high concentration of H2O2 
and myeloperoxidase can be produced by activated microglial cells (Giulian et al. 1998; 
Reynolds et al. 1999), and this in turn supplies further H2O2 outside the cortical cells. 
(6) H2O2 can easily cross the cellular membrane into cellular compartments and react 
with redox-active metal ions, causing oxidative damage to nucleic acids, proteins and 
lipids that are observed in AD-affected brain tissue (Sayre et al. 2000). 
 
Chapter 1 
 
27 
 
Figure 1-15: Summarised model for the metallobiology of Aβ in AD revealing the suggested sequence of 
biochemical processes leading to AD. Reproduced from (Bush 2003b). 
 
In 1934, Haber and Weiss proposed that the highly reactive hydroxyl radical could be 
generated from an interaction between superoxide and hydrogen peroxide, which has 
known then as the Haber-Weiss reaction (Haber and Weiss 1934). Thermodynamically, 
Haber-Weiss reaction is unfavourable in biological systems, and has a second order rate 
constant of zero in aqueous solution as reported by Kehrer (Kehrer 2000). However, 
Haber and Weiss discussed the ability of iron salts to serve as catalysts in this reaction, 
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and they illustrated that two chemical steps can be involved to give the net reaction of 
hydroxyl radical formation (Reaction 3). 
 
 
 
Many oxidative markers have been found in AD and reported that they can be formed 
according to Fenton reaction (Reaction 2) that includes the reaction of Fe or Cu in their 
reduced forms with H2O2 to form hydroxyl radicals that show high chemical activity 
and can attack many macromolecules, such as proteins, lipids and nucleic acids, and 
generate lipid peroxidation products, protein carbonyl modifications and nucleic acid 
adducts. All these oxidative modification products are characteristic of AD 
neuropathology (Smith et al. 1996; Smith et al. 1997). It has been elucidated that 
biological reducing substances, such as cholesterol and long-chain fatty acids, are 
required to recycle the redox-metal ions (Barnham et al. 2004; Smith et al. 2006a). 
Moreover, it has been reported that lipid oxidation products, such as oxysterols and 4-
hydroxynonenal, are increased in AD brain tissue and mouse models of the disease 
(Haeffner et al. 2005; Opazo et al. 2002; Smith et al. 2006a). 
 
Many amino acids in Aβ can be copper-induced oxidised by H2O2 to form different 
oxidative products. Copper can catalyse the oxidation of methionine at position 35 to 
form methionine sulfoxide and methionine sulfone (Ali et al. 2005; Ciccotosto et al. 
2004). Intermolecular histidine bridges have been formed in the presence of copper 
(Smith et al. 2006a). The tyrosine residue at position 10 has been oxidised using an 
copper/H2O2 oxidation system to many different oxidised products including 
nitrotyrosine and dityrosine, and many of them have been assessed in AD brain tissue 
and also in the CSF (Abdelrahim et al. 1997; Atwood et al. 2004; Barnham et al. 2004; 
Hensley et al. 1998; Smith et al. 2007; Yoburn et al. 2003). Different Aβ isoforms have 
been found to have different redox activity, and shown the following order Aβ42human > 
Aβ40human >> Aβ40mouse ~ 0 (Huang et al. 1999b). Similarly, different Aβ forms exhibit 
Fe3+ + O2−    Fe2+ + O2                             [1] 
Fe2+ + H2O2 Fe3+ + OH− + OH
.       [2]  
O2− + H2O2 " O2 + OH− + OH
.        [3]          
Fenton reaction 
Haber-Weiss reaction 
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different neurotoxicity in neuronal cultures which could be attributed to the variation in 
the redox activity behaviors of these Aβ forms that bind copper differently (Huang et al. 
1999b; Opazo et al. 2002). It has been observed that chelators such as clioquinol can 
significantly reduce the neurotoxicity of Aβ in cell culture by extraction of metal ions 
(Puglielli et al. 2005). 
 
  Parkinson’s disease  1.6.3
The involvement of metal ions in the pathogenesis of PD has been investigated and 
reviewed extensively (Barnham and Bush 2008; Kienzl et al. 1995; Kozlowski et al. 
2012; Sian-Hulsmann et al. 2011). Zinc and iron accumulation in the substantia nigra 
has been observed, whereas copper has been found to decrease (Barnham and Bush 
2008). It has been revealed that the elevation of iron may play a role in the oxidative 
stress and loss of dopaminergic neurons and also may contribute to the deposition of 
Lewy bodies (Barnham and Bush 2008; Kaur et al. 2003). This was essentially 
supported by in vivo observations in PD animal models showing that using iron 
chelators protect against and/or prevent PD (Kaur et al. 2003; Youdim et al. 2004; Zhu 
et al. 2007). Similarly, the overexpression of iron-sequestering ferritin is able to protect 
and/or prevent the death of dopaminergic neurons in PD animal models (Kaur et al. 
2003). 
 
It is well established that α-syn is a metalloprotein and in vitro is found to interact with 
zinc, copper and iron with different affinities (Barnham and Bush 2008; Brown 2009; 
Valiente-Gabioud et al. 2012). The interaction of α-syn with these metal ions leads to 
protein aggregation and covalent cross-linking (Cole et al. 2005; Paik et al. 1999; Paik 
et al. 2000). A number of in vitro studies have shown that α-syn fibrillisation 
accelerated in the presence of some metal ions such as Cu2+ (Binolfi et al. 2010; Paik et 
al. 1999; Uversky et al. 2001; Yamin et al. 2003). However, it is important to know that 
most of these studies have used high concentrations, i.e. millimolar, of both α-syn and 
metal ions, and this would not reflect the physiological relevance of these ions. 
Interestingly, Rasia et al. have found that in vitro incubation of α-syn with Cu2+ at 1:1 
molar ratio using a physiologically relevant concentration (100 µM) significantly 
enhanced α-syn fibrillisation by reducing the lag-time of α-syn fibrillisation (Rasia et 
al. 2005). By contrast, the other metal ions, such as Fe2+, Mn2+, Co2+ and Ni2+, hardly 
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effect the α-syn fibrillisation using (1:1) metal: α-syn ratios (Binolfi et al. 2006). The 
enhancement of α-syn fibrillisation by Cu2+ was attributed to the formation of a α-syn-
Cu2+ complex (Binolfi et al. 2010). The coordination of copper ions to α-syn has been 
investigated and the results revealed that α-syn has three binding sites. Two strong 
anchoring sites are located in N-terminal domain and corresponding to Met1 and His50, 
while the third anchoring site, which is weak and nonspecific, is located in C-terminal 
domain (Ahmad et al. 2012; Rasia et al. 2005). 
 
Recently, the neurotoxicity of oligomeric α-syn species has been tightly correlated with 
the interaction of copper with α-syn (Wang et al. 2010; Wright et al. 2009). The toxicity 
of α-syn was assessed in the presence of copper using cell culture, and the results 
revealed that only the oligomeric α-syn species is neurotoxic and requires the presence 
of copper but not iron (Wright et al. 2009). Using a cell culture, another study showed 
that copper has a critical role in both α-syn aggregation and localisation, compared to 
iron, which did not show any significant role in the aggregation formation and 
localisation (Wang et al. 2010). Reduction in copper levels was found to highly 
decrease the oligomer formation in the cells and also α-syn became more localised to 
the plasma membrane. Interestingly, these changes were reversed when copper was 
restored to the cell, indicating that copper ions palys a vital role in the toxicity of α-syn 
oligomers (Wang et al. 2010). 
 
 Lipofuscin(and(AD(pathogenesis(1.7
In 1912 the term "lipofuscin" was used for the first time (Hueck 1912), which originates 
from Greek lipo (for fat) and Latin fuscus (for dark). It is a complex matrix of oxidised 
proteins and lipid peroxidation products, along with lesser amounts of carbohydrates 
and metals (Porta 2002; Terman and Brunk 1998b, 2004). Iron is the major component 
of the metal content in lipofuscin (Brunk 1989), also copper and zinc have been found 
in lipofuscin (Elleder 1981; Gutteridge 1984). Chemical analysis of isolated lipofuscin 
pigments reveals that protein content represents 30 − 70% of the lipofuscin, while lipid 
represents 20 − 50% as reviewed in many studies (Brunk and Terman 2002; Terman 
and Brunk 1998b). It has been reported that carbohydrates represent only 4 − 7% of 
lipofuscin composition (Terman and Brunk 1998b). Proteomic and ultrastructural 
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analysis of human lipofuscin had identified over 160 proteins and revealed a 
heterogeneous core structure composed of lipofuscin granules which are surrounded by 
substantial extra-granular material (Gugiu et al. 2005). 
 
Lipofuscin is hydrophobic and insoluble yellow-brown pigment that accumulates in the 
nervous system of animals and it is more abundant in aged individuals than in young 
ones, therefore it is called ''aging pigment" (Szweda et al. 2003; Terman and Brunk 
1998a; Terman and Brunk 1998b). Lipofuscin is considered to be a biomarker of aging 
and the age-dependent accumulation of lipofuscin in the nervous system of individuals 
has made reliable estimation of absolute age possible. Currently, lipofuscin is defined 
operationally rather than structurally due to its complex chemical composition. 
Morphologically, lipofuscin inclusions appear yellow-brown under light microscopy, 
with variation in the amounts, intensity, and shade. Under light microscopy, lipofuscin 
is observed as a homogeneously dark mass with irregular shape and surrounded by a 
100 nm thick lysosomal membrane (Double et al. 2008). 
 
Auto-fluorescence is the most characteristic property of lipofuscin pigment, with an 
excitation wavelength around 400 nm and a broad range of emission maxima between 
530 and 650 nm (Porta 2002). The wide range of the emission is due to the differences 
in the sources of lipofuscin. However, although the nature of the auto-fluorescence 
substances that are responsible for the auto-fluorescence feature of lipofuscin is not yet 
completely known, evidence suggests that various fluorophores can be formed as a 
result of reactions between carbonyls (mainly aldehyde, produced by lipid peroxidation) 
and amino compounds (Brunk and Terman 2002). 
 
Two mechanisms have been suggested to explain cellular lipofuscin formation (Brunk 
and Terman 2002; Terman and Brunk 1998b): 
 
1- Age-dependent (unrelated) mechanism: In postmitotic cells, when the 
autophagocytosed material cannot be completely eliminated through lysosomal 
degradation or by exocytosis, this will result in lipofuscin formation by conversion of 
these indigestible material into lipofuscin, and the rate of the lipofuscin formation will 
be higher than its elimination rate. According to this mechanism, lipofuscin will 
accumulate more or less linearly with time. 
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2- Age-dependent (related) mechanism: Lipofuscin can be accumulated as a result of 
age-related changes in lysosomal function, such as inhibition of lysosomal enzymes, 
enhanced autophagocytosis, and/or decreased exocytosis. Formation of lipofuscin 
would be likely to be exponential.  
 
As described in section 1.6.2, oxidative stress is widely implicated in AD pathogenesis 
and also represents one of the biological pathways by which Aβ can be accumulated in 
the lysosomes. There is a great body of evidence that confirms the involvement of 
oxidative stress in lipofuscin pigment accumulation over age progression. It seems that 
the autophagocytosis of mitochondria is the major contributor to lipofuscin formation 
(Figure 1-16) (Collins et al. 1980). Although ROS, such as hydrogen peroxide, 
superoxide anion, and hydroxyl radical, can be formed from different in vivo sources 
(e.g. auto-oxidation, photochemical, and enzymatic reactions), mitochondria represent 
the main in vivo source of ROS formation (Chance et al. 1979; Loschen et al. 1971). At 
the same time, the mitochondrion is the main target of ROS attack (Harman 2002), 
resulting in the formation of peroxidised, undegradable macromolecules. Recently, 
Murakami and Shimizu have clarified the role of cytoplasmic superoxide radical as a 
possible contributing factor to intracellular Aβ oligomerisation in AD (Murakami and 
Shimizu 2012). It also has been suggested that intraneuronal Aβ oligomers cause 
neuronal death by activating endoplasmic reticulum stress, endosomal/lysosomal 
leakage and mitochondrial dysfunction (Umeda et al. 2011).  
 
In the same manner to iron ions, many transition metals, such as copper, can catalyse 
the hydroxyl radical generation. Hydrogen peroxide, an example of ROS, can easily 
diffuse into lysosomes and react with iron ions released from the degradation of 
different metalloproteins during their intralysosomal degradation. The interaction of 
hydrogen peroxide with iron ions results in the formation of the highly reactive 
hydroxyl radicals. The latter would attack intralysosomal macromolecules, such as Aβ, 
causing cross-linking of these materials and leading to lipofuscin formation (Figure 
1-16). The oxidative modification specially cross-linking of autophagocytosed material, 
is the most probable cause of non-degradability of these materials.  
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Figure 1-16: Schematic mechanism of lipofuscin formation in the lysosome. In mitochondria, hydrogen 
peroxide is generated from superoxide anions, a byproduct of mitochondria respiration. In the presence 
of ferrous ion, hydrogen peroxide can be converted into hydroxyl radical that attacks surrounding 
macromolecules and leads to oxidative modification. Red dots represent the oxidatively damaged 
undegradable macromolecules. LE is lysosome enzymes. Reproduced from (Brunk and Terman 2002). 
 
The excessive accumulation of these non-digested materials could result in 
endosomal/lysosomal leakage and, as a consequence, acid hydrolases will be released 
causing cell death. In support of this hypothesis, it has been shown that the inhibition of 
lysosomal proteases would dramatically enhance the effect of oxidative stress on 
lipofuscin formation, leading to delay in the degradation of autophagocytosed 
substances and allowing more time for its oxidation (Terman and Brunk 1998a). On the 
other hand, lipofuscin accumulation has been shown to be retarded by the iron chelator 
desferrioxamine, and many antioxidants including vitamin E, selenium, and glutathione 
(Terman and Brunk 1998b). Vitamin E deficiency is associated with increased 
lipofuscin accumulation (Moore and Wang 1947). 
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 Dityrosine(cross>linkage(1.8
Dityrosine is a tyrosine dimer that results from the ortho-ortho coupling of two tyrosyl 
radicals (Figure 1-17). It has a strong fluorescence emission maximum at 410 nm upon 
excitation at 285 − 325 nm depending on the pH of the solution (Abdelrahim et al. 
1997). Dityrosine was initially recognised in 1955 by Gross and Sizer (Gross and Sizer 
1955), who described the in vitro formation of dityrosine by peroxidase oxidation of 
tyrosine in the presence of H2O2. Previous work had established that peroxidase 
enzymes can catalyse the oxidation of phenols and aromatic amines by hydrogen 
peroxide (Elliott 1932). Later, it was revealed that mechanism of diphenyl compound 
production involved free radical formation as intermediates (Waters 1952). Based on 
these observations, Gross and Sizer suggested that dityrosine formation was achieved 
through generation of tyrosyl radical as an intermediate (Gross and Sizer 1959). The 
subsequent studies mainly focused on the native role of dityrosine in many elastic 
natural materials and also in invertebrate tissues. Dityrosine was found in resilin, the 
rubber-like protein found in arthropods (Andersen 1964), and this represents the first 
documentation of the natural occurrence of this cross-linker in proteins, explaining that 
its function was to stabilis resilin through formation of a stable three dimensional of 
network (Andersen 1964). It has been reported that dityrosine cross-links occur 
naturally in several elastic and structural proteins including elastin, fibroin, keratin, 
cuticlin, and collagen (Fujimoto 1975; Labella et al. 1967; Raven et al. 1971; Waykole 
and Heidemann 1976). In these proteins, dityrosine cross-links can contribute to 
increasing the mechanical strength and subsequently their insolubility (Skaff et al. 
2005).  
 
 
Figure 1-17: Chemical structure and molecular formula of dityrosine produced using Chemdraw ultra 8. 
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Moreover, it is believed to play a protective role in proteins (Bailey 1991; Kanwar and 
Balasubramanian 1999). Dityrosine cross-linking has also been implicated in the 
biosynthesis of thyroxine and melanin (Bayse et al. 1972). Additionally, dityrosine has 
been found in fungal cell wall proteins (Smail et al. 1995), the fertilization envelope of 
the sea urchin egg (Foerder and Shapiro 1977), Ascaris suum (Fetterer et al. 1993), and 
insect eggs (Li et al. 1996). Recently, many publications have demonstrated the 
dityrosine native role in many elastic and structural proteins (Dalsgaard et al. 2011; 
Fenaille et al. 2004; Hanft and Koehler 2005). Chakraborty et al. (Chakraborty et al. 
2010) have recently investigated the formation of dityrosine in the DNA binding 
domain of the regulatory factor X5. 
 
 Physiological(mechanisms(of(dityrosine(formation(in(oxidatively(1.9
damaged(proteins(
DiMarco and Giulivi (DiMarco and Giulivi 2007) reported that the mechanisms of 
dityrosine formation in oxidatively damaged proteins begin with the generation of a 
tyrosyl radical and this is consistent with reports from Atwood et al. (Atwood et al. 
2004). The production of dityrosine involves the ortho-ortho cross-linkage of two 
tyrosyl radicals (Figure 1-18). Consequently, protein dimers are formed and can be 
detected as protein dimers by Sodium Dodecyl Sulphate-Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) under reducing conditions (Giulivi and Davies 2001; 
Giulivi et al. 2003). 
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Figure 1-18: The mechanism of dityrosine formation in oxidatively damaged proteins begins with the 
generation of a tyrosyl radical, which then undergo radical isomerisation followed by diradical coupling, 
and finally tautomerisation. 
 
Tyrosyl radicals can be generated by different mechanisms. Atwood et al. (Atwood et 
al. 2004) demonstrated two biochemical mechanisms for the generation of tyrosyl 
radicals and subsequently dityrosine cross-links: metal-catalysed oxidative and 
peroxidase-mediated tyrosyl radical formation. 
 
Pre-existing Cu2+-tyrosinate complexes react with H2O2 to produce species that have 
phenoxy radical like character, which subsequently undergo bimolecular coupling. 
Alternatively, Barnham et al. (Barnham et al. 2004) revealed that the Aβ peptide 
coordinates Cu2+ to form an Aβ-Cu2+ complex. In turn, the Aβ-Cu2+ complex is able to 
produce H2O2 catalytically in the presence of a reducing substrate such as ascorbate and 
underling this process, tyrosine radicals are generated, which are later coupled and 
result in Aβ aggregation. Another oxidative mechanism of proteins involves peroxidase-
mediated tyrosyl radical formation (Atwood et al. 2004; Leeuwenburgh et al. 1997b; 
Marquez and Dunford 1995; Takasaki et al. 2005). Dityrosine can be generated by 
coupling of two tyrosyl radicals, which are generated by peroxidase.  
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 Dityrosine(as(a(biomarker(of(oxidative(stress(and(its(pathological(1.10
role(in(diseases(
Although dityrosine cross-links are formed naturally in many proteins for strength and 
protective purposes, the formation of dityrosine cross-links in proteins has also been 
implicated in many diseases, including AD and PD (Atwood et al. 2004; Souza et al. 
2000), cystic fibrosis (Van Der Vliet et al. 2000), atherosclerosis (Leeuwenburgh et al. 
1996), and cataracts in the eye lens (Bodaness and Zigler 1983; Wells-Knecht et al. 
1993). It has been reported that dityrosine cross-links in γb-crystallin, calmodulin, 
ribonuclease A, and bovine serum albumin (BSA) resulted in protein denaturation and 
enhanced precipitation (Kanwar and Balasubramanian 1999, 2000; Yoburn et al. 2003). 
 
It is also noteworthy that dityrosine can be formed in several proteins as a result of 
exposure to ROS, UV and γ−irradiation, aging, nitrogen dioxide, and lipid 
hydroperoxides (Giulivi and Davies 1993, 1994; Kato et al. 1994), and this may cause 
changes in the solubility, elasticity, and conformation of the cross-linked proteins 
(Souza et al. 2000). DiMarco and Giulivi (DiMarco and Giulivi 2007) reported that 
tyrosine was oxidised to dityrosine in response to oxidative stress by a peroxidase-
catalysed mechanism in chymotrypsin, myoglobin, haemoglobin, and calmodulin. In 
this regard, dityrosine has been used as an important biomarker for the identification of 
oxidative protein damage as well as aging diseases (DiMarco and Giulivi 2007; Giulivi 
and Davies 1994). Suitability of dityrosine as a biomarker for oxidative stress of 
proteins is attributed to its chemical stability. It remains unchanged by exposure to 
oxygen and high pH (DiMarco and Giulivi 2007). Furthermore, it is highly resistant to 
acid hydrolysis and proteases (Amado et al. 1984; Giulivi and Davies 1994).  
 
There has been a focus to investigate the possibility of using dityrosine as a marker of 
oxidative stress in many different diseases. Many analytical methods have been 
developed to enhance the sensitivity and selectivity to measure dityrosine levels with 
low concentration in real biological samples, and they are reviewed by (DiMarco and 
Giulivi 2007). In 1993, dityrosine was considered as an index of organismal oxidative 
stress in urine and red blood cells (Giulivi and Davies 1993).  In 1996, Malencik et al. 
applied isocratic HPLC assay with fluorescence detection to measure underivatised 
dityrosine in vitro (Malencik et al. 1996). Fluorescence HPLC was also used to measure 
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dityrosine in spiked samples of human CSF with detection limit of 60 picogrammes 
(Abdelrahim et al. 1997). Quantitative stable isotope dilution GC-MS assay was used to 
measure dityrosine levels in low density lipoprotein (LDL) that had been isolated from 
atherosclerosis plaques, and revealed a significant elevation of dityrosine levels 
compared to those in free-circulating LDL (Leeuwenburgh et al. 1997a). It has been 
found that dityrosine cross-linked proteins of mouse cardiac and skeletal muscle 
increased with age, and this increase is prevented by caloric restriction (Leeuwenburgh 
et al. 1997b). Isotope dilution GC-MS method, which is modified by Leeuwenburgh et 
al. (Leeuwenburgh et al. 1997a), has been used to quantify urinary dityrosine and o-
tyrosine in children suffering from kwashiorkor (Manary et al. 2000), and the results 
revealed a very significant elevation of dityrosine levels in the affected children 
compared to normal children. Moreover, they suggested that this increase in urinary 
dityrosine levels reflects an increase in oxidative stress rather than an alteration in renal 
excretion of its precursor amino acid, i.e. tyrosine (Manary et al. 2000).  
 
HPLC- electrochemical detection was used to measure dityrosine and nitrotyrosine in 
four specific sections of post-mortem brain tissue from both AD and control subjects 
(Hensley et al. 1998). Also, dityrosine was measured in CSF of AD and control 
subjects. The results revealed that dityrosine levels were elevated markedly in the 
hippocampus and neocortical regions of the AD brain and in ventricular cerebrospinal 
fluid (VF), suggesting that AD pathogenesis may involve the activation of oxidant 
producing inflammatory enzyme systems, including nitric oxide synthase (Hensley et al. 
1998). 
 
Enzyme-linked immunosorbent assay (ELISA) was used to investigate dityrosine in 
lipofuscin pigments from aged human brains (Kato et al. 1998). In this assay, polyclonal 
antibodies raised in rabbits were used to detect dityrosine. The results showed a 
significant elevation of dityrosine cross-links with age and the immunosorbent assay 
suggested “protein oxidation by free radicals and/or peroxidases may play an important 
role in lipofuscin accumulation” (Kato et al. 1998). Subsequently, Kato et al. has 
succeeded in preparing a monoclonal dityrosine antibody (1C3) used to investigate 
dityrosine in atherosclerotic lesions in Apo E deficient mice using 
immunohistochemical techniques, explaining that immunohistochemical techniques 
represent a simple method that provides details about dityrosine prevalence in cells and 
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tissues, preventing the complex sample pretreatment required for GC-MS and HPLC-
electrochemical detection (Kato et al. 2000). 
 
Dityrosine cross-linked Aβ42 dimer was formed and purified in vitro using 
H2O2/peroxidase (Galeazzi et al. 1999). The Aβ dimers were detected by high 
resolution SDS-PAGE electrophoresis, and the identity of dityrosine cross-links was 
confirmed using HPLC with fluorescence detection, suggesting that dityrosine may be 
involved in the formation of the amyloid plaques in AD (Galeazzi et al. 1999). 
 
Electrospray mass spectrometry and a dityrosine specific antibody (1C3) was used to 
investigate the dityrosine role in the Aβ aggregation mechanism in vitro and eventually 
in AD pathogenesis (Atwood et al. 2004). They found that incubation of Aβ with Cu2+ 
at a concentration lower than that in amyloid plaques leads to formation of Aβ 
oligomers that showed SDS-resistance, a characteristic feature of the neurotoxic Aβ 
extracted from Alzheimer’s brain (Walsh and Selkoe 2007). These Aβ oligomers were 
found to give a dityrosine fluorescence signal. Furthermore, they revealed that addition 
of H2O2 significantly promoted dityrosine formation compared to incubation with Cu2+ 
only (Atwood et al. 2004). 
 
Pennathur et al. investigated the use of dityrosine, o-tyrosine and nitrotyrosine as 
markers of oxidative stress in PD using a mouse model (Pennathur et al. 1999a). The 
PD mouse model was produced by injection of 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) 1 day before sacrifice. Dityrosine, o-tyrosine and 
nitrotyrosine in several brain regions were measured and the results revealed dityrosine 
and nitrotyrosine were increased in the striatum and midbrain, but not in brain regions 
resistant to MPTP. Pennathur et al. suggested that oxidative species including hydroxyl 
radicals, tyrosyl radicals or peroxynitrite might mediate the damage caused by MPTP to 
dopaminergic neurons (Pennathur et al. 1999a). Souza et al. have investigated the role 
of dityrosine in intracellular α–syn deposition in the Lewy bodies in PD, (Souza et al. 
2000). Human recombinant α-syn was incubated with nitrating agents and resulted in 
dityrosine cross-linked α-syn oligomers, which showed high stability. HPLC-UV and 
HPLC-fluorescence analysis following acid hydrolysis of resulting oligomers revealed 
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the formation of dityrosine cross-links, suggesting the mediation of oxidative and 
nitrative stress in the pathogenesis of PD (Souza et al. 2000). 
 
 
 Techniques(by(which(to(determine(the(oxidative(and(structural(1.11
modification(of(peptide/protein.(
 
 Liquid chromatography-mass spectrometry (LC/MS) 1.11.1
 Introduction 1.11.1.1
Coupling of MS to chromatographic techniques, such as LC and GC, has always been 
desirable due to high sensitivity and specificity of MS compared to other 
chromatographic detectors such as UV detection. Although the coupling of MS with LC 
is a powerful analytical technique that is used for many analysis applications, progress 
in this area was limited for a long period, and this is because of the relative 
incompatibility of existing MS ion sources with a continuous liquid stream. In 1989, 
Fenn developed the electrospray ion source (Fenn et al. 1989), and this made good 
progress and had an important impact in the application of LC-MS. One of the most 
important applications of LC-ESIMS peptide and protein analysis (Fenn et al. 1989). 
 
 The principle of mass spectrometry 1.11.1.2
The mass spectrometric analysis in general includes three essential steps, ionisation, 
fragmentation, and finally ion analysis (Figure 1-19). The first step in the mass 
spectrometric analysis, i.e. ionisation, is a process of converting the molecule of interest 
to a positively charged ion, which in turn undergoes many fragmentations to form many 
charged fragments. Finally, these ions and fragments are analysed on the basis of their 
mass to charge ratio (m/z) and eventually the resolved ions are detected according to 
their relative abundance.   
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Figure 1-19: Schematic diagram showing mass spectrometric analysis of a molecule. Firstly the analyte 
molecule undergoes ionisation to produce gas phase ion of the molecule, and then this molecular ion 
undergoes fragmentation to form many charged fragment ions. 
The mass spectrometry instrument consists of three major components (Figure 1-20): an 
ion source for producing gas phase ions of the compound under investigation, an 
analyser for separating the gaseous charged ions into their characteristic mass 
components based on their mass to charge ratio (m/z), and finally a detector for 
detecting the resolved ions and recording their relative abundance. All of these 
processes are operated under vacuum. 
 
 
Figure 1-20: An example of mass spectrometry instrument. An electron beam fragments gaseous analyte 
molecule into cations (positively charged ions), and then these ions are accelerated and subsequently 
deflected along a circular path by a magnet. The heaviest particles are deflected less than lightest 
particle and eventually detected based on their relative abundance. Adapted from 
(http://www.mhhe.com/physsci/chemistry/carey/student/olc/ch13ms.html). 
 
 Electrospray ionisation mass spectrometry 1.11.1.3
Both the ionisation and ion analysis processes can be performed using many different 
technologies. Different combinations of these two processes result in various types of 
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mass spectrometers. There are many types of ion source such as electrospray ionisation 
source (ESI), atmospheric pressure chemical ionisation source, and atmospheric 
pressure photo ionisation source. However, this description will focus on electrospray 
ionisation because it is used widely in many different areas in chemical, biochemical, 
pharmacological, and environmental studies. In addition, all of the mass spectra in this 
thesis were collected using an ESI.  
 
In ESI, electrical energy is applied to assist the conversion of ions from solution into the 
gaseous phase before they are subjected to ion analyser. Thus the ESI enhances the 
sensitivity of the MS to detect ions in solution. In addition to the ionic species, neutral 
molecules can be also analysed using ESI-MS. The ionic form of the neutral molecules 
can be produced in solution or in gaseous phase by either protonation or cationisation 
such as metal cationisation.   
 
Typically, the ESI process involves three steps to transfer the molecular ionic forms 
from solution into the gas phase as described in Figure 1-21. The first step is dispersal 
of a fine spray of charged droplets, followed by rapid solvent evaporation by application 
of heating and dry nitrogen, and finally, the residual electrical charge on the droplets 
transfer to the analyte molecule (Gross and Roepstorff 2011; Ho et al. 2003). 
 
 
Figure 1-21: Schematic diagram of electrospray ionisation mechanism. The ionic species of the analyte 
compound can be transferred from the solution into gaseous phase through three main steps.   The 
solution contained ionic species is pumped through a metal capillary tube, which is maintained at 2.5- 
6.0 kV, and then a fine spray of charged droplets is generated at the tip of the tube, followed by solvent 
evaporation and finally charge transferring from the charged droplets to the molecules.  
 
Within an ESI source, a continuous flow of liquid samples is pumped through a metal 
capillary tube, which is maintained at 2.5 to 6.0 kV, and then a mist of charged droplets 
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produced at the tip of the capillary tube, and followed by solvent evaporation under heat 
and nitrogen dry gas. As a result, the charged droplets are continuously reduced in size, 
and finally the charges transfer from the charged droplets to the molecules (Ho et al. 
2003; Pitt 2009). The emitted charged molecules are then accelerated into the mass 
analyser for subsequent analysis of molecular mass and measurement of relative ion 
abundance.  
 
 Tandem quadrupole mass spectrometry (MS/MS) 1.11.1.4
Tandem quadrupole mass spectrometry has been frequently used as a standard 
analytical tool for both GC-MS/MS and LC-MS/MS applications, especially for cases 
where accurate quantitation is desired. Continuous developments have been made for 
tandem quadrupole mass spectrometry to improve its resolution, sensitivity, and the 
covered mass range. A Quadrupole is a mass analyser in which ions are separated using 
an electric field, and typically it consists of four parallel hyperbolical or cylindrical 
metal rods. Each opposing rod pairs are held at the same potential that is composed of a 
DC and an AC component (Gross and Roepstorff 2011; Watson and Sparkman 2007).  
 
Tandem quadrupole also called triple quadrupole simply consists of three quadrupoles 
that are set up linearly as shown in Figure 1-22, in which the first (Q1) and third (Q3) 
quadrupoles are mass-selective, whereas the second quadrupole (Q2) serves as a 
collision cell. The targeted analyte ion, often called the precursor ion, is mass-selected 
by the Q1 and then collided with a collision gas (usually argon) in a Q2, which is 
always operated in the radio frequency (RF) mode. In Q2, the precursor ion undergoes 
further fragmentation and this process is known as collision-induced dissociation (CID). 
The resulting fragmented ions, usually called daughter ions, are related to the molecular 
structure of the precursor ions and can be analysed by a Q3 providing structural 
information of the precursor ions (Banerjee and Mazumdar 2012; Burlingame et al. 
1996; Ho et al. 2003). When a mixture of molecular ions, which have different m/z 
ratios are introduced into Q1, only mass-selected precursor ions are allowed to pass 
through the Q1 into Q2, while the other molecular ions are filtered out. Therefore there 
is no need to purify the sample prior to MS/MS analysis, and this advantage eliminates 
complicated and time-consuming sample purification procedures prior to MS analysis. 
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Figure 1-22: Schematic diagram showing a triple quadrupole MS/MS system. The first quadrupole (Q1) 
and third quadrupole  (Q3) are mass spectrometers and the centre quadrupole (Q2) is a collision cell. 
 
Tandem quadrupole mass spectrometry MS/MS can be operated in four different modes 
(Gross and Roepstorff 2011; Ho et al. 2003) based on Q1 and Q3 operation mode: 
 
1- Product scan (also known as daughter scan): Q1 is static, allowing only the mass-
selected ions of specific m/z ratio to pass through to fragmented in Q2, and then the 
resulting product ions are scanned in Q3 scans.  
 
2- Precursor scan (also known as parent scan): In this mode, a wide range of precursor 
ions is allowed to pass through Q1 to be fragmented in Q2. Whereas, Q3 is static and 
set up to select one unique product ion resulting from CID of a class of precursor ions.  
 
3- Neutral loss: Both Q1 and Q3 are scanned together at a constant difference in m/z 
ratio. This is used to monitor the loss of a neutral fragment for structurally related 
molecules from CID.  
 
4- Multiple reaction monitoring (MRM): Both Q1 and Q3 are static and focus on a 
distinct pair of precursor and product ions. This significantly induces both specificity 
and sensitivity of the MS/MS system and is often used in ESIMS/MS quantification 
analyses. 
 
 Biochemical applications of LC-ESIMS 1.11.1.5
LC-ESIMS is a powerful analytical tool that has been used widely and extensively in a 
wide range of biochemical application. Biochemical genetics was one of the first areas 
that benefitted from LC-ESIMS. Metabolic profiling of amino acids and acylcarnitines 
from blood spots for a range of inborn errors of metabolism have been assessed by 
electrospray tandem mass spectrometry and this was one of the early applications of 
Source Detector 
Q1 Q2 Q3 
Collision gas 
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LC-ESIMS (Rashed et al. 1997). Many books and reviews have reported the 
biochemical application of LC-ESIMS (Gross and Roepstorff 2011; High 2003; Ho et 
al. 2003). Quantification of proteins and peptides can be accurately assessed by LC-
ESIMS, and also post-translational modification and metabolites can be detected and 
quantified using LC-ESIMS (Cutillas and Timms 2010; Johnson and Eyers 2010; 
Lipton and Paša-Tolic 2009), and this can significantly enhance understanding the 
biochemical pathways of many biological systems. In addition to biochemical 
applications, LC-ESIMS has been frequently used in pharmacological, forensic and 
environmental studies to identify and quantify small molecules such as drugs, natural 
metabolites and pesticides (Gross et al. 2012; Jungblut 2012). Applying MS/MS, such 
as MRM, can significantly enhance the specificity of the LC-ESIMS/MS quantification. 
MRM has been frequently used in proteomics identification and quantification (Cutillas 
and Timms 2010; Kiyonami and Domon 2010). The use of MRM for quantitative 
biomarker analysis in proteomics and metabolomics was reviewed in many articles 
(Issaq and Blonder 2009; Kitteringham et al. 2009). 
 
 Fluorescence 1.11.2
 Introduction to fluorescence 1.11.2.1
Fluorescence is a process of absorbing and re-emitting light by a fluorescent molecule, 
i.e. fluorophore, on a timescale of about 10-8 seconds (Lakowicz 1999, 2007). The 
Jablonski diagram is usually used to demonstrate the processes that occur between the 
absorption and emission of light. As shown in the simplified Jablonski diagram (Figure 
1-23), after light absorption, the fluorophore is usually excited to some higher 
vibrational level of either S1 or S2, and then returns to the lower energy level, S0 and 
consequently light is emitted (Figure 1-23). An internal conversion process occurs when 
a fluorophore rapidly relaxes to the lowest vibrational level of S1. This process is 
generally complete prior to emission as it occurs within 10–12 seconds or less (Lakowicz 
2007).  
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Figure 1-23:A Simplified Jablonski diagram showing that photons are absorbed (hvA) and re-emitted 
(hvF) at different wavelengths. S0, S1, and S2 represent the singlet ground, first, and second electronic 
energy levels respectively. At each of these electronic energy levels the fluorophores can exist in a 
number of vibrational energy levels, labelled by 0, 1, 2. The transitions between states are labelled as 
vertical lines. hv represent the photon energy,  and v represents its frequency (Lakowicz 2007). 
 
Fluorescence usually emits from aromatic molecules, such as perylene and quinine. 
Each fluorophore has characteristic excitation and emission wavelengths. Fluorescence 
generally occurs at lower energies, i.e. longer wavelengths, and this is because the 
energy of the emission is less than that of absorption. The difference between the 
excitation and emission wavelengths is called the Stokes Shift (Figure 1-24). The 
Stokes Shift represents a key aspect in the detection of the emitted fluorescence in 
biological applications, as each fluorophore has a distinct characteristic Stokes shift. It 
is important to have a fluorophore with large Stokes shift as using fluorophores with 
very small Stokes will lead to overlap between the excitation and emission wavelengths, 
making the detection much more difficult. 
 
S2 
S1 
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hvF hvA 
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Figure 1-24: General excitation and emission spectra of a fluorophore. The difference between the 
excitation and emission wavelengths is called the Stokes Shift. As much as difference is large, the 
distinction would be easer. 
 
 Fluorophores 1.11.2.2
Generally, fluorophores can be divided into two main classes, intrinsic and extrinsic, 
based on their natural occurrence. Intrinsic fluorophores are molecules that naturally 
fluoresce, such as aromatic amino acids, NADH, flavins, derivatives of pyridoxyl, and 
chlorophyll. Extrinsic fluorophores are synthetic/external molecules that are added to a 
specimen to produce fluorescence when none exists, or to change the spectral properties 
of the specimen. Extrinsic fluorophores include dansyl, fluorescein, rhodamine, ThT 
and numerous other substances (Lakowicz 1999, 2007).  
 
Intrinsic protein fluorescence results from the presence of aromatic amino acids, 
tryptophan, tyrosine, and phenylalanine. They have distinct absorption and emission 
wavelengths as shown in Table 1-2. As shown in the table, the three residues differ 
greatly in their quantum yields and lifetimes.  The fluorescence spectra of the proteins 
containing these three residues are usually dominated by fluorescence from tryptophan. 
This is due to the indole groups in tryptophan that show higher UV absorbance and 
emission compared to the other amino acids (Lakowicz 2007). Phenylalanine emission 
can be observed only when a protein does contain neither tyrosine nor tryptophan 
residues.  
 
Wavelength  
Emission Absorption 
In
te
ns
ity
 
Stokes shift 
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Table 1-2: The table summarises the fluorescence characteristics of aromatic amino acids recorded in 
water at neutral pH. (Lakowicz 2007). 
Amino acid λex 
(nm) 
λex 
(nm) 
Bandwidth 
(nm) 
Quantum 
yield 
Lifetime 
(ns) 
Phenylalanine 260 282 _ 0.02 6.3 
Tyrosine 275 304 34 0.14 3.6 
Tryptophan 295 353 60 0.13 3.1 (mean) 
 
The three aromatic amino acids can serve as intrinsic fluorescent probes for protein 
conformational changes. Tryptophan fluorescence is extremely sensitive to its local 
environment, thus conformational changes of many proteins can be investigated through 
tryptophan fluorescence. Many phenomena such as protein–protein interactions and 
binding of ligands cause in spectral shifts of protein fluorescence emission. A blue shift 
and an increase in intensity of tryptophan emission has been reported upon decreasing 
the solvent polarity (Seidel et al. 1993). This can be interpreted by burial in the 
hydrophobic core of the protein (Giancotti et al. 1980). Predominantly, tyrosine 
emission is quenched in native proteins as a result of its interaction with the peptide 
chain or energy transfer to tryptophan. By contrast, enhanced tyrosine emission is 
observed upon denaturation of proteins (Lakowicz 2007). It has been showed that the 
intrinsic fluorescence of the tyrosine increased by about 400% as the Histone H1 protein 
folds from a random coil to a globular structure (Giancotti et al. 1977). Measurements 
of external quenching by a wide range of quenchers shows higher reduced quenching in 
the folded state as compared to the disordered state, indicate that the tyrosine is a buried 
residue (Giancotti et al. 1977; Giancotti et al. 1980). Tyrosine intrinsic fluorescence of 
Aβ has been widely used to investigate the metal association (Maiti et al. 2008; Syme et 
al. 2004; Tougu et al. 2008). 
 
Tryptophan, tyrosine, and phenylalanine fluorescence has been widely used to probe 
amyloid assembly. The aggregation of a Y39W α-syn variant was investigated using 
intrinsic tryptophan fluorescence as a probe and identified two classes of oligomeric 
intermediates, one formed during the lag period of fibril formation and the other present 
at the end of the process (Dusa et al. 2006). Similar studies of substituted tryptophan 
residue proteins, such as Aβ and β2-microglobulin have been also carried out (Kihara et 
al. 2006; Touchette et al. 2010). Tyrosine intrinsic fluorescence of Aβ has been found to 
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decrease at an early stage of Aβ aggregation, suggesting the possibility to use it as an 
indicator of Aβ aggregation (Rolinski et al. 2010). Recently, intrinsic and quenched 
tyrosine fluorescence has been used to investigate the structural switch from fiber to 
crystal structural of Sup35 yeast prion fragment, GNNQQNY (Marshall et al. 2010). 
Intrinsic phenylalanine fluorescence has been used to probe the fibrillisation of Aβ (16-
20), i.e., KLVFF. 
 
 Thioflavin T fluorescence 1.11.2.3
Thioflavin T, a benzothiazole dye, is widely used to determine the presence of amyloid 
fibrils. Upon binding to amyloid, ThT undergoes a red shift in its emission fluorescence 
maximum from 445 nm to ~ 482 nm (Khurana et al. 2005; LeVine 1993; Vassar and 
Culling 1959). Based on the chemical structure, the ThT dye has a hydrophobic group 
with a dimethylamino group attached to a phenyl group, which is then linked to a more 
polar benzothiazole group containing the polar nitrogen and sulfur (Figure 1-25). The 
presence of polar and hydrophobic groups raises the possibility for ThT molecules to 
form micelles in aqueous solution, in which the positively charged nitrogen pointing 
toward the solvent and with hydrophobic interior.  
 
 
Figure 1-25: Chemical structure of thioflavin T dye. ThT has two different groups in its chemical 
structure, polar and hydrophobic group. 
 
Although many mechanisms have been suggested to explain the binding of ThT to 
amyloid fibrils, the exact molecular mechanism of the ThT binding to amyloids remains 
elusive. It has been suggested that the mechanism underlies the enhancement 
fluorescence ThT involves hydrogen bond formation between charged nitrogen in the 
thiazole group to amyloid fibrils (Kelenyi 1967). Another explanation of the observed 
ThT fluorescence upon binding to amyloid was due to the formation of ThT micelles 
(Khurana et al. 2005), explaining that changes in the excitation spectra and enhanced 
emission fluorescence result upon binding of ThT micelles to amyloid fibrils. ThT 
micelles bound to the surface of amyloid fibrils were observed by atomic force 
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microscopy (Khurana et al. 2005). Recently, it has been suggested that ThT 
fluorescence enhanced upon binding with amyloids may arise from the formation of an 
ThT excimer (dimer or oligomer) localised at the surface of the mature fiber (Sabate et 
al. 2013). Structurally, ThT molecule has a pair of rings, i.e. benzothiazole and 
benzamine that freely rotating around a shared C–C bond (Figure 1-26). The photo-
physical properties of ThT were studied in various solvents and the results indicate that 
the quantum yield of ThT increases with viscosity of the solvent because of the 
impediment of the internal rotation of the two rings (Amdursky et al. 2012; Stsiapura et 
al. 2008). A hindrance of ThT rotational intrinsic movement upon binding to amyloid 
surfaces can result in ThT fluorescence enhancement through stabilisation of the 
fluorescent species (Sabate et al. 2013).  
 
 
Figure 1-26: Structural model showing the ThT rotational intrinsic movement. Adapted from (Robbins et 
al. 2012). Benzothiazole and benzamine rings are freely rotating around a shared C – C bond. 
 
ThT dye has been extensively used to follow amyloid formation due to its selectivity to 
bind amyloid fibrils and not amorphous aggregates (LeVine 1993), and it has been 
considered essential in defining a substance as amyloid (Nilsson 2004). Commonly, 
ThT fluorescence is used to follow kinetics of amyloid formation. However, induced 
ThT fluorescence varies greatly depending on the amyloid precursor of interest and can 
be very low for certain amyloidogenic short peptides (Sabate and Saupe 2007). The pH 
at which ThT is performed strongly affects the affinity of ThT to amyloid fibrils, and it 
has been revealed using pH 8 would greatly increase the affinity of the dye to the fibrils 
(LeVine 1999), thus maximum enhancement will gained. However, basic pH would not 
be always effective to produce amyloid fibrils since many proteins and peptides can not 
form fibrils at basic pH, therefore experiments must be carried out rapidly to avoid fibril 
dissociation (LeVine 1999). Furthermore, ThT dye exhibits great sequence specificity. 
Chapter 1 
 
51 
Sequences that contain aromatic residues, such as tyrosine and phenylalanine, seem to 
induce binding and that is probably due to hydrophobic interactions and π – π stacking 
(Wu et al. 2009). By contrast, the high content of positively charged residues inhibits 
the dye binding (Wu et al. 2009). 
 
 Circular dichroism  1.11.3
 Theoretical principles and instrumentation 1.11.3.1
Circular dichroism (CD) spectroscopy is a biophysical technique that is usually used to 
probe and investigate the secondary structure of peptides, proteins and nucleic acids by 
measuring the difference in the absorption of left and right circularly polarised light 
(Schellman 1975). In peptides and proteins, the asymmetry of the attached chemical 
groups surrounding the α-carbon atom of the amino acid can give rise to chirality, thus 
differential absorption of left and right circularly polarised light will be produced and 
consequently a CD spectrum obtained. Interaction of non-chiral molecules with chiral 
molecules will induce the chirality of the former and lead to CD signal production 
(Rodger 2010; Wallace and Janes 2009). CD can be expressed by the following 
equation: 
 
CD signal = AL – AR  
 
Where AL and AR are the absorption of the left and right circularly polarised light by the 
chiral substance respectively. The CD signal is wavelength dependent and at some 
wavelength the chiral molecules will absorb the left and right handed polarised light to 
different extents and the resulting CD signal could be either positive or negative 
depending on the relative intensity of the absorbance (Wallace and Janes 2009). 
 
 In a CD spectrometer, the linear polarised light that is emitted from a UV source, i.e. 
xenon arc lamp, is passed into a Photo elastic modulator (PEM) and converted into 
alternating left and right circularly polarised light (Kelly and Price 2000). Then, an 
optically active molecule absorbs the two circular polarised components to different 
extents, and the difference in absorption is detected with a Photo multiplier tube (PMT) 
as shown in Figure 1-27. Circularly polarised light, when passed through a chiral 
molecule, results in a beam that is elliptically polarised and this is because the chiral 
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molecule absorbs the circular polarised components with different magnitudes. Thus, 
the CD signal can also be expressed in terms of ellipticity (Wallace and Janes 2009). 
 
 
Figure 1-27: Schematic diagram describing the principle of CD spectroscopy. The linear polarised light 
that is emitted from UV source is passed into a Photo Elastic Modulator (PEM) and converted into 
alternating left and right circularly polarised light. An optically active molecule differently absorbs the 
two polarisations, and the difference in absorption is detected with a Photo Multiplier Tube (PMT). 
Reproduced from (http://www.isa.au.dk/facilities/astrid/beamlines/cd1/cd1_3.asp). 
 
The CD spectrum has three prominent regions, near UV, far UV and vacuum UV which 
correspond to ~360 − 260 nm, 260 − 190 nm, and 190 − 120 nm respectively (Wallace 
and Janes 2009). Furthermore, CD signals can be obtained in the visible wavelength 
region by coloured chiral molecules such as myoglobin. However, most CD 
measurements of biomolecules are carried out in the UV region. CD signals of amide 
groups in peptides and proteins dominate the far UV region, whereas distinct CD peaks 
in the near UV region are produced from the contribution of the aromatic side chains of 
proteins, e.g. tyrosine residues. Nucleic acids usually have CD signals over the entire 
UV range (Wallace 2009). Carbohydrates tend to produce peaks in the vacuum UV 
region, which can be obtained using synchrotron radiation CD (SRCD) (Wallace and 
Janes 2009). 
 
 Far-UV CD: electronic transitions of peptide bond in the protein  1.11.3.2
Typically, CD signals of amide groups in peptides and proteins dominate the far UV 
region, and they are produced by electronic transitions from a ground state orbital to 
excited state orbital. Mainly, the peptide bond exhibits two electronic transitions, i.e. n 
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to π* (nπ*) and π to π* (ππ*), which contribute significantly in the far UV CD of the 
proteins and peptides, and reflect their conformational structure (Greenfield 1996; Kelly 
et al. 2005). A CD band at ~ 220 nm is produced as a result of nπ* transition, whilst the 
ππ* transition induces a CD signal at ~190 nm as shown in Figure 1-28 (Norden et al. 
2010; Wallace and Janes 2009). 
 
 
Figure 1-28: Schematic diagram of the electronic transitions of the amide bond generating CD signals in 
the far-UV region. The ‘n’ is associated with the lone pair orbitals while the π0 and π* are non-bonding 
delocalised π -orbitals and anti-bonding orbitals respectively. Adapted from (Wallace and Janes 2009). 
 
The three dimensional secondary structure that is adopted by peptides and proteins 
modifies the electronic transitions of the peptide bond and this is due to the additional 
chirality features that is induced by interaction of the peptide chains and also by 
contributions of the side chain groups of the amino acids (Norden et al. 2010). In turn, 
different and characteristic CD spectra can be obtained in each case. The CD spectral 
features associated with different protein secondary structures are illustrated in Figure 
1-29. There are three main classes of secondary structure: α-helix, β-sheet, and random 
coil, each structure has a distinct CD spectrum. The α-helix conformation shows two 
negative CD bands at ~ 222 nm and ~ 208 nm and a positive band ~ 190 nm (Figure 
1-29), which corresponds to nπ*, ππ*parallel (ππ*║), and ππ* perpendicular (ππ*⊥) 
respectively (Wallace and Janes 2009). The ππ* parallel and perpendicular transitions 
produced as result of excition coupling that splits the ππ* transition into two 
components defined relative to the helix axis (Juban et al. 1997; Wallace and Janes 
2009). The CD spectrum of β-sheet conformation has two characteristic bands at ~ 215 
nm for nπ* and ~ 195 nm corresponds to ππ*, however, different types of β-sheet 
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structure show some wavelength shifting and spectrum shape variation (Wallace and 
Janes 2009). The random coil structure has a small positive band at ~ 217 nm for the 
nπ* transition, and a strong negative band ~ 197 nm for the ππ* transition (Bulheller et 
al. 2007; Juban et al. 1997). 
 
 
Figure 1-29: Schematic graph showing typical CD spectra for α-helical, β-sheet, and random coil 
structures. Reproduced from (http://www.proteinchemist.com/cd/cdspec.html). 
 
 Aromatic residues, such as tyrosine and tryptophan, can contribute to the far-UV CD 
spectra of protein. The contribution of aromatic residues has been studied extensively 
(Woody 1978, 1994). However, the contribution of the aromatic residues to the far-UV 
CD is less detectable than that in near-UV CD, and this is because peptide bond 
transitions dominate in the far-UV region. 
 
CD is an important technique that is used to determine and investigate the protein 
structure. However, the resolution of structural details is more limited than the 
information produced by other techniques such as X-ray crystallography or NMR 
spectroscopy, and this is because CD can determine only the total secondary structure 
content and cannot attribute secondary structures to specific regions of the molecule 
(Wallace and Janes 2009). Unlike X-ray crystallography, CD is really useful for 
determining secondary structure elements in solution. Additionally, CD is a powerful 
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method to examine protein structure under more physiological conditions compared to 
those required for NMR data collection such as low pH and high concentrations 
(Wallace and Janes 2009).  
 
 Near-UV CD: Aromatic contributions to CD spectra of proteins 1.11.3.3
Aromatic residues, such as tyrosine and tryptophan, have been found to have a 
considerable contribution to the CD spectra of proteins and peptides in the near-UV 
region through the aromatic transitions (Sreerama et al. 1999; Strickland 1974). The 
near-UV CD spectrum provides information about protein tertiary structure and reflects 
the conformational changes of these residues that are associated with different 
processes. The transitions of tyrosine and tryptophan residues in the near-UV region are 
shown in Figure 1-30, as well as the far-UV transitions of both α-helix and β-sheet. The 
tyrosine residue has one transition at ~ 275 nm in the near-UV, whereas tryptophan has 
two at ~ 295 nm and 267 nm (Hicks et al. 2010). 
 
 
Figure 1-30: Orientations of electronic transition polarisations for (A) α-helix, (B) β-sheet, (C) 
tryptophan and (D) tyrosine. Adapted from (Hicks et al. 2010; Rodger et al. 2006). 
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A red shift observed in the CD band (~ 275 nm) of tyrosine compared to phenylalanine 
(~ 263 nm) is due to the presence of the hydroxyl group (Fasman 1996). Moreover, the 
intensity of the tyrosine CD signal is much higher, thus the detection is much easier. 
Although protein structural studies are commonly performed in the far-UV, the 
theoretical basis and interpretation of the CD spectra in the near-UV region has been 
extensively studied (Horwitz et al. 1970; Strickland 1974). The near-UV CD spectral 
changes accompanied with folding processes can reflect the exposure and burial 
environment around the aromatic residues within protein structure. For example, a 
change in absorption of the tyrosine CD band has been used to investigate the extent of 
burial of the tyrosine residues in bovine pancreatic ribonuclease (Horwitz et al. 1970). 
The near-UV CD of aromatic residues containing proteins can be affected by the 
presence of metal ions and this could reflect the possibility of coordination of these ions 
with the protein via the aromatic residues. The presence of a zinc ion can affect the 
formation of insulin oligomers and this effect was studied by monitoring the near-UV 
CD spectrum development (Wood et al. 1975). 
 
 Structural determination of amyloidogenic peptides and proteins by CD 1.11.3.4
CD has been frequently used to investigate the conformational development that 
accompanies amyloid assembly and aggregation (Abe and Nakanishi 2003; Barrow et 
al. 1992; Marshall and Serpell 2009). The conformational changes during the 
conversion of monomeric species into β-sheet rich fibres were studied widely using 
both far and near-UV CD (Jean et al. 2008; Lee et al. 2007b). CD is a useful technique 
that can provide valuable details about the secondary structure of the early unfolded or 
partially folded oligomeric species and their subsequent role in amyloid assembly 
(Uversky and Fink 2004). A CD signal in the near-UV region at 285 nm has been 
attributed to amyloid formation by a non-amyloid-β component EQVTNVGGAVVTG 
(NAC1-13), as it does not contain any aromatic residues in the polypeptide backbone 
(Abe and Nakanishi 2003). Many near-UV CD studies have been carried out to follow 
amyloid fibril formation and the accompanied structural changes from different 
proteins, such as TTR (Colon and Kelly 1992), α-syn (Ulrih et al. 2008) and β-
microglobulin (Eakin et al. 2004). Also, CD was used to investigate the effects of Cu2+ 
on the secondary structure of PrP (Younan et al. 2011). 
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Similar to proteins, many short peptides exhibit the ability to form amyloid-like fibrils 
and macro-biostructures such as nanotubes, and their structure has been investigated 
using CD. However, short peptides that contain aromatic residues in their sequences 
significantly showed CD spectra that differ from the observed regular CD. Nanotubes 
that formed from diphenylalanine peptide showed a CD spectrum with two positive 
bands at 197 nm and 220 nm, and a broad negative band at ~ 280 (Gupta M 2007), 
suggesting that this red shift to 280 nm generated as a result of the phenylalanine 
residues stacking in the nanotube structure. Two tyrosine-containing peptides, APYG 
and LPYG, were designed to adopt β-turn conformation and were characterised using 
CD. The CD spectra exhibited two minima bands around 205 nm and 225 nm and a 
weak maximum around 193−195 nm (Tinker et al. 1988), and it was proposed that the 
CD minimum near 225 nm is characteristic of the β-turn.  Similarly, AAKLVFF peptide 
was found to give β-turn structure in solution interpreted from the observed negative 
maximum CD band at 228 nm and a weaker positive signal at 209 nm (Krysmann et al. 
2008), and was interpreted to arise from nπ* aromatic stacking interactions between 
phenylalanine residues. Interestingly, Aβ16-20 pentapeptide (KLVFF) with methylated 
K and V that inhibits Aβ fibrillogenesis has CD spectrum consistent with a β-sheet 
conformation with a red shift of 217 to 226 nm (Gordon et al. 2002) and this was 
attributed to a twist (Cerpa et al. 1996; Manning et al. 1988; Orpiszewski and Benson 
1999). 
 
Caution should take into account regarding interpretation of CD spectra of amyloid. 
Many factors can significantly complicate the CD data analysis and interpretation. 
Firstly, artificial linear dichroism (LD) signals that are generated from ordered systems 
can greatly mask the CD signal, as they have a much higher magnitude than CD 
(Davidsson et al. 1980). CD measurements are usually carried out on samples that show 
no direction dependence, i.e. isotropic samples. However, amyloid fibrils may show 
directional dependence, thus their collected CD spectra cannot be directly interpreted. 
Therefore, some sample pretreatment such as sonication is necessary to abolish the LD 
artifacts. Two other factors that can particularly affect the CD spectra are light 
scattering and absorption flattening (Ji and Urry 1969; Mao and Wallace 1984; Starck 
and Sutherland-Smith 2010). Light scattering is produced due to the presence of non-
dissolved particles that can lead to loss of light intensity and subsequently production of 
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false high measured absorbance. In amyloid samples the presence of aggregates will 
lead to light scattering. Absorption flattening leads to decrease of absorbance due to a 
decrease in the effective concentration of absorbers, i.e. particles able to absorb light. 
Amyloidogenic peptides and proteins usually aggregate to form oligomeric species that 
are may be suspended in solution, thus over time the effective concentration of the 
species that are able to absorb the light will decrease and result in false low measured 
ellipticity (Calloni et al. 2008; Starck and Sutherland-Smith 2010). 
 
 Good practical considerations in data collection 1.11.3.5
Many factors can affect the obtained CD spectrum leading to a poorly collected CD 
spectrum. Therefore, it is essential to optimise the data collection conditions ensuring 
careful sample preparation and applied instrument parameters. Sample preparation has 
an enormous influence on the quality of the obtained CD data. Good CD strategy should 
consider sample preparation in terms of purity, concentration and buffers used for 
dissolution. Many buffers and solvents have to be avoided in CD data collection, due to 
their ability to absorb the light in both far and near UV regions, and this consequently 
results in poor CD spectra (Kelly and Price 2000; Kelly et al. 2005). Also, it is 
important to choose a buffer/solvent that has ability to maintain protein integrity. The 
pathlength of the cuvette that is used to collect the data is another factor that should be 
taken into account. It has been revealed that pathlength of many cuvettes, especially the 
shortest ones, have an error in their cited length and need to re-determined before use 
(Wallace and Janes 2009).  
 
 Transmission electron microscope  1.11.4
 Introduction 1.11.4.1
The basic principle of electron microscopy is generally similar to light microscopy 
except that electron microscopes use an electron beam to illuminate the specimen 
instead of visible light as in light microscopy. As the electrons have much shorter 
wavelengths compared to visible light, electron microscopies have greater resolution. A 
high resolution of 0.1 − 0.2 nm can be gained by electron microscopes, whereas light 
microscopy can only provide a resolution of about few hundreds nm (Williams and 
Carter 2008). There are different types of electron microscopy such as transmission 
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electron microscope (TEM), scanning electron microscope (SEM), and scanning 
tunneling electron microscope (STM). 
 
Transmission electron microscope mainly consists of four parts; electron source, 
electromagnetic lens system, a sample holder, and an imaging system (Figure 1-31).   A 
tungsten filament at the top of a cylindrical column of about 2 m high is used as an 
electron source. A voltage in the anode accelerates the emitted electrons and applying 
higher anode voltage will enhance the electron speed, as a result a high-resolution 
image will be produced (Reimer and Kohl 2008). The collision of the electrons with air 
would lead to electron scattering, therefore, it is very important to evacuate the air from 
the whole optical system. A condenser, which consists of electromagnets called 
magnetic lenses, is used to focus the electronic beam on the specimen. The imaging 
system consists of two parts; electromagnetic lens system and a screen, which has a 
phosphorescent or fluorescent plate. The plate glows when hit by the transmitted 
electrons through a thin section of the sample.  Black and white images with high 
resolution are produced by interaction of energetic electrons and the sample under 
vacuum (Reimer and Kohl 2008).  
 
 
Figure 1-31: Schematic diagram showing the TEM. Adapted from (http://www.hk-
phy.org/atomic_world/tem/tem02_e.html). 
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Many morphological and compositional details can be provided by TEM. Two-
dimensional information with high-resolution images can be collected by TEM, thus 
TEM can be used in a wide range of science and industry applications. 
 
TEM has made a high impact in the study of AD, amyloid plaques and Aβ 
fibrillogenesis and has been reviewed in many publications (Harris 2005; Walsh et al. 
1997; Wegiel et al. 2001; Williams and Carter 2008). TEM was used widely to 
investigate the existence and structure of amyloid plaques in post-mortem brain sections 
from AD patient and transgenic (Tg) mouse animal AD models (Richardson et al. 2003; 
Sasaki et al. 2002; Wegiel et al. 2002; Wegiel et al. 2003). A wealth structural detail of 
extracellular diffuse and compact amyloid plaques has been provided by TEM. 
Moreover, an enormous number of AD studies using cultured neurons, microglia, 
astrocytes and other cells were performed using TEM (Sasaki et al. 2002; Wegiel et al. 
2001). Previously, TEM studies of brain and cell culture were performed using 
conventional thin sectioning of resin-embedded samples. Recently, pre- and post-
embedding antibody labelling protocols, also called TEM immunolabelling, have been 
modified and used to study amyloid plaques in brain sections from AD patients and a 
Tg mouse AD model (Al-Hilaly et al. 2013; Wang et al. 2012). Similarly, TEM 
immunolabelling has been used to study AD using various cell cultures in vitro (Al-
Hilaly et al. 2013; Romano et al. 2003; Soura et al. 2012).  
 
TEM has contributed extensively to knowledge regarding the structure and morphology 
of Aβ fibrils and other amyloid systems in vitro. TEM has been frequently used to 
monitor the fibrillogenesis process of many amyloid fibre-forming systems such as Aβ 
and α-syn, providing extensive morphological details of each characteristic species, i.e. 
oligomers, protofibrils, and fibrils (Bitan et al. 2003; Fitzpatrick et al. 2013; Soto et al. 
1995; Walsh et al. 1997). TEM runs parallel with a wide range of available biophysical, 
biochemical and biological techniques, such as XRFD, ESIMS, CD, NMR and ssNMR 
spectroscopy, to get insight into molecular and supramolecular amyloid structures and 
to study the fibrillogenesis (Marshall and Serpell 2010; Morris and Serpell 2012, 2013; 
Williams et al. 2010).  Negative staining TEM analysis of oligomerisation of Aβ40 and 
Aβ42 by Bitan et al. revealed the presence of ~ 5 to 20 nm spherical particles (termed 
“paranuclei”), which in turn aggregated to form larger elongated oligomers and clusters 
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(Bitan et al. 2003). Nybo et al. previously showed this for Aβ42 using TEM. A 
combination of biophysical techniques and TEM were used to identify Aβ protofilament 
intermediates involved in fibrillogenesis (Lashuel et al. 2000; Malinchik et al. 1998; 
Walsh et al. 1997). Aβ protofilament with ~ 5 nm width was identified. In a series of 
publications, fibrils morphologies formed from different Aβ peptides have been defined 
using negative stain TEM and generally found to be long, straight, unbranched fibrils 
with twisting as shown in Figure 1-32 (Fandrich et al. 2009; Meinhardt et al. 2009; 
Serpell 2000).  
 
 
Figure 1-32: Structural polymorphism of Aβ40 fibrils. (A) Schematic representation of an amyloid fibril 
showing the definitions of fibril width and crossover distance. (B) TEM images of negatively stained 
Aβ40 amyloid fibrils produced from the same sample, revealing different structural types of amyloid fibril 
polymorphism. Reproduced from (Fandrich et al. 2009). 
 
 TEM immunogold labelling 1.11.4.2
Immunogold labelling is a technique that has been used for more than seven decades to 
identify biomolecules particularly proteins in tissue and cell sections (Amiry-
Moghaddam and Ottersen 2013). The principle of immunogold labelling techniques is 
that antibodies can be labelled directly or indirectly using colloidal gold particles so that 
they can be visualised in the electron microscope (Figure 1-33) (Griffiths et al. 1993; 
Griffiths 1993). Thus, the target protein or epitope can be located and identified 
precisely within the section due to the selective binding properties of the applied 
antibody (Amiry-Moghaddam and Ottersen 2013). 
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Figure 1-33: Schematic representation showing the principle of immunogold labelling. Adapted from 
(http://www.lifesci.sussex.ac.uk/home/Julian_Thorpe/immuno4.htm). GaM and GaR, goat anti-mouse and 
anti-rabbit, are secondary antibodies that labelled with two different sized gold particles. M and R are 
primary antibodies that are raised against specific antigens in mouse and rabbit respectively. 
 
Using negative stain immunogold labelling TEM, the structure of both synthetic and 
neuronally secreted Aβ fibrils was assessed by Romano et al. (Romano et al. 2003). 
Monoclonal antibodies against Aβ peptide epitopes 1−17 and 17−24 were used, and the 
results showed that only the neuronally secreted Aβ fibrils interfere with long-term 
memory loss in an invertebrate, i.e. crab, learning model (Romano et al. 2003). In a 
recent study, a combination of immunogold labelling TEM and X−ray fluorescence 
microscopy has used to assess and follow the developments of Cu2+ and Zn2+ levels and 
their interaction with Aβ42 in the brain tissue of Tg mouse as AD model (Wang et al. 
2012). The results showed that Cu2+ and Zn2+ ions are associated with Aβ42 during 
plaque deposition (Wang et al. 2012). This observation provides strong evidence of the 
involvement of metal ions in the aggregation and toxicity of Aβ42. 
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 Research hypothesis and aims 1.11.5
AD and PD are neurodegenerative diseases and pathologically characterised by 
deposition of Aβ and α-syn into plaques or Lewy bodies respectively. Metal ion 
dyshomeostasis and oxidative stress have also been reported to be associated with AD 
and PD (Kenche and Barnham 2011; Lovell et al. 1998; Viles 2012). High levels of 
oxidative stress can be produced as a consequence of metal-protein interactions leading 
to protein misfolding and cross-link formation. One of the possible oxidative 
modifications of proteins is dityrosine cross-links which are suggested to play an 
important role in oligomer production. Increasing evidence points to the pivotal role of 
the Cu2+ ion in Aβ and α-syn misfolding and aggregation. However, no previous 
comprehensive in vitro and in vivo study has been carried out to establish the role 
played by dityrosine cross-links in amyloid fibril formation and to explain the link 
between dityrosine cross-links and misfolding of amyloidogenic proteins, such as Aβ 
and α-syn, leading to amyloid assembly. The aim of this study is to understand the role 
for oxidative stress and subsequent dityosine crosslinks in self-assembling peptides and 
neurodegenerative disease processes. 
 
The research aims here were firstly, synthesis of dityrosine as a standard for 
comparison, as it is not available commercially. Secondly, a system of oxidation using 
Cu2+/H2O2 was tested using two short peptides as a model system to provide more 
information about the nature of oxidative modification on tyrosine containing peptides. 
Two previously characterised short tyrosine-containing peptides, HYFNIF and VIYKI, 
were used to determine and optimise the oxidative conditions required to form 
dityrosine cross-links and analyse any possible structural changes. The oxidative 
conditions used Cu2+/H2O2 that are believed to enhance oxidative modifications in vivo.  
 
In chapter five, in vitro and in vivo investigation of dityrosine cross-links in Aβ 
examined the effects on fibril stability and morphology providing more details to 
enhance our understanding of the putative role played by dityrosine cross-links in Aβ 
and subsequently in the pathogenesis of AD. The relevance of dityrosine cross-linked 
Aβ was investigated by examining the existence of dityrosine in plaques in AD brains 
and in CSF. These aims were to define the role of dityrosine cross-links in the 
pathogenesis of AD.  
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Finally, in parallel, chapter six aims to investigate the role of dityrosine cross-links in α-
syn aggregation and to identify the tyrosine involved. Studying the influence of 
dityrosine cross-links in the α-syn conformation and solubility during fibrillogenesis 
provides insights into the importance of oxidative modification of tyrosine residues in 
the pathogenesis of PD.  
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2 Materials and Methods  
 General(2.1
Milli-Q filtered water with a resistivity of 18.2 MΩ was used in all preparations. A 
microbalance (Denver Instruments SI-234) with a tolerance of ± 0.1 mg was used in all 
balance measurements. All pH measurements were made using a FiveEasyTM pH meter 
connected to LE409 pH electrode (Mettler-Toledo AG, Switzerland). In order to 
minimise sample loss and binding of fibrillar substances, low-binding plastic wares, 
including Eppendorf low-bind sterile (Eppendorf, Hamburg, Germany) and AvantGuard 
low-bind sterile filter barrier tips, were used. To remove any cross contaminated 
material, routine cleaning of cuvette was achieved using water, followed by 2% 
Hellmanex, water, ethanol, and finally drying with nitrogen gas. Also, 2 M nitric acid 
was used to clean the cuvette surfaces from sticky contaminated material. 
 
 Methods(relevant(to(chapter(4(2.2
 
 Preparation of Waltz peptide fibrils 2.2.1
The lyophilised Waltz peptides (See 4.1), HYFNIF and VIYKI (JPT peptide 
technologies, Germany), were dissolved in 0.22 µm filtered Milli-Q water and 
incubated at a concentration of 2 mg/ml for one week at room temperature in order to 
generate fibrillar HYFNIF and VIYKI. Fibril formation was confirmed by negative 
stain TEM as described in section 2.2.11. The stock solutions of the fibrils were stored 
in the dark at room temperature until required. 
 
 Monitoring oxidation of HYFNIF and VIYKI fibrils 2.2.2
 A stock solution of both HYFNIF and VIYKI fibrils was diluted in (a) water and (b) 50 
mM phosphate buffer pH 7.4, to a final concentration of 0.1 mM. The diluted fibrils 
were incubated with Cu2+ (0.1 mM) and H2O2 (2.5 mM) at 37 °C with agitation of 300 
rpm for three days. To monitor dityrosine formation, the fluorescence spectra were 
recorded every 24 h as described in fluorescence methods (section 2.2.4). Controls were 
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obtained either in water or in 50 mM phosphate buffer pH 7.4 as illustrated in Table 
2-1. 
 
Table 2-1: Details of control preparation for waltz peptides comparison. 
Substrate Control 1 Control 2 Control 3 
HYFNIF or VIYKI fibrils X X X 
Cu2+ X - - 
H2O2 - X - 
Phosphate buffer X X X 
Water X X X 
 
 Oxidation of HYFNIF and VIYKI fibrils for CD studies 2.2.3
(a) A stock solution of HYFNIF and VIYKI fibrils was diluted in water to a final 
concentration of 1.135 and 1.480 mM respectively and incubated in the presence of 
Cu2+ at a molar ratio of 1:1 (Cu2+/peptide) and H2O2 (28.3 mM) and (37.0 mM) 
respectively. The oxidation reactions were performed at 37 °C with agitation of 300 rpm 
for three days. CD spectra were recorded as explained in CD measurement using a 0.1 
mm path length cuvette (section 2.2.6). 
 
(b) 0.25 mM of VIYKI fibrils was oxidised using Cu2+ (250 µM) and H2O2 (6.25 mM) 
in phosphate buffer (12.5 mM) at 37 °C with agitation at 300 rpm for three days. CD 
spectra were recorded every 24 h as explained in CD measurement using a 1 mm 
cuvette. 
 
 Tyrosine and dityrosine fluorescence 2.2.4
Fluorescence measurements were made using a Varian Cary Eclipse fluorimeter (Varian 
Ltd., Oxford, UK) with a single cell peltier accessory set at 21 °C.  Fluorescence spectra 
were collected using 1 cm path length quartz cuvette (Starna, Essex, UK). Dityrosine 
fluorescence was monitored using an excitation wavelength of 320 nm and the emission 
wavelength was monitored between 340 and 500 nm, with maximum fluorescence 
intensity at around 410 – 420 nm. Tyrosine fluorescence signal was monitored using an 
excitation wavelength of 280 nm and emission wavelength of 305 nm. Excitation and 
emission slits were both set to 10 nm, and the scan rate was set to 300 nm/min with 2.5 
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nm data intervals and an averaging time of 0.5 s. The photomultiplier tube detector 
voltage was set at 500 V. 
 
 Standard curve of dityrosine 2.2.5
To estimate the dityrosine content of HYFNIF and VIYKI peptides, we generated a 
dityrosine standard curve. A set of dityrosine standard concentrations (0.1, 0.5, 1, 2, 3, 
and 5 µM) was made up in Milli-Q water. Each concentration was prepared in triplicate 
and dityrosine fluorescence was recorded for each concentration using an excitation 
wavelength of 280 nm and an emission wavelength of 410 nm. The mean values of 
dityrosine fluorescence intensity for each concentration were plotted against dityrosine 
concentration and a line as function was fitted by linear regression analysis using 
Microsoft Excel 2011 software. This equation was then used to quantify the dityrosine 
content of HYFNIF and VIYKI peptides. 
 
 Circular dichroism spectroscopy  2.2.6
Far and near UV CD spectra were collected using a Jasco J-715 spectropolarimeter 
(Jasco UK, Great Dunmow, UK) connected to a peltier temperature control system. All 
spectra were recorded at 21°C with a continuous scan at a pitch of 0.1 nm and a scan 
rate of 50 nm/min (response time 4 sec, slit width 1 nm). The spectra were recorded 
between 180 − 320 nm by averaging triplicate scans and corrected by subtracting the 
averaged triplicate scans of blank buffer spectra. Quartz demountable cells (Starna 
Scientific Ltd) were used to measure the CD intensity, and generally the path lengths 
were between 1− 0.1 mm to obtain better spectra with a high tension voltage (HT [V]) 
of > 600. 
 
Raw data was processed and converted into molar ellipticity (degree.cm2. dmol-1) using 
the following equation: 
 
θ (deg.cm2.dmol-1) = 100. θ (mdeg) / c (M). l (cm)  
 
Where l is path length in cm, c is molar concentration of the sample in mole/L, and θ is 
ellipticity reading in mdeg.  
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CD spectra of the non-oxidised and oxidised HYFNIF and VIYKI fibrils were recorded 
either in water or in 12.5 mM phosphate buffer at pH 7.4, and the secondary structures 
at different concentrations were explored. 
 
 Linear dichroism artifact identification  2.2.7
Linear dichroism artefacts, which arise from the orientation effects of fibrils, was 
determined by placing the cuvette close to the detector and rotate it around the optical 
axis as shown in Figure 2-1. 
 
 
Figure 2-1:Linear dichroism artefact identification by placing the cuvette at 0 and 90 deg to the detector. 
 
 Sample preparation for LC-ESIMS/MS analysis 2.2.8
Oxidised (100 µM) HYFNIF and (50 µM) VIYKI fibrils prepared in water were 
lyophilised using a Modulyo 4K Freeze Dryer (Edwards, Crawley, England), and then 
hydrolysed using evacuated sealed tubes under acidic conditions of (6 M) HCl, 10% 
TFA, and 1% phenol at 110 °C for 48 h. The resulting hydrolysates were then dried 
under nitrogen gas, dissolved in 100 µl of 0.1% formic acid in water and then filtered 
using a Millipore 0.22 µm filter into a 0.2 ml tube. 
 
 Detection of dityrosine by LC-ESIMS/MS 2.2.9
20 µl of oxidised fibril hydrolysate was injected on to a Phenomenex Gemini 3u 
C6−phenyl 110 (150 mm x 4.6 mm, 3 micron) column using an HPLC system (Waters 
Alliance 2695, Ireland) coupled to the mass spectrometer (MicroMass Quattro Premier, 
Waters, Ireland) operated in the MRM mode with positive ESI. The solvents for the 
0 deg 90 deg 
Cuvette Detector Cuvette Detector 
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mobile phase were A: 0.1% formic acid in water; and solvent B: 0.1% formic acid in 
acetonitrile. The gradients were as follows: t = 0 min, 0% B; t = 1 min, 0% B; t = 15 
min, 100% B; t = 20 min, 100% B; t = 25 min, 0% B; t = 30 min, 0% B, and the flow 
rate was 200 µl/min. Mass spectrometric detection was performed by positive ESI 
tandem mass spectrometry on a triple quadrupole mass spectrometer (MicroMass Quttro 
Premier, Waters, Ireland). The conditions for the mass spectrometer were as follows; 
electrospray ionisation spray voltage 3.5 kV, the cone voltage 35 V, the source 
temperature at 100 °C, whereas the desolvation temperature was 400 °C. Argon was 
used as the collision gas at 5.95 x 10-3 mbar at 26 ev collision energy. 
 
 Exploring the effect of buffer type on dityrosine cross-link formation  2.2.10
In order to investigate the effect of buffer type on dityrosine cross-link formation in 
both HYFNIF and VIYKI fibrils, 0.1 mM HYFNIF and 0.1 mM VIYKI fibrils were 
incubated respectively with Cu2+ using 1:1 molar ratio and 2.5 mM H2O2 in; a) 50 mM 
phosphate buffer pH 7.4 and b) 50 mM HEPES buffer pH 7.4 and the oxidation 
reactions were performed at 37 °C with agitation of 300 rpm for 26 h. The dityrosine 
formation was monitored by fluorescence and the spectra were recorded over 26 h. 
 
 Negative stain TEM 2.2.11
Four microliter aliquots of fibril samples were placed onto Formvar/carbon coated 400-
mesh copper grids (Agar Scientific, Essex, UK) for 1 min, and the excess was removed 
using filter paper. Subsequently the grid was washed using 4 µl of Milli-Q water filtered 
with 0.22 µm filter and blotted dry, then negatively stained twice with 4 µl of filtered 
2% (w/v) uranyl acetate for 1 min and blotted dry. The grid was allowed to air-dry 
before examination on a Hitachi 7100 transmission electron microscope (Hitachi, 
Germany) fitted with a Gatan Ultrascan 1000 CCD camera (Gatan, Abingdon, UK) at 
an operating voltage of 100 kV. 
 
 Immunogold labelling negative stain TEM  2.2.12
A modified phosphate-buffered saline, pH 8.2, containing 1% BSA, 500 µl/l Tween-20, 
10 mM NaEDTA, and 0.2 g/l NaN3 (henceforward termed PBS+), was used throughout 
all the following procedures for all dilutions of antibodies and secondary gold probes. 
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HYFNIF and VIYKI fibrils were oxidised in phosphate buffer for 3 h as described 
previously in section 2.2.2, and immunogold labelled ‘on grid’ for dityrosine (Thorpe et 
al. 2004). In general, 4 µl aliquots of the oxidised fibrils were pipetted onto Formvar/ 
carbon coated 400 mesh copper TEM support grids (Agar Scientific, Essex, UK), left 
for 1 min, the excess was removed by filter paper, and then blocked in normal goat 
serum (1:10 in PBS+) for 15 min. Grids were then incubated with (10 µg/ml IgG) 
mouse dityrosine monoclonal antibody (Japan Institute for the Control of Aging JaICA, 
Shizuoka, Japan) for 2 h at room temperature, rinsed in 3x2 min PBS+, and then 
immunolabelled in a 10 nm gold particle-conjugated goat anti-mouse IgG secondary 
probe (GaM10 British BioCell International, Cardiff, UK; 1:10 dilution) for 1 h at room 
temperature. After 5x2 min PBS+ and 5x2 min distilled water rinses, the grids were 
negatively stained as described in negative stain TEM.  
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 Methods(relevant(to(chapter(5(2.3
 
 Preparation of fibrillar and oligomeric Aβ42 2.3.1
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) Aβ42 was purchased from rPeptide (Bogart, 
GA, USA). To remove preformed aggregates in the rPeptide purchased Aβ42, 
lyophilised Aβ42 (0.2 mg) was dissolved in 200 µl of HFIP >99.0% (Williams et al. 
2010; Williams et al. 2011), and the mixture was vortexed for 60 s and sonicated in a 
50/60 Hz bath sonicator for 60 s. The HFIP was removed using nitrogen gas current, 
and the peptidic films were vacuum desiccated for 30 min. Then Aβ42 film was 
resolubilised in 200 µl of dimethyl sulfoxide (DMSO) >99.7%, extra dry (Acros 
organics, Belgium), and the mixture was vortexed for 60 s and then sonicated for 60 s. 
In turn, the mixture was added to a 2 ml Zeba buffer exchange spin column (Thermo 
Scientific, USA) equilibrated with 0.22 µm filtered Milli-Q water. A 40 µl of 0.22 µm 
filtered Milli-Q water was added to the column immediately after mixture absorbed into 
the column resin. The column was spun in a 4 °C controlled Mikro 22R centrifuge 
(Hettich UK, Manchester, UK) at 1000 g for 2 min. The eluted peptide was centrifuged 
in at 4 °C with 16,000 g for 30 min to remove contaminants and preformed fibrillar 
material. The supernatant was placed in a clean nonstick microcentrifuge tube and kept 
at 4 °C until use to minimise fibrillisation. The concentration was determined using a 
molar extinction coefficient of 1490 M-1cm-1 and the absorbance was measured at a 
wavelength of 280 nm using an Eppendorf Biophotometer (Eppendorf UKLtd., 
Cambridge, UK). The resulting stock peptide concentrations of 90-130 µM were used 
immediately for early oligomeric Aβ42 experiments, or incubated for at least two weeks 
at room temperature (22 °C) in order to generate Aβ42 fibrils (confirmed using TEM). 
 
 Oxidation of fibrillar and early oligomeric Aβ42 2.3.2
Stock solutions of soluble or fibrillar Aβ42 were diluted in (a) water or (b) 50 mM 
phosphate buffer pH 7.4 to obtain 20 µM Aβ42 as a final concentration and incubated 
with or without (20 µM) Cu2+ and (0.5 mM) H2O2 at 37 °C with agitation in a shaking 
incubator for three days.  The oxidation reaction was quenched using a final 
concentration of 250 µM EDTA. 
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 Dityrosine cross-linked Aβ42 fibril stability  2.3.3
Aβ42 was assembled under oxidising and non-oxidising conditions and stored at - 80 
°C for more than one year and the dityrosine content was assessed using fluorescence 
with an excitation wavelength of 320 nm as described in section 2.2.4. Both oxidised 
and non-oxidised Aβ42 fibrils were centrifuged for 30 min at 16,000 g at 4 °C, and then 
the soluble Aβ42 concentration in the supernatant was measured using absorbance at 
280 nm (as described for peptide preparation in section 2.3.1). TEM grids were 
prepared to examine the Aβ42 fibrils in the pellet. The oxidised and non-oxidised fibrils 
were then dissolved in 80% (v/v) formic acid with agitation. The resulting solution was 
centrifuged using the same conditions above, and again the dissolved Aβ42 
concentration was determined. TEM grids for the pellet were prepared to examine the 
morphology of the dissolved fibrils and to compare their density. 
 
 Fluorescence spectroscopy 2.3.4
Fluorescence spectra of dityrosine were recorded every 24 h. Fluorescence 
measurements were made as described previously in section 2.2.4. 
 
 Sample preparation for LC-ESIMS/MS analysis 2.3.5
Oxidised Aβ42 fibrils prepared in water, were lyophilised using a Modulyo 4K Freeze 
Dryer (Edwards, Crawley, England), and then hydrolysed using evacuated sealed tubes 
under acidic conditions of (6 M) HCl, 10% TFA, and 1% phenol at 110 °C for 48 h. The 
resulting hydrolysate was then dried under nitrogen gas, dissolved in 100 µl of 0.1% 
formic acid in water and then filtered using a Millipore 0.22 µm filter into a 0.2 ml tube. 
 
 Detection of dityrosine by LC-ESIMS/MS 2.3.6
Dityrosine formation in oxidised Aβ42 hydrolysate was detected using LC-ESIMS/MS 
as described previously in section 2.2.9. 
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 Thioflavin T fluorescence assay  2.3.7
The fibril formation of Aβ42 was monitored using ThT fluorescence. A 0.2 µm filtered 
(3.14 mM) aqueous ThT stock solution was prepared and stored frozen at − 20 °C in 
1−10 µl aliquots until required. ThT was added to 10 µM Aβ42 sample (50 mM 
phosphate buffer pH 7.4) to a final concentration of 20 µM, gently vortexed, and 
allowed to bind for 3 min before readings were taken. Using a microvolume cuvette 
(Starna, Essex, UK) of 1 cm path length, ThT fluorescence was measured using a 
Varian Cary Eclipse fluorimeter (Varian, Oxford, UK) with excitation wavelength of 
450 nm. The emission spectrum was recorded between 460 − 600 nm at 21°C. 
Phosphate buffer baselines were subtracted from the data. Excitation and emission slits 
were set to 5 nm and 10 nm respectively. The scan rate was 600 nm/min with 1 nm data 
intervals and an averaging time of 0.1 s. The voltage on the photomultiplier tube was set 
to high (800 v) and experiments were carried out in triplicate to confirm trends. 
 
 Negative stain TEM 2.3.8
Negative stain TEM of Aβ42 fibrils were performed as in section 2.2.11. 
 
 SH-SY5Y neuroblastoma cell treatment with Aβ42 2.3.9
Undifferentiated human neuroblastoma SH-SY5Y cells were provided by Mrs. Maris 
Stewart-Parker. The cells were incubated with final concentration of 10 µM Aβ42 or 
buffer only at 37 °C for 24 h.  
 
 Immunogold labelling TEM of sections 2.3.10
AD and aged matched control brain from middle frontal gyrus tissues (Table 2-2) were 
obtained from London Neurodegenerative Diseases Brain Bank. Tissue was removed 
according to Local Ethics Committee guidelines, and informed consent for brain 
donation was obtained from the next of kin"and stored at –80 °C until required. SH-
SY5Y cells were incubated for 24 h with a final concentration of freshly prepared 10 
µM Aβ42 and control cells were administered with buffer only (Soura et al. 2012). SH-
SY5Y cells and brain tissues were prepared for immunogold labelling TEM by 
minimal, cold fixation and embedding protocols that were performed by Dr. Julian 
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Thorpe (Thorpe et al. 2001). Immunogold labelling was performed using an established 
methodology (Thorpe 1999), with PBS+ buffer being used for all dilutions of immuno 
reagents and for rinsing. Thin sections were collected upon TEM support grids, then 
incubated with normal goat serum (1:10 dilution) for 30 min at room temperature to 
block non-specific secondary antibody binding. In turn, grids were labelled with 
(10µg/ml IgG) anti-dityrosine mouse monoclonal antibody (Japan Institute for the 
Control of Aging JaICA, Shizuoka, Japan) or double-labelled using a mixture of 
(10µg/ml IgG) anti-Aβ42 rabbit polyclonal antibody AB5078P (Chemicon, Temecula, 
CA, USA) and (10µg/ml IgG) anti-dityrosine mouse monoclonal antibody and 
incubated overnight at 4°C. After 3x2 min PBS+ rinses, sections were then 
immunolabelled with GaM10 or a mixture of GaR5 and GaM10 secondary probes (both 
1:10 dilution), respectively, for 1 h at room temperature. After 3x10 min PBS+ and 
4x5min distilled water rinses, the grids were post-stained in 0.22 µm-filtered 0.5% 
(w/v) aqueous uranyl acetate for 1 h. The grids were examined on a Hitachi 7100 TEM 
(Hitachi, Germany) fitted with a Gatan Ultrascan 1000 CCD camera (Gatan, Abingdon, 
UK), and operating with a voltage of 100 kV. 
 
Table 2-2: Demographic details of cases from which middle frontal gyrus tissues were obtained. 
Case  Age Sex Pathological diagnosis 
Normal 1 89 F Control case but with Hypoxic-type changes and 
amyloid angiopathy  
Normal 3 80 F Control-minimal ageing changes 
AD 1 68 M Alzheimer’s disease HP-tau stage 6 with mild to 
moderate amyloid angiopathy 
AD 2 93 F Alzheimer’s disease HP-tau stage 6 with 
moderate amyloid angiopathy 
AD 3 91 M Alzheimer’s disease HP-tau stage 6 with 
moderate amyloid angiopathy 
AD 4 86 F Alzheimer’s disease HP-tau stage 6 with mild 
amyloid angiopathy 
AD 5 77 F Alzheimer’s disease -modified Braak BNE stage 
5 
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 Analysis of immunogold labelled sections 2.3.11
Counting and size analyses of immunogold particle were performed using in house 
software written by Dr. Kyle Morris in Matlab. Briefly, raw digital electron micrograph 
images files were uploaded and circular particles detected using inbuilt Matlab circular 
Hough transforms functions. The detection range diameter was calculated from user 
input and conversion to pixel size values read from the image header. 15 or 10 nm gold 
particles were distinguished from 5 nm particles based on a user-selected threshold of 7 
nm. 
 
 Immunogold labelling, negative stain TEM (for fibrils and cerebrospinal 2.3.12
fluid) 
A PBS+ buffer was used throughout all the following procedures for all dilutions of 
antibodies and secondary gold probes. Aβ42 fibrils were oxidised and assembled as 
described in oxidation of fibrillar and early oligomeric Aβ42 (section 2.3.2) and 
immunogold-labelled ‘on grid’ for dityrosine as described in section 2.2.12. 
 
CSF samples from AD patients and control age matched subjects (Table 2-3) were 
obtained from the London Neurodegenerative Diseases Brain Bank. CSF was removed 
according to Local Ethics Committee guidelines, and informed consent for brain 
donation was obtained from the next of kin. The samples were stored at –80 °C in a 
locked freezer until needed. When required, they were diluted with Milli-Q water (1:3). 
Diluted CSF samples were double-immunogold-labelled for dityrosine and Aβ42 as 
described in section 2.2.12, except grids were incubated in a mixture of (10 µg/ml IgG) 
anti Aβ42 rabbit polyclonal antibody AB5078P (Chemicon, Temecula, CA, USA) and 
(10 µg/ml IgG) mouse monoclonal dityrosine antibody (Japan Institute for the Control 
of Aging JaICA, Shizuoka, Japan). A mixture of 5 nm gold particle-conjugated goat 
anti-rabbit IgG (GaR5 British BioCell International, Cardiff, UK) and 15 nm gold 
particle-conjugated GaM (British BioCell International, Cardiff, UK; 1:10 dilution) was 
used for the secondary gold probe. 
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Table 2-3: Demographic details of cases from which cerebrospinal fluid were obtained. 
Case  Age Sex Pathological diagnosis 
AD 1 68 M Alzheimer’s disease HP-tau stage 6 with mild to 
moderate amyloid angiopathy 
AD 2 93 F Alzheimer’s disease HP-tau stage 6 with 
moderate amyloid angiopathy 
AD 3 91 M Alzheimer’s disease HP-tau stage 6 with 
moderate amyloid angiopathy 
Normal 1 
 
89 F Control case but with hypoxic-type changes and 
amyloid angiopathy 
Normal 2 92 F Control-some amyloid angiopathy 
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 Methods(relevant(to(chapter(6(2.4
 
 Preparation of α-syn 2.4.1
The lyophilised full-length human recombinant α-syn (1 mg) in final buffer of 10 mM 
Tris-HCl (pH 7.4) was purchased from rPeptide (Bogart, GA, USA) or provided by Dr. 
Shahin Zibaee (Molecular Biology Lab., MRC Centre, Cambridge). The provided α-syn 
was of high purity and does not show any Cysteine misincorporation to Tyrosine at 
position 136, which has been observed for about 20% of human α-syn expressed in 
Escherichia coli (Masuda et al. 2006). The peptide was resuspended in Milli-Q filtered 
water at concentration of 2 mg/ml, and then the Tris-HCl buffer was removed using 
Vivaspin-500 concentrator tube, 3000 MWCO PES (Sartorius stedim biotech, 
Germany). Briefly, the resuspended α-syn was centrifuged at 14,000 g for 30 min, 
subsequently the obtained concentrated α-syn was again diluted with Milli-Q filtered 
water at a concentration of 2 mg/ml and the concentrating process was repeated. The 
resulting α-syn solution in water was collected and filtered using 0.22 µm syringe filter 
to remove any preformed aggregates. Finally, the concentration was determined using a 
molar extinction coefficient of 5120 M-1cm-1 and the absorbance was measured at a 
wavelength of 280 nm using an Eppendorf Biophotometer (Eppendorf UKLtd., 
Cambridge, UK) (Lucas et al. 2010). 
 
 Cu2+- catalysed oxidation of α-syn 2.4.2
Prior to oxidation, α-syn stock solution was prepared as described in section 2.4.1, to 
remove any preformed aggregates and fibrils. Soluble α-syn monomer was incubated 
with Cu2+ using molar ratio of 1:1 and concentration of 50 µM and to initiate the 
oxidation reaction, H2O2 (1.25 mM) was added. The oxidation reaction was performed 
in 20 mM HEPES (pH 7.4) at 37 °C with agitation of 400 rpm. After 24 h, the oxidation 
reaction was stopped using EDTA at a final concentration of 1.25 mM. The dityrosine 
formation was monitored by fluorescence spectrophotometer as described in section 
2.2.4. Controls were obtained by incubation of 50 µM α-syn with and without Cu2+ in 
20 mM HEPES buffer pH 7.4 at 37 °C with agitation of 400 rpm. 
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 Exploring the effect of Cu2+ on the α-syn fibrillogenesis and structure 2.4.3
To examine the effect of Cu2+ on the α-syn fibrillogenesis, a concentration range of 
Cu2+ (50, 100, 400 µM) was used at molar ratio of 1:1 with α-syn. Then the fibril 
growth and morphology were examined using ThT fluorescence and TEM respectively. 
Also, CD was used to measure the secondary structure of the formed fibrils. Moreover, 
XRFD was used to further examine the structure. 
 
 Tyrosine and dityrosine fluorescence 2.4.4
Fluorescence measurements were made using a Varian Cary Eclipse fluorimeter (Varian 
Ltd., Oxford, UK) with a single cell peltier accessory set on 21 °C. Tyrosine and 
dityrosine fluorescence was measured using excitation wavelengths at 280 and 320 nm 
respectively as described in section 2.2.4. 
 
 ThT fluorescence assay 2.4.5
The α-syn fibril growth was monitored using ThT fluorescence performed as in section 
2.3.7.  
 
 Circular dichroism spectroscopy  2.4.6
CD was used to measure the α-syn conformational changes associated with fibril 
formation. CD experiments were carried out at 21 °C in a JASCO J-720 
spectropolarimeter as described previously in section 2.2.6.  
 
 Negative stain TEM 2.4.7
The α-syn fibril growth and morphology was visualised by negative stain TEM, the 
detailed protocol and preparation were the same as in section 2.2.11.  
 
 Dityrosine detection using LC-ESIMS/MS  2.4.8
For LC-ESIMS/MS analysis, 24 h oxidised α-syn (50 µM) was first desalted to remove 
the HEPES buffer that could affect the mass spectrum. The desalting was performed 
using Amicon ultra-4 centrifugal filter units, 10k NMWL (M Millipore, USA) and 
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centrifuged at 6000 RPM and a temperature of 4 °C. The resulting α-syn was then 
hydrolysed using evacuated sealed tubes under acidic conditions of (6 M) HCl, 10% 
TFA, and 1% phenol at 110 °C for 48 h. In turn, the α-syn hydrolysate was dried using 
nitrogen gas then resuspended in 0.1% formic acid in water and filtered using 0.22 µm 
syringe filter unit and finally analysed by LC- ESIMS/MS that operated on MRM mode 
as described in section 2.2.9. 
 
 HPLC analysis of oxidised α-syn 2.4.9
The HPLC analysis was performed using an Agilent 1100 Series HPLC system 
(Cambridge, UK). Reversed-phase gradient chromatography was performed using a 
binary solvent system composed of TFA 0.085% (v/v) in acetonitrile (solvent B) and 
TFA 0.1% (v/v) in water (solvent A). The solvents were mixed using an G1312A binary 
pump at 1 ml/min as follows: From 0 to 1 min the composition of A–B was held at 95% 
A, from 1 to 20 min the composition of the solvent was changed, via a linear gradient to 
95% B and then from 20 to 27 min the solvent was changed to 95 % A to rinse the 
column. The solvent was then held at 95%A for 3 min for column re-equilibration prior 
to the next injection. Oxidised and non-oxidised α-syn samples were injected into C– 4 
Phenomenex (150 X 4.6 mm) column and α-syn monitored using UV detector at 
wavelength of 226 nm. 
 
 SDS-PAGE electrophoresis  2.4.10
SDS-PAGE electrophoresis analysis was performed as described previously (Bollag and 
Edelstein 1991). The separation gel consisted of 12% (w/v) acrylamide, 0.32% (w/v) 
bis-acrylamide, 0.1% SDS, and 0.38 M Tris-HCl (pH 8.8). The polymerisation was 
initiated by addition of 5 µl TEMED and 50 µl freshly prepared ammonium persulfate 
(APS) solution per 10 ml of the gel solution. The stacking gel consisted of 5% (w/v) 
acrylamide, 0.13% (w/v) bis-acrylamide, 0.1% (w/v) SDS, and 0.38 M Tris-HCl (pH 
6.8) and polymerisation was initiated by addition of 5 µl TEMED and 20 µl freshly 
prepared ammonium persulfate (10% w/v) per 4 ml of the gel solution.  Electrophoresis 
buffer consisted of 25 mM Tris-HCl (pH 8.3), 19 mM glycine, and 0.1% (w/v) SDS. 
Laemmli sample buffer (Sigma-Aldrich, UK), which consisted of 4% SDS, 20% 
glycerol, 10% 2-mercaptoethanol, 0.004% bromophenol blue and 0.125 M Tris- HCl 
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(pH 6.8), was used in preparation of the protein samples using 1:1 volume ratio, then 
the resulting mixture was boiled for 5 min at 100 °C and centrifuged for 1 min. The 
SDS electrophoresis analysis was performed using Bio- Rad chamber (Bio-Rad, 
Hercules) under constant voltage (200 V). A protein marker standard (Sigma-Aldrich, 
UK) with range of 6,500 – 200,000 Da was run along side with the samples.  
 
The separated protein bands were visualised using Coomassie Brilliant Blue R-250 and 
Silver staining. The Coomassie Brilliant Blue R-250 staining was performed as 
described previously (Bollag and Edelstein 1991). Generally, the gel was incubated in 
the Coomassie stain solution for ~ 1 h with gentle shaking, and then rinsed with 
deionised distilled water several times. For de-staining, the gel was incubated with ~ 50 
ml of Coomassie gel destain solution with overnight agitation. 
 
The silver staining was performed according to the manufacture's instructions (Bio-Rad, 
U.S.). In brief, the gel was placed in the fixative enhancer solution with gentle agitation 
for 20 min, then rinsed with deionised distilled water for 10 min, this step was repeated 
once more and then the rinsed water was decanted. For staining, the gel was placed in 
the staining solution for ~15 – 20 min until the desired staining was reached, then 5 % 
(v/v) acetic acid was added and left for 15 min to stop the reaction. Finally, the gel was 
rinsed for 5 min with Milli-Q water, and then the gels were photographed.  
 
 In gel digestion protocol 2.4.11
The α-syn oxidation mixture (after 5 h of oxidation) were separated by SDS-PAGE and 
stained using Coomassie Blue as described above, then the separated bands (monomer 
and dimer) were excised and divided into 3 − 4 pieces and de-stained with 30% 
acetonitrile for 15 min with agitation followed by 50% acetonitrile / 25 mM ammonium 
bicarbonate for 15 min with agitation. This step was repeated until the gel pieces were 
completely de-stained. The de-stained gel pieces were then dehydrated using vacuum 
centrifugation for 5 min without heating. 12.5 ng/ml of trypsin solution in 25 mM 
ammonium bicarbonate was added and the gel pieces were allowed to rehydrate for 5 
min, then the excess trypsin solution was removed and the gel pieces covered by 25 mM 
ammonium bicarbonate and incubated at 37 °C for 6 h. Formic acid was added to ~5% 
(v/v) and the resulted mixture was vortexed and centrifuged at 1000 g for 1 min and the 
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supernatant was removed, the remaining peptides were extracted from the gel pieces 
using 50% acetonitrile with agitation and brief sonication. This step was repeated and 
all supernatants were pooled and the volume was reduced by vacuum centrifugation. 
The resultant sample solution was stored at –80 °C until analysed by nanoLC-LTQ-
OrbitrapXL mass spectrometry.  
 
 α-syn fibril preparation for XRFD 2.4.12
α-syn fibrils were formed in 20 mM HEPES buffer (pH 7.4) by incubation with and 
without Cu2+ at molar ratio of 1:1 and concentration of 400 µM for 5 days at 37 ºC and 
with agitation of 450 rpm. To remove HEPES buffer, which can affect the quality of X-
ray diffraction, the resulting fibrils were centrifuged for 30 min at 20,000 g and 4 ºC, 
then the obtained pellet was re-suspended in 10 µl Milli-Q water and aligned as 
described below. 
 
 X-ray fibre diffraction  2.4.13
Fibre diffraction specimens were prepared by suspending a 10 µl droplet of α-syn fibril 
solution, which is prepared as described above, between two wax-tipped 1.2 mm O.D, 
0.94 mm I.D borosilicate capillaries (Harvard apparatus), then left at room temperature 
in a parafilm sealed petri dish until dry. X-ray diffraction patterns were collected using a 
Rigaku 007HF Cu Kα (λ 1.5419 Å) rotating anode generator with a Saturn 944+ CCD 
detector with exposure times of 10 – 120 seconds and specimen to detector distances of 
50 or 100 mm. The images were displayed and examined using Mosflm (Leslie 1992). 
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3 Dityrosine synthesis and characterisation   
 Introduction(3.1
Dityrosine is a tyrosine dimer that results from the ortho-ortho coupling of two tyrosyl 
radicals (Figure 1-18). It has a strong fluorescence emission maximum at 410 nm upon 
excitation at 285-325 nm depending on the pH of the solution (Abdelrahim et al. 1997). 
The formation of cross-linked tyrosine is one of oxidative modifications that may 
mediate the toxicity of Aβ oligomers (Atwood et al. 2004). The aim of this chapter is 
the synthesis of a dityrosine standard, which is not commercially available, and its use 
as a reference in the rest of the study. 
 
 Protocols(of(dityrosine(synthesis(3.2
Several methods have been described for the synthesis of dityrosine (Hutton and Skaff 
2003; Lee et al. 2008; Tilley et al. 2004), here we present the most efficient two 
methods that were used to prepare dityrosine. 
 
 Enzymatic oxidative coupling of tyrosine derivative 3.2.1
A wide variety of tyrosine derivatives have been oxidised by peroxidase-hydrogen 
peroxide system to produce dityrosine. This oxidation includes phenolic coupling 
through carbon-carbon construction. Jacob et al. prepared dityrosine through the 
oxidative phenolic coupling of L-tyrosine converted to the tyrosyl radical by 
myeloperoxidase, and they revealed that the major reaction of tyrosyl radicals under 
these conditions is dimerisation to form dityrosine (Jacob et al. 1996). Alternatively, 
Malencik et al. employed horseradish peroxidase (HRP) to catalyse the oxidative 
coupling of tyrosine (Malencik and Anderson 1996). Consequently, dihalogenated 
tyrosine derivatives have been used to synthesise dityrosine using HRP as a catalyst 
(Guo et al. 1997). The amino group of dihalogenated tyrosine was acylated to prevent 
possible side reactions (Figure 3-1). Recently, Lee et al. have used N-Boc-L-tyrosine as 
the substrate of HRP and synthesised dityrosine on a large scale (Lee et al. 2011a). 
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Figure 3-1: Dityrosine synthesis using horseradish peroxidase and hydrogen peroxide system. 
 
1.1.1 Dityrosine synthesis by Suzuki-Miyaura coupling reaction 
The palladium-catalysed Suzuki-Miyaura cross coupling is one of the most efficient 
strategies for carbon-carbon bond formation. It is widely used in organic synthesis to 
build more complex molecules from simple precursors. The Suzuki-Miyaura coupling 
reaction is based on the coupling of an aryl or vinyl halide with a boronic acid 
derivative, in the presence of a palladium catalyst and base (Hutton and Skaff 2003). 
 
Doan et al. reported that the Suzuki-Miyaura cross-coupling reaction has been used in 
many applications (Doan et al. 2008). For example, the synthesis of Losartan, an 
angiotensin II receptor antagonist, is one of the Suzuki-Miyaura coupling reactions 
applied in the pharmaceutical industry. 
 
Dityrosine was prepared through a tandem Miyaura borylation-Suzuki coupling of 3-
iodotyrosine derivative (Skaff et al. 2005). It involves protection of 3-iodo-L-tyrosine 
under standard conditions, followed by Miyaura borylation with bis(pinacolatodiboron) 
to give the tyrosine-3-boronate derivative. In turn, the tyrosine-3-boronate derivative 
was coupled with 3-iodo-L-tyrosine derivative by Suzuki coupling to give protected 
dityrosine (Figure 3-2). 
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Figure 3-2: Two-step Suzuki-Miyaura coupling reaction. Adapted from Skaff et al., 2005. 
 
This procedure was developed to prepare the protected dityrosine through a one-pot, 
tandem Miyaura borylation-Suzuki coupling from the 3-iodo-L-tyrosine derivative 
(Figure 3-3). 
 
 
Figure 3-3: One-pot tandem Suzuki-Myiaura coupling reaction. Adapted from Skaff et al., 2005. 
 
3-Iodo-L-tyrosine                          3-Iodo-L-tyrosine 
                                                      derivative  
Protected dityrosine 
Iodotyrosine derivative 
Protected dityrosine                              Dityrosine 
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 Experimental(3.3
 Dityrosine synthesis 3.3.1
In order to explore the most effective strategy of dityrosine synthesis, four protocols 
were tested as described below:  
 
 Suzuki-Miyaura coupling reaction 3.3.1.1
Dityrosine was prepared in three steps based on the procedure of Skaff et al. (Skaff et 
al. 2005) with some modifications. 
 
Step 1: Synthesis of N-Cbz-4-O-benzyl-3-iodo-L-tyrosine ester (3-iodo-L-tyrosine 
derivative). 
 
 
Figure 3-4: Chemical structure of N-Cbz-4-O-benzyl-3-iodo-L-tyrosine. 
 
3-Iodo-L-tyrosine (2.5 g, 8.14 mmole) was added to an ice-cold solution of potassium 
carbonate (3.38 g, 24.4 mmole) in 30 ml water, then 4.2 ml of 50% (v/v) benzyl 
chloroformate in toluene solution was added over 30 min at 0 °C. The mixture was 
stirred at 25 °C for 21 h. In turn, the resulting mixture was acidified to pH 4.0 with 3 M 
HCl and extracted with EtOAc (4x50 ml). In order to obtain Cbz-3-iodo-L-tryrosine, the 
combined organic extracts were washed with saturated sodium chloride solution (2x50 
ml), dried using MgSO4, and concentrated in vacuo to give white powder. 
Subsequently, the crude Cbz-3-iodi-L-tyrosine was added to a solution of potassium 
carbonate (3.4 g, 24.6 mmole) and tetrabutylammonium iodide (40 mg) in 100 ml of dry 
acetone. Later, a nitrogen gas was bubbled through the mixture for 15 min, then 2.15 ml 
of benzyl bromide was added and the resulting mixture was heated under reflux in the 
dark for 20 h. The resulting mixture was cooled and concentrated in vacuo and 50 ml of 
water was added to the residue and the resulting mixture was extracted with DCM 
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(3x50 ml). The combined organic extracts were dried using MgSO4 and concentrated in 
vacuo to give pale yellow oil. Flash chromatography was carried out on silica using 
EtOAc/hexane (1:3-1:1 gradient) to give the desired compound (3.45 g, 68%) as a 
colourless solid: 1H NMR (500 MHz, Chloroform-d) δ 7.55 (d, 1H), 7.40 – 7.30 (m, 
15H), 6.92 (dd, J = 1.9, 8.0 Hz, 1H), 6.67 (d, J = 8 Hz, 1H), 5.26 (br d, J = 7.0 Hz, 1H), 
5.17 – 5.08 (m, 6H), 4.70 – 4.60 (m, 1H), 3.07 – 2.96 (m, 2H); 13C NMR (126 MHz, 
cdcl3) δ 171.1 (C), 156.4 (C), 155.5 (C), 140.1 (CH), 136.4 (C), 134.9(C), 130.2(CH), 
130.1 (C), 128.7 (CH), 128.7 (CH), 128.6 (C), 128.5 (CH), 128.5 (CH), 128.2 (CH), 
128.1 (CH), 128.1 (CH), 127.9 (CH), 127.0 (CH), 112.5 (CH), 86.8 (C), 70.9 (CH2),  
67.4 (CH2), 67.0 (CH2), 54.9 (CH), 36.9 (CH2); HR-MS (ESI +ve) m/z calculated for 
[M+Na]+ 644.0904, found 644.0893. See appendix i and ii for 1H and 13C NMR specta 
of 3-iodo-L-tyrosine derivative respectively. 
 
Step 2: Synthesis of protected dityrosine 
 
 
Figure 3-5: Chemical structure of protected dityrosine. 
 
Bis(pinacolato)diboron (20.5 mg, 0.086 mmole) was added to a solution of iodotyrosine 
derivative (52.9 mg, 0.09 mmole), Pd(dppf)Cl2.NH2-Cl2 (2.0 mg), and potassium 
carbonate (44.7 mg, 0.36 mmole) in 1.5 ml of dry DMSO. The resulting mixture was 
stirred under nitrogen at 80 °C for 48 h. In turn, it was extracted with EtOAc (3x30 ml) 
and the combined organic extracts were washed with 50% saturated sodium chloride 
solution (2x30 ml), dried using MgSO4, and concentrated in vacuo to give crude 
protected dityrosine as a dark brown oil. Subsequently, the oil was chromatographed on 
silica eluting with ether/DCM/hexane (1:2:3-1:2:2 gradient) to give pure protected 
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dityrosine (16.7 mg, 40%) as a pale yellow oil: 1H NMR (600 MHz, Chloroform-d) δ 
7.28 – 7.08 (m, 30H), 6.98 – 6.96 (m, 2H), 6.91 (dd, J = 1.9, 8.4 Hz, 2H), 6.77 (d, J = 
8.4 Hz, 2H), 5.22 (br d, J = 7.8 Hz, 2H), 5.10 – 4.98 (m, 8H), 4.89 (s, 4H), 4.66 – 4.62 
(m, 2H), 3.10 – 2.97 (m, 4H); 13C NMR (151 MHz, cdcl3) δ 171.41 (C), 155.63 (C), 
155.30 (C), 137.35 (C), 136.22 (C), 135.12 (C), 132.57 (CH), 129.19 (CH), 128.50 
(CH), 128.43 (CH), 128.36 (CH), 128.34 (CH), 128.26 (CH), 128.05 (CH), 127.99 
(CH), 127.48 (C), 127.33 (CH), 126.53(CH), 113.12 (CH), 70.26 (CH2), 67.09 (CH2), 
66.87 (CH2), 54.92 (CH), 37.33 (CH2) (one quaternary carbon not observed); HR-MS 
(ESI, +ve) m/z calculated for [M+Na]+ 1011.3827, found 1011.3833. See appendix iii 
and iv for 1H and 13C NMR specta of protected dityrosine respectively. 
 
Step 3: Hydrogenation of protected dityrosine 
30 mg of 10% palladium on charcoal was added to a solution of 290 mg of protected 
dityrosine in 12 ml of dry MeOH. The resulting mixture was stirred under hydrogen 
using 1 bar pressure at 25 °C for 48 h. The resulting mixture was filtered through Celite 
and refluxed with 30 ml of 6 M HCl for 10 h, then concentrated in vacuo to give crude 
dityrosine. RP-HPLC was carried out in order to obtain pure dityrosine, which was then 
dried using a Freeze dryer (Edwards, England). 
 
 Dityrosine synthesis using KBrO3 3.3.1.2
10 mg of L-tyrosine was dissolved in 2 ml deionised water with addition of 100 µl (1.6 
M) HCl. The resulting mixture was divided into six glass (13x100 mm) tubes. Then 2 
ml aqueous potassium bromate (2.4 mM) was added to each tube, which were covered 
with aluminium foil and heated at 150 °C for 25 min in a convection oven. The 
resulting mixture was cooled, concentrated in vacuo and dissolved in 3 ml of deionised 
water. The resulting mixture was centrifuged through 0.22 µm nylon centrifuge tube 
filters at 2700 g, and analysed by mass spectrometry as described in section 3.3.2.2 
(Tilley et al. 2004). 
 
 Dityrosine synthesis via Mn(III)-mediated oxidation of tyrosine 3.3.1.3
Mn(III) acetate (25 ml, 5 mM) was added to 25 ml of (5 mM) tyrosine solution in 0.2 M 
phosphate pH 2.1. After 1 min the resulting mixture was filtered to remove any 
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undissolved Mn(III) acetate and the filtrate was dried under vacuum at 80 °C. Ammonia 
water was added in excess to remove the phosphate, which was in turn filtered and the 
remaining ammonia water was removed in vacuo. Unreacted tyrosine remaining in the 
dry material was removed by washing with cold acidic water (4 °C, pH 2) and filtration. 
The resulting product was analysed by mass spectrometry as described in section 3.3.2.2 
(Lee et al. 2008). 
 
 Enzymatic-catalysed synthesis of dityrosine 3.3.1.4
Dityrosine synthesis was achieved here according to modifications of established 
procedures (Atwood et al. 2004; Guo et al. 1997), which is involved two steps: 
 
Step 1: Synthesis of diiodo diacetyl dityrosine.  
 
 
Figure 3-6: Chemical structure of diiodo diacetyl dityrosine. 
 
20 units of HRP were added to a clear solution of N-acetyl-3,5-diiodo-L-tyrosine (190 
mg, 0.4 mmole) in 40 ml of 0.1 M phosphate buffer pH 6.0 containing 10% of 
acetonitrile then mixed gently. Immediately, H2O2 (0.48 ml, 1 M) was added then the 
reaction mixture was stirred gently for 60 min at 24 °C, quenched with 1.2 ml of 1 M 
NaHSO3 and the pH of the mixture was adjusted to 7.5 with 1 M NaOH. After stirring 
for 10 min the mixture was acidified to pH 3.0 with 2 M KHSO4 and then extracted with 
ethyl acetate (3x30 ml). The combined organic residues were concentrated in vacuo to 
give a tan residue, which was purified by flash chromatography using 
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EtOAc/acetone/acetic acid (100: 10: 2 gradient) to give (41 mg, 29.1%) 3,3`-diiodo-
N,N`-diacetyldi-L-tyrosine. 1H NMR (500 MHz, Acetone-d6) δ 7.64 (s, 2H), 7.33 (d, J = 
8.0 Hz, 2H), 7.14 (s, 2H), 4.82 – 4.76 (m, 2H), 3.16 (dd, J = 13.9, 5.3 Hz, 2H), 2.93 (dd, 
J = 13.9, 7.9 Hz, 2H), 1.91 (s, 3H);13C NMR (126 MHz, acetone) δ 172.80 (C), 171.85 
(C), 170.54 (C), 153.19 (C), 140.89 (CH), 133.63 (CH), 131.82 (C), 86.19 (C), 53.91 
(CH), 37.02 (CH2), 22.56 (Me); HR-MS (ESI, +ve) m/z calculated for [M+H]+ 
696.9538, found 696.9531. See appendix v and vi for 1H and 13C NMR spectra of 
diiodo diacetyl dityrosine respectively. 
 
Step 2: De-protection of protected dityrosine 
The resulting 3,3`-diiodo-N,N`-diacetyldi-L-tyrosine was hydrogenated in 50% 
methanol acetic acid to give N,N`-diacetyldi-L-tyrosine, which was heated at reflux in a 
1:1 mixture of tetrahydrofuran and concentrated HCl for 6 h to give dityrosine. Gel 
filtration on sephadex G-10 was carried out in order to remove the salt and further 
purification achieved using RP-HPLC. Finally, the purified dityrosine was dried by 
Freeze dryer (Edwards, England), and then analysed by mass spectrometry, 
fluorescence photometer, and NMR as described below. 
 
 Detection and characterisation of synthesised dityrosine 3.3.2
 HPLC analysis 3.3.2.1
The HPLC analysis was performed using an Agilent 1100 Series HPLC system fitted 
with an ultraviolet absorbance detector at 280 nm. Purified dityrosine (10 µl) was 
injected onto a C18 SunFire reversed–phase column (5 µm particle size, 4.6x250 mm, 
Waters, Ireland) using a stepwise gradient (3, 20, 100, 3) of acetonitrile containing 0.1% 
Trifluoroacetic acid (TFA) at 0, 10, 20, 30 min respectively, with a flow rate of 1 
ml/min and a column temperature of 25 °C. Dityrosine eluted at 11.6 min and collected, 
in turn it was dried using nitrogen gas for further analyses. 
 
 Mass spectrometric detection  3.3.2.2
High resolution mass spectrum (HRMS) of synthesised dityrosine was acquired using 
Bruker Daltonios Apex III 4.7 Tesla Fourier Transform ion cyclotron resonance mass 
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spectrometer (FT-ICR-MS) with ESI. The synthesised dityrosine was dissolved in a 
solution of 1:1 methanol and water with 0.1% formic acid. 
 
 Fluorimetric detection  3.3.2.3
The purified dityrosine was detected by measuring the fluorescence intensity on Varian 
Cary Eclipse fluorimeter (Varian, UK), using excitation wavelength 280 nm and 
emission wavelength 410 nm in acidic solution (0.02 N HCl).  
 
 NMR analysis  3.3.2.4
The identity and purity of synthesised dityrosine were confirmed by 1H and 13C NMR 
spectra, which were recorded in D2O on Varian VNMRS 500 MHz spectrometer using 
residual protic solvent as an internal reference.  
 
 Development of LC-ESIMS/MS method for analysis of dityrosine 3.3.2.5
A- Mobile phase optimisation 
A primary goal of the present work was to optimise the LC-ESIMS/MS condition 
including, mobile phase composition and choosing an effective column, that enables 
efficient analysis of dityrosine. A preliminary optimisation of the mobile phase was first 
performed using tyrosine standard instead of dityrosine due to the limitation of the 
dityrosine amount that I have prepared and also because of the similarity in 
chromatographic behavior of tyrosine and dityrosine, which was previously seen in 
optimising the HPLC condition. Standard tyrosine was analysed in ESI ve+ with two 
different mobile phase eluents, and the mass spectra were acquired using full scan mode 
and Phenomenex Synergi 4u Hydro-RP 80 Å (150 mm x 2 mm, 4 micron) column. For 
the first experiment the mobile phase eluent was: (A) 0.1% formic acid in water and (B) 
methanol. For the second experiment the mobile phase eluent was: (A) 10 mM 
ammonium acetate adjusted to pH 5.8 using acetic acid, and (B) methanol. The LC 
conditions in both experiments were as described in Table 3-1 using a flow rate of 0.2 
ml/min. Mass spectrometric detection was performed by ESI ve+ tandem mass 
spectrometry on a triple quadrupole mass spectrometer (MicroMass Quttro Premier, 
Waters, Ireland). The conditions for the mass spectrometer were as follows; 
electrospray ionisation spray voltage 3.5 kV, the cone voltage 35 V, the source 
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temperature at 100 °C, whereas the desolvation temperature was 400 °C. Argon was 
used as the collision gas at 5.95 x 10-3 mbar at 26 eV collision energy. 
 
Table 3-1: Liquid chromatography conditions that were used in tyrosine detection using LC-ESIMS/MS. 
Time (min) A% B% Curve 
0 100 0 1 
15 0 100 6 
20 100 0 6 
30 100 0 1 
 
B- Column performance  
Two different columns were tested to gain better mass spectrometry detection of 
dityrosine, Phenomenex Synergi 4u Hydro-RP 80 Å (150 mm x 2 mm, 4 micron) and 
Phenomenex Gemini 3u C6-phenyl 110 Å (150 mm x 4.6 mm, 3 micron) column. For 
the detection using Gemini 3u C6-phenyl column, 0.1% formic acid was used as a 
modifier with an acetonitrile and water mobile phase using a flow rate of 0.2 ml/min. 
The mass spectrum was acquired on MRM mode using LC condition as described in 
(Table 3-2). 
Table 3-2: Liquid chromatography conditions which were used in dityrosine detection by LC-ESIMS/MS, 
using Phenomenex Gemini 3u C6-phenyl 110 A° (150mm x 4.6mm, 3 micron) column.  
Time (min) A% B% Curve 
0 100 0 1 
1 100 0 1 
15 0 100 6 
20 0 100 1 
25 100 0 6 
30 100 0 1 
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Mass spectrometric detection was performed by ESI ve+ tandem mass spectrometry on 
a triple quadrupole mass spectrometer (MicroMass Quttro Premier, Waters, Ireland). 
The conditions for the mass spectrometer were as follows; ESI voltage 3.5 kV, the cone 
voltage 35 V, the source temperature at 100 °C, whereas the desolvation temperature 
was 400 °C. Argon was used as the collision gas at 5.95 x 10-3 mbar at 26 eV collision 
energy. 
 
Dityrosine detection using Phenomenex Synergi 4u Hydro-RP 80 Å was performed as 
described above in tyrosine detection using formic acid as a modifier and solvent B was 
acetonitrile instead of methanol, and following the same LC and mass conditions.  
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 Results(and(discussion(3.4
 Dityrosine synthesis  3.4.1
Dityrosine is an unusual amino acid that results from a carbon-carbon bond formation 
between two tyrosine residues. Although many protocols have been developed to 
synthesise dityrosine, just a few strategies have succeeded in preparing dityrosine to 
sufficient yield. To compare the relative efficiency of dityrosine synthesis strategies, 
four alternative enzymatic and chemical oxidative coupling methods were evaluated as 
follows: enzymatic oxidative phenolic coupling (Guo et al. 1997), the Suzuki-Miyaura 
coupling reaction (Skaff et al. 2005), Mn(III)-mediated oxidation of tyrosine (Lee et al. 
2008), and chemical oxidative coupling of tyrosine by KBrO3 (Tilley et al. 2004). 
 
Dityrosine formation by enzymatic oxidative phenolic coupling was achieved according 
to the method described by Guo et al. (Guo et al. 1997) with some modifications. N-
acetyl-3,5-diiodo-L-tyrosine was oxidatively dimerised under enzymatic conditions 
using horseradish peroxidase and hydrogen peroxide in phosphate buffer pH 6. The 
modification of the original procedure included the reduction of phosphate buffer 
concentration from 0.2 to 0.1 M, which resulted in a significantly higher yield of 
dityrosine. Further modifications were included increasing the incubation period to 60 
min instead of 10 min and mixing the reaction mixture very gently. The latter change 
strongly affected the product yield and that due to enzyme inactivation by prolonged 
agitation (Malencik et al. 1996). Finally, 3,3'-diiodo-N,N'-diacetyl di-L-tyrosine 
(DADT) was hydrogenated in 50% methanolic acetic acid (Atwood et al. 2004) which 
gave higher yield than the aqueous methanolic HCl (Nishiyama et al. 1994). 
 
Alternatively, dityrosine can be prepared by chemical oxidative coupling using different 
oxidative agents. Authentic dityrosine was synthesised in three steps from 3-iodo-L-
tyrosine using the one pot Miyaura borylation-Suzuki coupling strategy, which is the 
most efficient method among the chemical oxidative coupling methods. The amino, 
carboxyl, and hydroxyl groups were blocked under standard conditions to prevent any 
side reactions such as decarboxylation. In addition, the use of benzyl carbamate, ester, 
and ether protective groups was employed to allow a one-step global deprotection of the 
protected dityrosine derivative. Subsequently, the protected 3-iodo-L-tyrosine 
underwent Miyaura borylation with bis(pinacolatodiboron) to give tyrosine-3-boronate 
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derivative. In turn, the tyrosine-3-boronate derivative coupled with 3-iodo-L-tyrosine 
derivative through Suzuki coupling to give the protected dityrosine. Then the 
conversion of protected dityrosine was achieved by treatment with palladium-on-
charcoal under an atmosphere of hydrogen and 6 bar pressure.  
 
Published data have established that the Suzuki-Miyaura coupling reaction is the most 
effective among the chemical and enzymatic oxidative coupling strategies in 
preparation of dityrosine. On the other hand, high level skills and experience of organic 
synthesis are required to perform the Suzuki-Miyaura coupling procedure and 
furthermore it takes longer than other procedures as shown in Table 3-3. 
 
Table 3-3: Comparison of dityrsoine synthesis protocols. It is revealed that Susuki-Miyaura coupling 
procedure (protocol 2) has higher yield. 
Number Reference Starting material Number of 
steps 
Reported  
Yield % 
Experimental  
Yield % 
1 Lee et al., 2008 L-tyrosine One 15.8 - 
2 Skaff et al., 2005 3-Iodo-L-tyrosine Three 53 15 
3 Tilly et al., 2004 L-tyrosine One 31 - 
4 Guo et al., 1997 N-acetyl-3,5-
diiodo-L-tyrosine 
Two - 10 
 
Finally, both Lee et al. (Lee et al. 2008) and Tilley et al. (Tilley et al. 2004) described a 
simple procedures to rapidly prepare dityrosine from L-tyrosine in good yield using 
Mn(III) acetate and KBrO3 respectively as oxidising agents. Unfortunately, although I 
repeated these protocols several times, these methods did not give me the desired 
product. In the Tilley et al. method the formation of dityrosine requires the proximity of 
two tyrosyl radicals, thus the bromonation would be favoured because of steric 
hindrance requirements. 
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 Detection and Characterisation of Synthesised Dityrosine 3.4.2
Detection and characterisation of synthesised dityrosine were performed by RP-HPLC 
followed by mass spectrometric and fluorimetric detection. In addition, 1H NMR and 
13C NMR were obtained to confirm that the oxidation product of tyrosine derivatives, 
which were prepared using different procedures, was dityrosine. 
 
The purified dityrosine was loaded onto a C18 SunFire column and monitored using a 
UV absorbance detector at absorbance 280 nm. The RP-HPLC pattern of the purified 
dityrosine (Figure 3-7) showed a major single peak with retention time (Rt =11.6 min) 
and maximum absorbance at 280 nm. Consequently, the major peak was collected and 
dried in N2 flow, then redissolved in methanol and water 50:50 in 0.1% formic acid in 
order to obtain the mass spectrum.  
 
 
Figure 3-7: RP-HPLC chromatogram of synthesised dityrosine with retention time 11.6 min at 
absorbance 280 nm. 
 
Synthesised ditryrosine was analysed by Bruker Daltonics APEX III 4.7 Tesla Fourier 
Transform ion cyclotron resonance mass spectrometer (FT-ICR-MS) with ESI +ve and 
found to be m/z [M + H]+ 361.1404 compare with calculated m/z 361.1394 (Figure 3-8), 
and that was consistent with published results (Guo et al. 1997; Lee et al. 2008; Skaff et 
al. 2005). 
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Figure 3-8: Mass spectrum of synthesised dityrosine. HRMS of dityrosine is calculated m/z 361.1394 and 
found to be 361.1404. The mass spectrum reveals the most intense fragmentation ion 315.1348, which is 
used later on detection of dityrosine by LC-MS/MS using MRM mode.  
 
Dityrosine is a fluorescent molecule, thus fluorescence intensity measurements were 
carried out on a Cary Eclipse fluorescence spectrophotometer. The results showed a 
fluorescence signal at emission wavelength 405 − 410 nm and excitation at 280 nm in 
(0.02 N) HCl (Figure 3-9) and this agrees with data reported by (Jacob et al. 1996). In 
contrast, tyrosine exhibits fluorescence signal at emission 305 nm and excitation 280 
nm (Lakowicz 2007). 
 
 
Figure 3-9: Fluorescence spectrum of synthesised dityrosine showing characteristic dityrosine 
fluorescence signal at 410 nm. The excitation wavelength was set at 280 nm. 
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The 1H NMR spectrum of synthesised dityrosine and its chemical structure are shown in 
Figure 3-10. This spectrum is very similar to those published elsewhere (Jacob et al. 
1996; Lee et al. 2008; Skaff et al. 2005). The 1H NMR spectrum contained six proton 
signals with chemical shifts of: 7.30 ppm (H, d), 7.21 ppm (H, s), 7.07 ppm (H, d), 4.26 
ppm (H, m), 3.35 ppm (H, dd), and 3.26 ppm (H, dd) (Figure 3-10). 
 
The 1H NMR spectrum of tyrosine shows two equivalents sets of aromatic shifts at δ 6.9 
and 7.2 ppm (Sharma and Jain 1998). On the other hand, the synthesised dityrosine 
appeared to have three different sets of aromatic protons at δ 7.30, 7.21, and 7.07 ppm 
(Figure 3-10), and that were consistent with the 1H NMR spectrum of dityrosine 
reported elsewhere (Lee et al. 2008; Sharma and Jain 1998; Skaff et al. 2005). 
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Figure 3-10: (A) 1H NMR spectrum of synthesised dityrosine. The spectrum was recorded in D2O on 
Varian VNMRS 500 MHz using residual protic solvent as an internal reference. The 1H NMR spectrum of 
dityrosine shows six proton signals. Dityrosine appeared to have three different sets of aromatic protons 
at δ 7.30, 7.21, and 7.07 ppm. 
 
The 13C NMR spectrum of synthesised dityrosine reveals nine carbon signals with 
chemical shift of: 173.93, 153.09, 132.00, 130.20, 126.78, 125.93, 116.70, 56.05, and 
35.41, as shown in Figure 3-11. The chemical structure of dityrosine shows nine 
different carbon atoms: 3 aromatic (CH), 3 aromatic (C), 1 aliphatic (CH2), and 1 (C) 
from carboxylic group. The carbon atom types and their corresponding chemical shift 
are described in Table 3-4, and they literature values match well.  
 
Table 3-4: 13C NMR chemical shifts of authentic dityrosine and their corresponding carbon atom. 
Number of carbon atom Type of Carbon (CHn) Chemical shift (δ) ppm 
3 CH (aromatic) 130.20, 126.78, 116.70 
3 C (aromatic) 153.09, 132.00, 125.93 
1 CH (aliphatic) 56.05 
1 CH2 (aliphatic) 35.41 
1 C (from carboxylic group) 173.93 
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Figure 3-11: 13C NMR spectrum of authentic dityrosine recorded in D2O on Varian VNMRS 500 MHz 
using residual protic solvent as an internal reference. The 13C NMR spectrum revealed nine carbon 
signals which corresponding to the carbon atoms of dityrosine. 
 
 Development of LC-ESIMS/MS methodology to detect dityrosine 3.4.3
A range of experimental conditions was examined in order to facilitate the detection of 
dityrosine using LC-ESIMS/MS, include mobile phase optimisation and column 
performance. 
 
 Mobile phase optimisation  3.4.3.1
Mass spectrometry is a powerful tool for detection and monitoring the posttranslational 
modifications of proteins (Cox et al. 2005). However, mobile phase composition and its 
pH seem important to obtain better chromatographic separation and mass detection. A 
preliminary optimisation of the mobile phases was first performed using tyrosine 
standard instead of dityrosine due to the limitation of dityrosine amount that was 
prepared and also because of the similarity in chromatographic behavior of tyrosine and 
dityrosine, which was previously seen in optimising HPLC seperetion condition. 
Standard tyrosine was analysed using LC-ESIMS/MS.  
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Two different mobile phase systems were tested, and the mass spectra were acquired 
using full scan mode and Phenomenex Synergi 4u Hydro-RP 80 Å (150 mm x 2 mm, 4 
micron) column. For the first experiment the mobile phase eluent was: (A) 0.1% formic 
acid in water (pH 2.7), and (B) methanol. For the second experiment the mobile phase 
eluent was: (A) 10 mM ammonium acetate adjusted to pH 5.8 using acetic acid, and (B) 
methanol. The results indicate that using ammonium acetate as a modifier improves the 
retention time from 2.2 min, in the case of formic acid as a modifier, to 5.8 min (Figure 
3-12). In turn, this would improve the resolution. 
 
 
Figure 3-12: LC-ESIMS/MS chromatograms of tyrosine standard acquired on full-scan mode using 
Phenomenex Synergi 4u Hydro-RP 80 A° (150 mm x 2 mm, 4 micron) column. A) LC-MS chromatogram 
obtained using formic acid as a modifier with retention time of 2.2 min. B) LC-MS chromatogram 
obtained using ammonium acetate as a modifier with retention time of 5.8 min. Using ammonium acetate 
as a modifier result in better retention time. 
 
LC-ESIMS/MS of the dityrosine standard was accomplished using 10 mM ammonium 
acetate (pH 5.8) as a modifier, the mass spectra were acquired on both full-scan and 
single ion reaction (SIR) mode. Further mass analyses show a peak with retention time 
of 7.5 min that corresponds to the dityrosine standard (Figure 3-13, B), compared to 
tyrosine, which has retention time 5.7 min (Figure 3-13, A), indicating good 
chromatographic separation.  
A 
B 
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Figure 3-13: LC-ESIMS/MS chromatograms showing tyrosine standard in panel A, dityrosine standard in 
panel B and C. The LC-MS chromatograms were acquired using 10 mM ammonium acetate (pH5.8) as a 
modifier and Phenomenex Synergi 4u Hydro-RP 80 A° (150 mm x 2 mm, 4 micron) column.  
 
 In order to improve the mass sensitivity and specificity of dityrosine, the SIR technique 
was carried out using 10 mM ammonium acetate to monitor protonated ion [M+H]+ 
361.1 (Figure 3-13, C). Using the SIR technique, a much higher sensitivity of dityrosine 
detection and also better peak shape was obtained (Figure 3-13, C).  
 
 Column performance 3.4.3.2
Although adding ammonium acetate to the mobile phase improved the retention time, 
detecting dityrosine at low concentrations is still challenging due to signal suppression 
by ammonium ions. As a result, a new chromatographic strategy was followed using a 
different column, and formic acid as a modifier instead of ammonium acetate. Formic 
acid helped to avoid ion suppression and also to obtain good peak shape and retention 
time.  
 
Two different types of columns were tested in terms of column performance in 
dityrosine retention: Phenomenex Synergi 4u Hydro-RP 80 A° (150 mm x 2 mm, 4 
micron) and a Phenomenex Gemini 3u C6-phenyl 110 Å (150 mm x 4.6 mm, 3 micron) 
column. The latter shows higher efficiency in dityrosine retention using formic acid as a 
A 
C 
B 
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modifier instead of ammonium acetate and that resolves the signal suppression problem. 
Moreover the MRM technique was used (Figure 3-14, A) instead of a full-scan (Figure 
3-14, B), resulting in much higher sensitivity and specificity.  
 
Elimination of carbon chain length from C18, in Phenomenex Synergi 4u Hydro-RP 80 
Å column, to C6 in Phenomenex Gemini 3u C6-phenyl 110 Å, resulted in reduction of!
the hydrophobic character of the stationary phase and improved the retention of 
dityrosine, which is hydrophilic. Also, adding a phenyl group to the end of the carbon 
chain leads to an aromatic-aromatic interaction, which in turn modulates dityrosine 
retention in the stationary phase.!!! 
 
 
Figure 3-14: LC-ESIMS/MS chromatograms of dityrosine. A) LC-ESIMS/MS chromatograms of 
dityrosine standard acquired on MRM mode using Phenomenex Gemini 3u C6-phenyl 110 A° (150 mm x 
4.6 mm, 3 micron) column and formic acid as a modifier with retention time of 5.5 min. B) LC-ESIMS/MS 
chromatograms of dityrosine standard acquired on full-scan mode using Phenomenex Synergi 4u Hydro-
RP 80 A° (150 mm x 2 mm, 4 micron) column and formic acid as a modifier with retention time of 1.8 
min. 
 
Characterisation of authentic dityrosine was achieved using Phenomenex Gemini 3u C6-
phenyl 110 Å (150 mm x 4.6 mm, 3 micron) column, the mass spectrometry was 
operated in the MRM mode with ESI ve+. The solvent of the mobile phase were A: 
0.1% formic acid in water; and solvent B: 0.1% formic acid in acetonitrile, and the flow 
rate was 200 µl/min. Dityrosine has been reported to show a fragmentation pattern 
A 
B 
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(Figure 3-15) to give the following protonated product ions at m/z; 315, 283, 269, 254, 
and 237 (Fenaille et al. 2004; Takasaki et al. 2005). 
 
 
 
Figure 3-15: Dityrosine fragmentation pattern as proposed by (Takasaki et al. 2005) and (Fenaille et al. 
2004). 
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Dityrosine identification was achieved by monitoring the transition reactions; 
361.1→315, 361.1→283, 361.1→269, 361.1→254, and 361.1→237 as shown in 
(Figure 3-16, A). The mass spectrum shows that 361.1→315 transition is the most 
intense (Figure 3-16, B), thus it will be used to detect dityrosine in the rest of the study. 
 
 
Figure 3-16: A) LC-ESIMS/MS chromatograms of authentic dityrosine were recorded using MRM mode, 
showing the characteristic dityrosine product ions. B) The total ion chromatogram of authentic dityrosine 
with m/z 361 [M+H]+ (the protonated ion of dityrosine). 
 
In LC-MS, certain modifiers are often added to the mobile phase to obtain better 
resolution and retention. Formic and acetic acid are commonly used as modifiers due to 
their ability to improve retention and/or peak shape. Moreover, many mass 
spectrometric analyses are accomplished in positive mode, which is achieved by the 
addition of a proton to form the molecular ion [M+H]+. However, polar and ionic 
compounds are poorly retained on the column that used in RP-HPLC and usually elute 
near the solvent front. Volatile salt, such as ammonium acetate and formate, are mobile 
phase modifiers for LC-MS detection that achieved under neutral conditions. However, 
compared to their corresponding organic acid, i.e. acetic and formic acid respectively, 
their use in mass analyses is more complex. They have limited solubility in organic 
solvents and also the pH value of mobile phase is changed during a gradient. Using 
ammonium salts could result in mass signal suppression due to affinity of ammonium 
ion toward proton, in turn affects the amount of protonated ion in the gas phase that 
ultimately reaches the mass detector (Watson and Sparkman 2008).  
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Ion pairing reagents, e.g. TFA, are commonly used to enhance the retention of ionic and 
hydrophilic compounds by ion pair formation. TFA is commonly added to mobile phase 
for RP-HPLC of proteins and peptides, resulting in a neutral species formation, 
increasing the hydrophobic character, and enhancing the retention. In addition, TFA 
improves peak shape and resolution by reducing silanol interaction (Watson and 
Sparkman 2007). Whereas TFA is often cited as a good modifier for PR-HPLC due to 
its ability to improve retention and peak resolution, the presence of TFA in the mobile 
phase adversely affects the mass signal (Watson and Sparkman 2008). 
 
 Conclusion(3.5
Dityrosine is a tyrosine dimer that results from the ortho-ortho coupling of two tyrosine 
residues. However, as dityrosine was not commercially available it was very important 
to synthesise authentic dityrosine and use it in the rest of our study as a standard. In this 
chapter, dityrosine synthesis was explored using several protocols and milligram 
quantities were prepared. Synthesised dityrosine was characterised using different 
analytical techniques including RP-HPLC, mass spectrometry, fluorescence 
spectrophotometry, and NMR. Our results revealed that Suzuki-Miyaura coupling 
reaction is the most effective among the chemical and enzymatic oxidative coupling 
strategies in preparation of dityrosine. In order to detect dityrosine in our samples, LC-
ESIMS/MS method was developed and optimum conditions were obtained. The data 
shows that using formic acid as a modifier in the mobile phase results in acquiring 
better mass spectra, moreover Phenomenex Gemini 3u C6-phenyl 110 Å showed better 
performance in dityrosine retaining using formic acid as a modifier.  
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4 Results and Discussion  
Cu2+/H2O2 oxidation system leads to dityrosine generation in 
two short amyloidogenic peptides 
 
 Introduction(4.1
Amyloid fibrils are associated with a large number of diseases in which proteins and 
peptides abnormally assemble to form insoluble amyloid deposits in tissues. It has been 
well established that amyloid fibrils share a core cross-β structure (Jahn et al. 2010; 
Serpell et al. 1999) and many different proteins and peptides can form amyloid-like 
fibrils, which all share an amyloid-like conformation (Dobson 2003; Jahn et al. 2010; 
Sunde et al. 1997). The recent focus on the importance of sequence on amyloid forming 
propensity has lead to a number of algorithms designed to identify short amyloidogenic 
peptides (Maurer-Stroh et al. 2010; Pawar et al. 2005). Waltz is an algorithm aimed at 
identifying amyloidogenic peptides with a particular emphasis on the position of 
particular amino acid residues and this has identified a number of peptides that form 
highly ordered amyloid-like fibrils that share amyloid properties (Maurer-Stroh et al. 
2010). Several of these peptides identified contain aromatic residues including tyrosine, 
which is often favoured at position five within a hexapeptide but is also allowed at 
positions two and four (Maurer-Stroh et al. 2010). The hexa- and pentapeptides 
HYFNIF and VIYKI were of particular interest due to their highly organised fibrillar 
structure and the positions of the tyrosine residues allowing for potential dityrosine 
formation. The current study explored the oxidative modification of two short peptides, 
HYFNIF and VIYKI, using the Cu2+/H2O2 oxidation system, and studied the 
morphological and conformational changes of these amyloid fibrils over the oxidation 
process. This chapter describes the investigation into the influence of dityrosine cross-
linking (Figure 1-17) on the assembly and structure of the HYFNIF and VIYKI 
peptides. These peptides were selected as simple amyloid model systems that have been 
previously structurally characterised (Morris et al. 2013b) to better understand the 
dityrosine formation at a structural level and to optimise the oxidation conditions. In 
turn, these oxidation conditions can be used to enhance the dityrosine cross-link 
formation in both Aβ and α-syn as shown in chapter 5 and 6 respectively. 
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 Results(and(discussion((4.2
 Oxidation of tyrosine containing synthetic amyloid-like fibrils 4.2.1
The Waltz identified peptides, HYFNIF and VIYKI, form well characterised amyloid 
fibrils in water. These have been extensively studied by TEM, CD, LD, and XRFD 
(Morris et al. 2013b). HYFNIF and VIYKI peptides were dissolved in water at a 
concentration of 1.14 and 1.48 mM respectively and allowed to assemble to form fibrils 
at room temperature for 7 days. They were examined using negative stain TEM, which 
showed the expected long straight unbranching amyloid-like fibrils. Some showed 
lateral association and twisted morphologies as shown in insets (Figure 4-1). 
Fluorescence spectroscopy of the preformed amyloid fibrils at a concentration of 100 
µM revealed a strong peak at 305 nm, characteristic of the fluorescence arising from 
tyrosine residues (Figure 4-1).  
 
 
Figure 4-1: (A) Fluorescence spectrum of (100 µM) VIYKI amyloid-like fibrils in water, and transmission 
electron microscopy image obtained from VIYKI fibrils. B) Fluorescence spectrum of HYFNIF amyloid-
like fibrils in water at concentration of 100 µM, and transmission electron microscopy image obtained 
from HYFNIF fibrils. Upon excitation at 280 nm the tyrosine residue results in a peak at 305 nm. 
 
 
0 
25 
50 
75 
100 
125 
150 
290 315 340 365 390 415 440 
!"
#$
"%
&#
'(
)*
+,
+-(
.*/$0$"1#2()"3-(
0.1 µm 
0 
25 
50 
75 
100 
125 
150 
290 315 340 365 390 415 440 
!"
#$
"%
&#
'(
)*
+,
+-(
.*/$0$"1#2()"3-(
0.1 µm 
A 
B 
Chapter 4 
 
108 
Comparison of the signal intensity arising from the two peptides revealed a significantly 
stronger signal (a.u. ~ 125) for fibrils formed by VIYKI compared to HYFNIF (a.u. ~ 
40). This may reflect differences in the arrangements of the peptides within the fibrils 
and the exposure/burial of the tyrosine residues as discussed later. 
 
To shed light on the relative susceptibility of HYFNIF and VIYKI fibrils to oxidative 
dityrosine cross-linking, the effect of oxidation on the assemblies was examined, using 
Cu2+/ H2O2. Preformed amyloid-like fibrils of HYFNIF and VIYKI were incubated for 
72 h in the presence of Cu2+ (100 µM) and H2O2 (2.5 mM) in water (pH of 5.0 and 6.1 
respectively) at 37 ºC with agitation by shaking at 300 rpm. Fluorescence spectroscopy 
was used to monitor the extent of amyloid-like fibril oxidation and the results showed a 
new signal at 410 nm (Figure 4-2) corresponding to dityrosine cross-linking formation 
and consistent with the fluorescence signal exhibited by the dityrosine standard (Figure 
3-9). This was accompanied by a corresponding decrease in the signal intensity at 305 
nm arising from tyrosine (Figure 4-2). Again, differences in signal intensity were 
observed, whereby oxidised fibrils formed by HYFNIF gave a much lower signal than 
VIYKI. It might be that tyrosine residues in HYFNIF are more buried compared to that 
in VIYKI, thus they have less propensity to cross-link. 
 
 
Figure 4-2: Time course monitoring of HYFNIF and VIYKI fibril oxidation in water. 100 µM of (A) 
VIYKI and (B) HYFNIF fibrils were incubated in presence of Cu2+/ H2O2 in water for three days at 37˚C 
with agitation of 300 rpm. The insets showing dityrosine fluorescence signal arising at 410 nm, indicating 
of tyrosine oxidative modification under Cu2+-catalysed stress. 
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The presence of dityrosine in oxidised fibrils was confirmed using LC-ESIMS/MS 
following acidic hydrolysis of the oxidised VIYKI and HYFNIF fibrils. The dityrosine 
formation was identified using transition reactions ions 361.1→315, the most intense 
transition reaction ion as shown in chapter three, and has a retention time 5.5 min 
(Figure 4-3), consistent with that of authentic dityrosine. 
 
 
Figure 4-3:! LC-ESIMS/MS chromatograms recorded in the MRM mode for dityrosine from authentic 
dityrosine, VIYKI and HYFNIF fibrils hydrolysate. Oxidised VIYKI and HYFNIF fibrils were obtained 
from incubation of 50 µM VIYKI and 100 µM HYFNIF fibrils with Cu2+/H2O2 in water at 37 ºC with 
agitation of 300 rpm. In HYFNIF hydrolysate, there is a slight shift in the retention time due to 
experimental error of the LC-MS.  
 
LC-ESIMS/MS (MRM) technique is characterised by high sensitivity and specificity 
(Cox et al. 2005; Orhan et al. 2005), which enables us to follow and detect oxidative 
modifications of peptides and proteins at low concentration. Although the dityrosine 
that resulted from oxidation of 50 µM HYFNIF fibrils can be detected using LC-
ESIMS/MS (MRM), hydrolysis of 100 µM oxidised HYFNIF fibrils resulted in a better-
shaped (higher intensity and sharper) peak as shown in Figure 4-3, and this is because 
more dityrosine was released. Also, this could reflect the resulting dityrosine content in 
HYFNIF fibrils. 
 
 
Authentic)Dityrosine)
VIYKI)Hydrolysate)
HYFNIF)Hydrolysate)
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To estimate the dityrosine content in oxidised HYFNIF and VIYKI peptides, a 
dityrosine standard curve was generated. A set of dityrosine standard concentrations 
(0.1, 0.5, 1, 2, 3, and 5 µM) was made up in Milli-Q water using the synthetic 
dityrosine. Each concentration was prepared in triplicate and dityrosine fluorescence 
was recorded for each concentration using an excitation wavelength of 280 nm and 
emission wavelength 410 nm. The mean values of dityrosine fluorescence intensity for 
each concentration were plotted against dityrosine concentration and a standard curve 
was constructed by linear regression analysis using Microsoft Excel 2011 software 
(Figure 4-4). The equation of this line was used to quantify the dityrosine content of 
HYFNIF and VIYKI peptides, taking into account any differences in the environment 
of the dityrosine residues. 
 
 
Figure 4-4: Standard calibration curve for dityrosine standard (error bars indicate ± standard deviation 
of three experimental repeats). Linear standard curve of dityrosine was obtained over a concentration 
range (0.1-5 µM), dityrosine fluorescence signal was line when plot against concentration (inset panel). 
 
Although LC-ESIMS/MS (MRM) has a high sensitivity and selectivity and can be used 
to quantify dityrosine content with high accuracy, dityrosine content was assessed using 
fluorescence spectroscopy due to possible incomplete release of dityrosine using acid 
hydrolysis. In addition, fluorescence spectroscopy shows high sensitivity and no need to 
hydrolyse the peptide, making it a good technique to quantify dityrosine. After 24 h of 
oxidation, 0.06 and 0.2 µM of dityrosine was obtained from the oxidation of (100 µM) 
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HYFNIF and (100 µM) VIYKI fibrils respectively (Figure 4-2), indicating that more 
dityrosine was formed in VIYKI fibrils compared with HYFNIF.  
 
By contrast, 0.15 and 0.1 µM of dityrosine was formed in HYFNIF and VIYKI fibrils 
respectively after 72 h of oxidation, suggesting that further oxidation took place in 
VIYKI fibrils, whilst HYFNIF fibrils exhibited more resistance to the oxidative 
modification. There are many factors that need to be taken into account regarding the 
fluorescence data analysis. Firstly, HYFNIF and VIYKI have different molecular 
proportions of tyrosine residue. While HYFNIF consist of six amino acids, VIYKI has 
just five and that could result in more intense tyrosine fluorescence signal compared 
with HYFNIF. Secondly, both HYFNIF and VIYKI have different amino acid 
sequences and that could affect the oxidation process. Finally, the arrangement of the 
tyrosine residue within fibrils is completely different, as described later, consequently 
the tyrosine environment (buried/exposure) may play an important role in the resultant 
fluorescence signal. 
 
 Dityrosine cross-link formation at physiological pH 4.2.2
To maximise the oxidation conditions and to examine the pH effect on the extent of 
oxidation, 100 µM of both HYFNIF and VIYKI fibrils were oxidised in phosphate 
buffer pH 7.4 under Cu2+/ H2O2 condition. The fluorescence results indicate that the 
dityrosine formation increased significantly over oxidation time in phosphate buffer pH 
7.4 (Figure 4-5, A and Figure 4-6, A) compared to that in water (~ pH 6.1 for VIYKI 
and 5.0 for HYFNIF) (Figure 4-2). The oxidation of VIYKI fibrils over time revealed 
that dityrosine signal reaches the maximum amount after 24 h of incubation, while no 
significant increase was observed between 24 and 48 h of incubation. Prolonged 
oxidation was observed after 72 h of incubation, which appeared to result in a decline in 
dityrosine yield. Dityrosine can undergo further oxidative modification to form 
trityrosine, another tyrosine oxidative modification product (Jacob et al. 1996; Skaff et 
al. 2005). By contrast, HYFNIF fibrils exhibited more resistance to the oxidation, 72 h 
of incubation with Cu2+/H2O2 was required to yield maximum amount of dityrosine as 
shown in Figure 4-6, A.  
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Figure 4-5: Time course monitoring the VIYKI fibril oxidation in phosphate buffer pH 7.4. 100 µM of 
VIYKI fibrils were incubated in presence (A) and absence (B) of Cu2+/ H2O2 respectively, and the data 
revealed dityrosine fluorescence signal arising at 410 nm upon incubation with Cu2+/ H2O2. In addition, 
VIYKI fibrils were incubated with (C) Cu2+ only, and (D) H2O2 only showing no indication of a dityrosine 
signal at 410 nm.  
 
 
Figure 4-6: Time course study showing oxidation of HYFNIF fibrils in phosphate buffer pH 7.4. 100 µM 
of HYFNIF fibrils were incubated in presence (A) and absence (B) of Cu2+/ H2O2 respectively. In 
addition, HYFNIF fibrils were incubated with (C) Cu2+, and (D) H2O2 only. 
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It is obvious that HYFNIF fibrils oxidised to give dityrosine linkages in a different 
manner than for VIYKI fibrils, which showed a higher propensity to form dityrosine 
linkages. The result of oxidation over time of HYFNIF and VIYKI amyloid-like fibrils 
revealed that dityrosine cross-link formation in VIYKI fibrils is more rapid than for 
HYFNIF fibrils (Figure 4-7), and also more dityrosine was yielded in VIYKI fibrils. 
This conclusion is supported by the TEM micrograms of oxidised HYFNIF and VIYKI 
fibrils, which revealed an extensive morphological change in oxidised VIYKI fibrils 
compared with HYFNIF (Figure 4-8). 
 
 
Figure 4-7: Dityrosine formation extent in both (A) VIYKI and (B) HYFNIF fibrils using phosphate buffer 
pH 7.4. The data show that VIYKI fibrils form dityrosine linkage rapidly and more efficiently than 
HYFNIF.  
 
Addition of H2O2 alone to the amyloid-like fibrils did not result in any dityrosine cross-
links formation as shown in (Figure 4-5, D) and (Figure 4-6, D), indicating the 
importance of catalytic role played by Cu2+ ions in the oxidative coupling of tyrosine 
residues. The addition of Cu2+ ions to the oxidation solution induced dityrosine cross-
link formation and this is consistent with the results reported for Aβ (Atwood et al. 
2004; Huggins et al. 1993; Smith et al. 2007). Furthermore addition of Cu2+ ions only 
showed no dityrosine signal and also quenched the tyrosine fluorescence signal at 305 
nm as shown in (Figure 4-5, C) and (Figure 4-6, C), and that may be due the 
coordination of Cu2+ ion with tyrosine residue or that tyrosine residue located close to 
the binding site of the Cu2+ as shown for Aβ  (Maiti et al. 2008; Tougu et al. 2008).  
 
 
Quenching of tyrosine signals were also observed after 24 h of incubation of VIYKI 
fibrils with and without H2O2 as shown in (Figure 4-5, D, and B) respectively, and this 
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could be attributed to maturation of the fibril structure leading to further quenching of 
tyrosine by solvent or precipitation of the fibrils at pH 7.4. 
 
On the other hand, the tyrosine signal was enhanced after 24 h of incubation of 
HYFNIF fibrils with and without H2O2 as shown in (Figure 4-6, D and B) respectively, 
which could be due to increased solubility of HYFNIF fibrils in phosphate buffer over 
the agitation, in turn that will result in more tyrosine residues to be solution accessible. 
Also, HYFNIF fibrils could be undergoing a structural change as they mature that 
enhances the tyrosine signal. 
 
Studies of autoxidation and oxidation by H2O2 of phenols catalysed by Cu2+-
ethylenediamine complexes (Kushioka 1983; Kushioka et al. 1989) showed that Cu2+-
ethylenediamine complexes have the ability to catalyse the oxidation of phenols and 
produce biphenol compounds. It was demonstrated that the mechanism of the oxidation 
of phenols involved Cu2+ ion coordination to nitrogen and oxygen of the phenols and 
explained that the coordination of oxygen to Cu2+ is weaker than that of nitrogen. These 
results support the notion of formation of carbon-carbon covalent bond in the proteins 
and peptides that contain tyrosine residues (which has a phenyl group in it’s side chain) 
in their backbone. In our study, Cu2+-peptide complexes can be formed by coordination 
of Cu2+ with HYFNIF via His and Tyr residues, and VIYKI via Lys and Tyr residue. 
These complexes can catalyse the oxidation of tyrosine residue and produce dityrosine 
via a C-C bond. As explained above, Cu2+-ethlenediamine complexes can catalyse the 
formation of C-C bond to produce biphenol compounds, however the ability of these 
complexes to catalyse the oxidation of phenols is different. The most catalytically active 
complexes are those that are less stable (Kushioka 1983). It has been shown that 
imidazole moiety of the His residue exhibits high affinity toward Cu2+ ion, forming a 
stable complex (Patel et al. 2002). In general, amino acid sequence has an important 
influence on the Cu2+ ions coordination, while the side chains of some amino acid, e.g. 
histidine and glutamine, show high affinity toward binding to metal ions, other exhibit 
less affinity (Glusker 1999). HYFNIF and VIYKI peptides have different amino acid 
sequences and this in turn will affect the coordination with Cu2+ ions, and as a result 
different amounts of dityrosine will result. Another factor that could affect the 
dityrosine formation is the steric hindrance provided from the neighbouring amino acid 
side chains within the fibril architecture. 
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The pH value has a profound influence on the electrostatic nature of the peptide via 
changing the net peptide charge. However, Cu2+ ions coordination to peptides and 
proteins can also be affected by the pH value. For example, it has been shown that 
binding of Cu2+ to Aβ is highly pH-dependent (Atwood et al. 1998), explaining that 
there is a transition between two complex forms as the pH is raised (Syme et al. 2004). 
Cu2+ ions are acting as electrophiles and sharing electron pairs with other atoms to form 
ionic bond or charge-charge interactions. At a neutral pH value, Cu2+ ion concentrations 
can be high (Glusker 1999), and as a consequence more Cu2+ ions are available to form 
complexes with the ligands. It is important to generate a neutral or negatively charged 
peptide to facilitate the coordination with Cu2+ ions. At pH 7.4, HYFNIF and VIYKI 
peptide have a more neutral net charge (0.1 and 0.8 respectively) than that in water (1.2 
for HYFNIF and 1.1 for VIYKI), where the pH is more acidic (the pI of HYFNIF and 
VIYKI fibrils are 8.0 and 10.3 respectively). As a result, Cu2+-peptide complexes can be 
easily generated at pH 7.4, subsequently these complexes can catalyse the tyrosine 
cross-linking, and that may explain why less dityrosine yield was obtained at acidic pH 
in water compared to more efficient dityrosine formation at pH 7.4.  
 
 Morphological changes of amyloid-like fibrils over oxidation 4.2.3
The appearance of the oxidised amyloid-like fibrils were visualised by electron 
microscopy and displayed a remarkable diversity. The image of oxidised fibrils in 
phosphate buffer showed evidence of shortening of the fibrils (49.0 – 863.0 nm for 
VIYKI, and 104.0 – 2435.0 nm for HYFNIF), compared to those non-oxidised (1762.0 
– 1855.0 nm for VIYKI), and also clumping of short fibrils (Figure 4-8). 
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Figure 4-8: Morphological changes over oxidation in phosphate buffer pH 7.4. Transmission electron 
micrographs of non-oxidised HYFNIF and VIYKI after 24 h of incubation in (50 mM) phosphate buffer 
pH 7.4 with agitation of 300 rpm reveal they have amyloid-like fibrillar morphologies. Upon oxidation 
using Cu2+/H2O2, amyloid-like fibrils showed evidence of shortening (VIYKI 49.0 - 863.0 nm, HYFNIF 
104.0 - 2435.0 nm) of the fibrils compared to the non-oxidised fibrils (VIYKI 1762.0 - 1855.0 nm).  
 
A previous study (Morris et al. 2013b), showed that HYFNIF and VIYKI peptide are 
found to spontaneously form a fibrillar structure upon incubation in water. It is clear 
that upon oxidation and dityrosine cross-link production, morphological changes were 
observed, in particular for VIYKI fibrils (Figure 4-8). The latter undergoes extensive 
fragmentation due to oxidative modification, resulting in the formation of shorter fibrils, 
which in some cases become noticeably thicker (40 nm). In contrast, HYFNIF fibrils 
showed less morphological changes upon oxidation and this is consistent with the 
HYFNIF peptide’s apparent lesser ability to form dityrosine cross-links. However, it is 
not clear if the dityrosine cross-linking process may affect the self-assembly ability of 
HYFNIF and VIYKI peptide. Incubation of 100 µM of preformed amyloid-like fibrils 
in (50 mM) phosphate buffer pH 7.4 for 24 with agitation of 300 rpm did not result in a 
significant morphological change, and the TEM micrographs revealed that both 
HYFNIF and VIYKI fibrils morphologies are maintained over incubation period as seen 
in Figure 4-8 (non-oxidised fibrils). Non-oxidised HYFNIF and VIYKI fibrils are 
heterogeneous, long, straight, and unbranched fibrils (Figure 4-8).  
200 nm 
Non-oxidised VIYKI fibrils Oxidised VIYKI fibrils 
100 nm 200 nm 
Non-oxidised HYFNIF fibrils Oxidised HYFNIF fibrils 
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In order to examine the morphologies of fibrils that assembled under oxidative stress 
conditions, attempts to generate the monomeric species of both HYFNIF and VIYKI 
peptide were carried out using HFIP or NaOH. Unfortunately, both HYFNIF and 
VIYKI peptides exhibited high resistance to monomerision.  
 
 Negative stain immunogold labelling TEM 4.2.4
To further identify the dityrosine cross-link, and to show the dityrosine distribution in 
the oxidised fibrils, TEM immunogold labelling using a dityrosine specific monoclonal 
antibody (1C3) was performed. Figure 4-9 and Figure 4-10 show labelling using an 
anti-dityrosine, gold-conjugated antibody on HYFNIF and VIYKI amyloid-like fibrils 
revealing gold distributed close to the fibrils that were grown in an oxidising 
environment. Non-oxidised HYFNIF and VIYKI fibrils did not label with the dityrosine 
antibody. Very strong evidence of dityrosine identity was provided using these specific 
monoclonal dityrosine antibodies, and also it represents an initial examination of the 
possibility of using these antibodies to detect the presence of dityrosine in both plaques 
and CSF samples from AD patient as described further in chapter five.  
 
 
Figure 4-9: TEM immunogold labelling. Non-oxidised and oxidised HYFNIF fibrils were gold labelled 
using a dityrosine.antibody. (100 µM) HYFNIF fibrils were oxidised for three hs using (100 µM) Cu2+ 
and (2.5) mM H2O2 in (50 mM) phosphate buffer pH 7.4. The oxidation process was undertaken at 37 º C, 
and agitation 300 rpm. The scale bars represent 0.2 µm. The immunogold labelling micrographs shows 
positive labelling for dityrosine in oxidised fibrils compared with non-oxidised fibrils that did not label 
with dityrosine antibody. 
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High magnification TEM micrographs of oxidised VIYKI fibrils, which had been 
labelled with the gold-conjugated dityrosine antibody, revealed that dityrosine cross-
links are distributed along the fibrils (Figure 4-10). It appears that dityrosine coupling is 
undertaken within the fibrils. Although fluorescence data showed that much higher 
dityrosine fluorescence intensity was generated in oxidised VIYKI fibrils, it is obvious 
that less gold labelling was observed in oxidised VIYKI fibrils (Figure 4-10) compared 
to oxidised HYFNIF fibrils (Figure 4-9), and this may support the view that dityrosine 
cross-link is formed internally within fibrils. Consequently, the dityrosine cross-link 
epitope is less accessible to bind the antibody. 
 
 
Figure 4-10: TEM immunogold labelling. Non-oxidised and oxidised VIYKI fibrils were gold labelled for 
dityrosine. 100 µM VIYKI fibrils were oxidised for three hs using (100 µM) Cu2+ and 2.5 mM H2O2 in 
phosphate buffer 50 mM, pH 7.4. The oxidation process was undertaken at 37 º C, and agitation 300 rpm. 
 
The immunogold labelling TEM micrographs of dityrosine in both non-oxidised 
HYFNIF and VIYKI fibrils provide a strong evidence of dityrosine antibody specificity 
toward dityrosine verses tyrosine, and shows that tyrosine residues in non-oxidised 
fibrils did not cross bind with the dityrosine antibody.  
 
 Exploring the effect of buffer type on dityrosine formation 4.2.5
It has been shown that the Cu2+ coordination is varying in different buffer conditions 
(Tougu et al. 2008). To examine the efficiency of dityrosine formation in amyloid-like 
fibrils under oxidative conditions, and to explore the performance of the metal-catalysed 
oxidation system using different types of buffers, phosphate and HEPES buffers were 
used. HYFNIF and VIYKI fibrils with a concentration of 100 µM were incubated with 
Cu2+/H2O2 in 50 mM HEPES buffer pH 7.4, and in 50 mM phosphate buffer pH 7.4. 
0.1 µm 0.1 µm 0.2 µm 
Non Oxidised VIYKI fibrils  Oxidised VIYKI fibrils 
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The oxidation process was undertaken for 26 h at 37 ºC, and dityrosine formation was 
monitored using an excitation wavelength of 320 nm instead of 280 nm, which was 
used previously (Figure 4-11). It has been demonstrated that using an excitation 
wavelength of 320 nm produced much stronger dityrosine emission signal (Malencik 
and Anderson 1991; Malencik et al. 1996; Smith et al. 2007). Initially, the results 
revealed that VIYKI fibrils exhibited more susceptibility to form dityrosine linkages 
than HYFNIF fibrils in both HEPES and phosphate buffer. Moreover, using phosphate 
buffer in the oxidation process of VIYKI fibrils leads to higher yield of dityrosine 
formation compared to that using HEPES buffer as shown in Figure 4-11, B and A 
respectively. Fluorescence data show that after 26 h of oxidation of VIYKI fibrils in 
phosphate buffer, high dityrosine intensity at around 410 – 420 nm was obtained 
compared to that in HEPES buffer (Figure 4-11, A). 
 
 
Figure 4-11: Dityrosine cross-link formation efficiency using two different types of buffers, HEPES and 
phosphate buffer. (A) & (B) Oxidation of VIYKI fibrils in HEPES and phosphate buffer respectively. (C) 
& (D) Oxidation of HYFNIF fibrils in HEPES and phosphate buffer respectively. Dityrosine formation 
was monitored using excitation wavelength of 320 nm. The emission spectra were recorded over 340-600 
nm. Inserts showing dityrosine fluorescecne increase with time. 
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Alternatively, HYFNIF fibrils show less ability to form dityrosine cross-links in both 
buffers compared with VIYKI fibrils (Figure 4-11, C and D), indicating that the 
differences in the amino acid sequences of the amyloidoegenic peptide and their 
structural architecture affect their ability to produce dityrosine cross-links. The intensity 
of the dityrosine signal at 410 – 420 nm obtained from HYFNIF fibrils after 26 h of 
oxidation was much less than the signal from VIYKI fibrils. Also, it took just 15 min to 
give a significant dityrosine signal in VIYKI fibrils (Figure 4-11, B), compared to the 2 
h required to yield dityrosine in HYFNIF fibrils (Figure 4-11, D). Our results show that 
using phosphate buffer to perform the Cu2+-catalysed oxidation process produces 
increased dityrosine formation Figure 4-12. 
 
It has been revealed that HEPES buffer is the most suitable buffer to perform copper 
coordination experiment, since it does not form ternary complexes with copper ions, 
(Tougu et al. 2008), thus HEPES would not compete with peptide and proteins to bind 
copper ions. However, it seems from our data that HEPES buffer is less efficient at 
producing dityrosine. This might be due to the formation of stable Cu2+/peptide 
complexes in HEPES buffer, which in turn may have less catalytic activity.  
 
 
Figure 4-12: Using different types of buffer significantly affects the performance of copper-catalysed 
oxidation process, and in turn the amount of resulting dityrosine. A) Oxidation of VIYKI fibrils in 
phosphate buffer gives much higher signal of dityrosine compared to that in HEPES buffer. B) No 
significant differences of dityrosine formation in HYFNIF fibrils using HEPES and phosphate buffer upon 
early points of oxidation compared to that in VIYKI, but at 26 h it is clear that using phosphate buffer 
yields more dityrosine in HYFNIF fibrils.  
 
Morphological changes of HYFNIF and VIYKI fibrils upon oxidation were examined 
by TEM, and the TEM images revealed significant morphological changes upon 
oxidation of HYFNIF and VIYKI especially in phosphate buffer as shown in Figure 
4-13. Electron micrographs of oxidised VIYKI fibrils revealed significant changes upon 
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oxidation, it is clear that VIYKI fibrils underwent fragmentation as a result of oxidation. 
Shorter VIYKI fibrils with larger diameters were observed after 26 h of oxidation in 
phosphate buffer, while less fragmentation was observed after 26 h of oxidation in 
HEPES buffer (Figure 4-13), and that may reflect the extent of oxidation using different 
types of buffers. 
 
 
Figure 4-13: TEM micrographs of oxidised HYFNIF and VYIKI fibrils formed in both HEPES and 
phosphate buffer pH 7.4. While VIYKI fibrils underwent noticeable morphological changes upon 
oxidation in both HEPES and phosphate buffer, HYFNIF fibrils showed less changes especially in 
HEPES buffer.  
 
Similar to VIYKI fibrils, HYFNIF fibrils underwent fragmentation upon oxidation in 
phosphate buffer, but TEM images showed that after 26 h of oxidation in phosphate 
buffer both long and short HYFNIF fibrils were observed (Figure 4-13). The 
fluorescence results (Figure 4-11) revealed that HYFNIF fibrils have less ability to form 
dityrosine cross-links and that may suggest that this leads to the less affected 
morphology of oxidised HYFNIF fibrils. It is clear from the TEM micrographs of both 
oxidised HYFNIF and VIYKI fibrils in HEPES buffer that they underwent less 
fragmentation, and the main morphological change is that the fibrils became thicker and 
clumped together along the fibril length (Figure 4-13). 
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 Structural development of HYFNIF and VIYKI fibrils upon oxidation 4.2.6
The structures of HYFNIF and VIYKI fibrils have been extensively studied using a 
wide variety of techniques including XRFD, CD, LD, and FTIR (Morris et al. 2013b). 
The data showed that both HYFNIF and VIYKI fibrils have a cross-β conformation, 
and also indicated an important role played by aromatic side chains in peptide packing 
and in the stability within the fibrils. 
 
CD spectra of HYFNIF and VIYKI fibrils showed features that were unlike commonly 
observed spectra shown for cross-β rich amyloid fibrils (Figure 4-14). Although a 
classic β-sheet conformation shows a typical signal at ~ 195 (positive) and ~ 216 nm 
(negative), HYFNIF and VIYKI fibrils exhibited slightly shifted signals (Figure 4-14). 
VIYKI fibrils exhibited a negative signal maximum at 218 – 220 nm (Figure 4-14, B) 
that corresponds to the negative β-sheet signal. On the other hand a positive maximum 
signal at 200 nm was observed in CD spectra of both HYFNIF and VIYKI fibrils, which 
could be attributed to an artefactual LD signal (explained below). Additionally, two 
signals arising from tyrosine were observed at 275 and 235 nm were observed (Figure 
4-14). The signal at 275 nm underwent splitting into two peaks at 276 and 282 nm and 
was taken to arise from electron coupling of the tyrosine residues indicating proximity 
of tyrosines within the amyloid-like fibril structure (Marshall et al. 2011; Morris et al. 
2013b). 
 
To test if the signal at 200 nm is arising from the artefactual LD signal, CD spectrum 
was recorded by positioning the cuvette at 90 deg, and showing the inversion the signal 
at 200 nm which in turn indicates the orientation dependent of this signal (Figure 4-15). 
The artefactual LD signal results from the alignment of the amyloid-like fibrils within 
the cuvette due to sample loading (Davidsson et al. 1980). 
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Figure 4-14: Near and far UV CD spectra of non-oxidised (A) (1.135 mM) HYNIF and (B) (1.480 mM) 
VIYKI fibrils. The region from 200-250 nm (far UV) shows the secondary structure, and the near UV 
region 250-310 nm shows the tertiary structure. Both, HYFNIF and VIYKI fibrils show unusual CD 
spectrum with a positive maximum signal at 200 nm that attributed to LD effect. 
 
Linear dichroism is the difference in the absorbance of light linearly polarised parallel 
and perpendicular to the orientation axis (Norden et al. 2010), and can be only obtained 
from the sample that is intrinsically orientated or can be aligned by external force 
during the measurement. This LD effect is more pronounced than CD effects (Norden et 
al. 2010), therefore this can dominate a spectrum. Some linearly polarised light will exit 
along with the circularly polarised light due to inefficiencies in the photoelastic 
modulator (Norden et al. 2010). Because LD signal is orientation dependent, rotating 
the cuvette by 90 deg should invert the spectrum, by contrast the CD signals are not 
orientation dependent and rotation will not affect the signal. LD signals could dominate 
the CD spectrum because LD effects are stronger than CD (Davidsson et al. 1980; 
Norden et al. 2010). 
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Figure 4-15: CD spectra of non-oxidised A) HYFNIF and B) VIYKI fibrils recorded by positioning the 
cuvette at 0 and 90 deg, and showing the inversion the signal at 200 nm which is attributed to the 
artefactual LD signal. The upper panel inset shows that the signal arising from contribution of tyrosine 
residues does not invert by positioning the cuvette at 90 deg. 
 
CD showed interesting development in both near and far UV CD spectra of oxidised 
amyloid-like fibrils in water. Incubation of HYNIF fibrils with Cu2+/H2O2 resulted in 
the appearance of a positive CD band at 190 nm and a negative band at 220 nm and is 
accompanied by a loss of signal at 200 nm thought to arise from artefactual LD from the 
self-aligned fibrils (Figure 4-16). The oxidised VIYKI fibrils showed a decrease in the 
intensity of tyrosine peaks at 275 nm and 235 nm, and decrease of the peak at 200 nm 
(Figure 4-16). CD spectra from oxidised fibrils are consistent with more commonly 
observed signatures for β-sheet structure. Moreover, disappearance of the artefactual 
LD signal in the resulting CD spectra indicates less alignment of oxidised fibrils. 
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Figure 4-16: Structural development upon oxidation. CD spectra of (1.135 mM) HYNIF and (1.480 mM) 
VIYKI fibrils (A) before and (B) after incubation with Cu2+/H2O2 in water. Incubation of Waltz peptides 
with Cu2+/H2O2 leads to abolish of LD signal at 200 nm, and also appearance of the β-sheet bands. 
Moreover, a significant decline in tyrosine bands at 276 and 235 nm was obtained which corresponding 
to loss of tyrosine residue due to the oxidative modification. 
 
CD spectra of oxidised HYFNIF and VIYKI fibrils were measured to gain insight into 
the effect of dityrosine cross-linking on the secondary and tertiary structures upon the 
oxidation process. The CD results have indicated that under Cu2+/H2O2 condition, both 
oxidised HYFNIF and VIYKI fibrils have β-sheet structure. Incubation of HYNIF 
fibrils with Cu2+/H2O2 causes an appearance of a positive CD band at 190 nm, which is 
thought to be masked by the strong LD signal in the CD spectra of non-oxidised fibrils, 
and a negative signal 220 nm and is accompanied by a loss of positive LD band at 200 
nm (Figure 4-16). These results suggest that oxidised fibrils have lost their ability to 
self-align (resulting in LD contamination of signals) and that may be due to formation 
of dityrosine cross-linked fibrils, which prevents the lateral alignment that leads to LD 
artefacts. This is supported by observation of TEM images, which show that oxidised 
fibrils become shorter and more clumped than that non-oxidised. The near UV CD 
spectrum of non-oxidised VIYKI fibrils exhibits two prominent negative bands at 276 
and 282 nm, which arise from tyrosine residues (Figure 4-14, B). The oxidised VIYKI 
fibrils exhibit a marked reduction in the intensity of these two signals likely to result in 
the transition to dityrosine formation. 
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Further CD experiments were performed to monitor changes in the main chain 
conformation of VIYKI fibrils over dityrosine cross-linking formation at pH 7.4. As 
described before that oxidation using phosphate buffer yields more dityrosine (section 
4.2.2), thus CD spectra of oxidised VIYKI and HYFNIF using phosphate buffer were 
recorded. Unfortunately, oxidised HYFNIF fibrils precipitated out of the solution, and 
no CD signal was recorded. The oxidised VIYKI fibrils exhibit a marked reduction in 
the intensity of tyrosine two bands, and that could be due to a loss of tyrosine residues 
as a result of oxidation. Additionally, there was a significant increase in bands at 218 
nm (Figure 4-17) suggesting an increase in β-sheet content.  
 
 
Figure 4-17: CD spectrum development over oxidation of (0.25 mM) VIYKI fibrils at pH 7.4. A 
significant decline in the intensity of the tyrosine signals at 275 nm and 235 nm was observed, indicating 
tyrosine losing during the oxidation. Interesting increase in the intensity of the signal at 218 nm observed 
arising form β-sheet conformation. 
 
In order to test whether LD is contributing to the CD spectrum of oxidised VIYKI 
fibrils, the CD spectrum was obtained by positioning the sample at both 0 deg and 90 
deg to the detector (Figure 4-18), and no inversion in any signal was observed, 
indicating that none of these bands belong to LD artifacts. 
-100 
-80 
-60 
-40 
-20 
0 
20 
40 
60 
80 
193 218 243 268 293 318 
10
#3
%[θ
]%(
de
g%
cm
2 %d
m
ol
#1
)%
Wavelength%(nm)%
0%h% 24%h% 48%h%
Chapter 4 
 
127 
 
Figure 4-18: CD spectra of (0.1 mM) VIYKI fibrils after 48 h of oxidation in phosphate buffer pH 7.4. 
The spectra were obtained by positioning the cuvette at 0 and 90 deg to the detector. No LD effect was 
observed after oxidation, indicating that the fibrils underwent a structural development upon oxidation 
that prevent fibrils from be aligned and consequently abolished the artefactual LD signal. 
 
To gain more structural details from oxidised HYFNIF and VIYKI fibrils, the fibrils 
were aligned to test them using XRFD, but unfortunately alignment was unsuccessful 
for any fibrils probably due to the short length of the resulting fibrils after oxidation. 
 
Many different models of peptides that contain tyrosine residues have been used to 
investigate the oxidative modification of tyrosine and the formation of dityrosine 
linkages by applying different oxidation system including the MCO systems and the 
enzymatic system (Ali et al. 2004; Kato et al. 2001). N-acetyl tyrosine was used as a 
model of tyrosine in proteins to investigate dityrosine formation using four different 
MCO systems (Kato et al. 2001). Among these MCO systems (Metal-catalysed 
oxidation), Cu2+/H2O2 was the most effective to generate dityrosine and also showed a 
specificity to produce dityrosine (Ali et al. 2004; Kato et al. 2001). Ali and co-workers 
were successful in showing the same specificity of Cu2+/H2O2 system at pH 7.4 to 
generate dityrosine using N-acetyl tyrosine ethyl ester as a model for tyrosine in 
proteins (Ali et al. 2004).  
 
In this chapter, two short peptides containing tyrosine residues were used as a model 
system to investigate the effect of oxidation and their ability to form a dityrosine cross-
link. Data presented here, suggest that the phenol groups of tyrosine residues are in 
close proximity to one another in VIYKI fibrils (Figure 4-19) and this proximity may 
make the C−C covalent bonding easier than in HYFNIF fibrils in which the phenol 
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groups are ordinated far away from each other (Figure 4-19). Also, from the structural 
model of the VIYKI fibrils (Figure 4-19, down panel), it appears that a dityrosine 
crosslink can be formed within and between the fibrils. These results are consistent with 
other studies conducted on the structural features of HYFNIF and VIYKI fibrils and can 
be rationalised from structural models which suggest that there is close packing of the 
aromatic side groups, specifically tyrosine (Morris et al. 2013b). It seems that 
preorganisation of amyloid-like fibril structure affects the efficiency of dityrosine cross-
link formation.  
 
 
Figure 4-19: Structural models of HYFNIF (Top panel), and VIYKI (Down panel) fibrils determined from 
XRFD (Morris et al. 2013). In VIYKI fibrils the phenol groups of tyrosine side chain are orientated to be 
close enough to form dityrosine linkage. While, in HYFNIF fibrils the phenol groups are ordinated far 
away from each other and this could result in less dityrosine yield. Graphics generated using PyMol 
(DeLano 2002). Adapted from (Morris et al. 2013b). 
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Tyrosine fluorescence decreases when the residue goes from a more buried environment 
to a more solvent-exposed environment (Marshall et al. 2011). Moreover, it has been 
reported that in aqueous solvents the fluorescence of tyrosine (that is solvent-exposed) 
is quenched by the carbonyl group in the peptide bond, however the quenching 
mechanism is unknown (Marshall et al. 2011). From the structural model of VIYKI 
fibril, it is clear that tyrosine residues are located a way from the fibril surface (Figure 
4-19), which could result in less fluorescence quenching, whilst in HYFNIF fibrils, 
tyrosine residues are located on the fibril surface, and this may explain the tyrosine 
fluorescence quenching. 
 
Potential contribution of other amino acid groups must be taken into account. As shown 
in some studies, His residues can form His-bridges in Aβ via coordination with Cu2+ 
(Curtain et al. 2001; Smith et al. 2006a). In the same manner, we hypothesize that the 
HYFNIF peptide could coordinate with Cu2+ to form His-bridges, as a result, this could 
affect the extent of dityrosine cross-linking. Formation of His-bridged species could 
leads to more steric hindrance that prevent dityrosine production. Moreover, as 
explained previously, His residues have high affinity toward Cu2+, forming a stable 
complex that may have less catalytic activity, yielding less dityrosine. 
 
 Future work 4.2.7
More structural measurement, e.g. LD, can be applied to find if dityrosine has a unique 
LD signal and consequently enhance our understanding of the role of dityrosine as a 
cross-linker in the protein. Synthesis of dityrosine cross-linked peptides with protection 
against other oxidative modifications on other residues would be more ideal model. 
Moreover, more precise details could be gained by using a pure dityrosine cross-linked 
peptide. For future work, it would be better to keep the parallel peptides the same as 
much as possible, this will rule out many factors that could affect the interpretation of 
the result. For example, the contribution of the neighbouring residues will be the same, 
if the same amino acid sequence is used. Also, the difference in the net charge of the 
peptide should be minimal. As dityrosine is intrinsically fluorescent, more evidence can 
be gained using confocal microscopy about whether the dityrosine can be intra- or inter 
fibrils. Many β-sheet peptides have been extensively explored as potentially useful 
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bionanomaterials due to their ability to self assemble to form large complex structures, 
such as nanotubes, from simple monomers (Morris and Serpell 2010). Applying 
dityrosine cross-linking to generate synthetic fibrils that are stronger than without 
dityrosine would have potential technological applications (Figure 4-20), for example in 
the synthesis of bionanomaterials. Recently, dityrosine cross-linking was used to 
increase the mechanical stability of a peptide-based hydrogel (Ding et al. 2013), 
explaining that the mechanical stability was enhanced through the formation of a 
densely entangled fibrous network of dityrosine cross-linked peptide dimers. 
 
 
Figure 4-20: Suggested structural model of the suggested PKYKVVEYEP peptide explaining how 
dityrosine cross-links can stabilise the resulting fibrils. Inter-β-strands and/or inter-β-sheets phenol 
groups of tyrosine residues can be coupled through C-C to form dityrosine that in turn can stabilise the 
fibrils. Generated using PyMol (DeLano 2002). 
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 Conclusion(4.3
Oxidative stress of Aβ and α-syn has been frequently implicated in the pathogenesis of 
AD and PD respectively (Butterfield 2002; Eskici and Axelsen 2012; Jomova et al. 
2010; Souza et al. 2000). Dityrosine cross-links represent one of the most important 
modifications resulting from the oxidation of many proteins under oxidative stress 
conditions, and could affect the folding and the structure of the affected protein. 
However, studying and investigating dityrosine cross-linking in small peptide models 
can enhance our understanding of dityrosine’s role in the folding and assembly of other 
physiologically relevant peptides and proteins such as Aβ and α-syn (see chapter 5 and 
6). The hexa- and pentapeptides HYFNIF and VIYKI were of particular interest due to 
their highly organised fibrillar structure and the positions of the tyrosine residues 
allowing potential dityrosine formation. In the current study, the oxidative modification 
of the two short peptides, HYFNIF and VIYKI, using Cu2+/H2O2 oxidation system was 
explored, and also the morphological and conformational changes of these amyloid 
fibrils over the oxidation process were studied. The results showed that VIYKI fibrils 
have a greater ability than HYFNIF fibrils to oxidise and produce dityrosine cross-links, 
and also demonstrated that the preorganised fibrils can enhance dityrosine formation by 
bringing two tyrosine residues close enough to cross-link covalently. The results are in 
good agreement with structural models of HYFNIF and VIYKI fibrils from a previous 
study, which revealed that phenolic groups of the tyrosine residues in VIYKI fibrils are 
packing closely together and become in a close proximity that could make the tyrosine 
cross-link more favorable (Morris et al. 2013b). In contrast, the structural model of 
HYFNIF fibrils revealed that side chain of tyrosine residues are organised away from 
each other, and as a consequence, dityrosine formation was more restricted. The pH of 
the oxidation environment has a strong influence on the dityrosine production and that 
is due to the net peptide charge. Although the CD and TEM data of the oxidised fibrils 
revealed interesting structural and morphological changes upon the oxidation processes, 
no dityrosine characteristic signal was observed in CD.  
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5 Results and Discussion  
The importance of dityrosine crosslinking in Alzheimer's disease 
 Introduction(5.1
Previous studies have shown that copper interactions with Aβ could be responsible for 
causing dityrosine cross-linking and accompanying Aβ aggregation (Atwood et al. 
2004; Barnham et al. 2004; Yoburn et al. 2003). High concentrations of copper (0.4 
mM), zinc (1 mM), and iron (1 mM) have been found in amyloid plaques and have been 
implicated in the pathogenesis of AD (Bush 2003a; Lovell et al. 1998; Suh et al. 2000). 
Smith et al. (Smith et al. 2006a) demonstrated that the generation of the Aβ toxic 
species is modulated by both the Cu2+ concentration and the ability to form 
intermolecular histidine bridges. Many studies have demonstrated that Cu2+ ions 
coordinate to Aβ via the three histidine residues His6, His13, His14 and Tyr10 (Figure 
5-1) (Atwood et al. 2004; Curtain et al. 2001; Tickler et al. 2005). However, a recent 
study showed that Tyr10 is not the fourth bound ligand, but it locates close to the metal 
centre (Maiti et al. 2008). 
 
 
Figure 5-1:Copper ion coordination to Aβ peptide. Cu2+ ion coordinates Aβ via the three histidine 
residues His6, His13, and His14, whilst the fourth ligand could be Tyr 10. Adapted from (Tickler et al. 
2005). 
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Barnham et al. revealed that the Aβ peptide coordinates Cu2+ to form an Aβ-Cu2+ 
complex. In turn, the Aβ-Cu2+ complex is able to produce H2O2 catalytically in the 
presence of a reducing substrate such as ascorbate and underling this process, tyrosine 
radicals are generated that are later coupled and result in Aβ aggregation (Barnham et 
al. 2004). 
 
The investigations presented here aim to explore the role of Cu2+ in the generation of 
dityrosine crosslinks in Aβ peptide, thier potential role in AD and subsequently, Aβ 
aggregation and assembly. The in vitro experimental model presented here can help in 
understanding the early events leading to chemical, structural and conformational 
modifications before the conversion of soluble Aβ to amyloid fibrils and the eventual 
formation of senile plaques in AD. In turn, this data could help to design a new inhibitor 
for an irreversible Aβ deposition process and identify a potential biomarker for early 
AD. Herein, we have explored the role of Cu2+ ions in the formation of dityrosine cross-
links in Aβ using many different techniques, including fluorescence spectrophotometry, 
mass spectrometry and transmission electron microscopy. Immunogold labelling, which 
has high selectivity and sensitivity, has been used to test the prevalence of dityrosine 
crosslinks in brain tissue and CSF from AD.  
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 Results(and(Discussion(5.2
 In vitro oxidation of Aβ42 resulting in the formation of dityrosine cross-5.2.1
links 
To gain insights into dityrosine crosslink formation process under Cu2+/ H2O2 oxidation 
conditions, formation of dityrosine crosslinks was induced in both preformed fibrils and 
early soluble species following solubilisation of Aβ42. A wide variety of different 
techniques were used to establish our understanding of the role of dityrosine in Aβ42 
assembly and aggregation.  
 
 Dityrosine formation in preformed Aβ42 fibrils 5.2.1.1
Initially, we were interested to probe the ability of preformed Aβ42 fibrils to form 
dityrosine crosslinks and whether induced dityrosine crosslinks can affect the fibril 
morphology. In order to achieve this, oligomeric Aβ42 species were incubated in water 
for at least two weeks to form Aβ42 fibrils. The fibril formation was confirmed using 
TEM (Figure 5-4). Preformed Aβ42 fibrils were incubated with and without Cu2+/ H2O2 
in phosphate buffer pH 7.4. Oxidation of preformed Aβ42 fibrils was monitored over 
time and dityrosine crosslinks were monitored using fluorescence spectrometry. The 
data shows a fluorescence signal arising between 410 – 420 nm corresponding to 
dityrosine formation (Figure 5-2, A). By contrast, no dityrosine fluorescence signal was 
observed upon incubation of preformed Aβ42 fibrils in phosphate buffer in the absence 
of Cu2+/ H2O2 (Figure 5-2, B).  
 
 
Figure 5-2: Formation of dityrosine crosslinks in Aβ42 fibrils. Preformed Aβ42 fibrils were incubated in 
the presence (A) and absence (B) of Cu2+/H2O2 for 72 hs and the appearance of dityrosine detected using 
fluorescence!ex 320 nm and em 410-420 nm. 
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To further confirm the presence of dityrosine within the oxidised Aβ42 fibrils, the 
fibrils (oxidised in water instead of phosphate buffer) were hydrolysed using 6 M HCl, 
10% TFA, and 1% phenol for 48 h and examined using LC-ESIMS/MS (Figure 5-3, B). 
The dityrosine content was identified by LC-MS/MS using transition reaction ion m/z 
361.1→315 and a retention time of 5.5 min (Figure 5-3, A), consistent with that of a 
dityrosine standard (see chapter three). The dityrosine crosslinks showed high resistance 
to cleavage under acid hydrolysis (6 M HCl at 110 °C), and this highlights the stability 
of dityrosine. It has been reported that dityrosine shows resistance to cleavage by 
protease including trypsin, chymotrypsin, and pronase (Smail et al. 1995).  
 
 
Figure 5-3: The dityrosine content was confirmed using LC-ESIMS/MS that is set on MRM mode. A) LC-
ESIMS/MS chromatograms from authentic synthetic dityrosine, B) hydrolysate from oxidised preformed 
Aβ42 fibrils, C) hydrolysate from Aβ42 fibrils formed under oxidation conditions for three days (the 
fibrils were obtained from incubation of soluble Aβ42 with Cu2+/H2O2 in water at 37 ºC with agitation. 
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Negative stain TEM was used to compare oxidised fibrils with non-oxidised fibrils to 
evaluate any morphological changes to the sample and revealed short, clumped 
networks of fibrils in the oxidised sample after 24 h (Figure 5-4) compared to long, 
straight, and well-dispersed fibrils, common characteristic morphological features of 
amyloid fibrils, observed in the sample prior to oxidation (0 h). This may suggest that 
the fibrils are cross-linked laterally to form a network and this is consistent with Tyr10 
being exposed on the surface of the fibrils and available for dityrosine crosslinking, 
between either protofilaments or perhaps individually crossing fibrils.  
 
 
Figure 5-4: Electron micrographs showing the morphology of fibrils prior to oxidation (0 h) and 
following 24 h oxidation. Aβ42 fibrils exhibited short, clumped networks after 24 h of oxidation 
compared to well dispersed fibrils at zero h of oxidation.   
 
Structures of Aβ42 and Aβ40 fibrils have tyrosine residues at position 10 at the end of a 
β-sheet core (Glatzel et al. 2005; Paravastu et al. 2008), showing that they may be 
surface exposed and available to be involved in lateral association (Figure 5-5). 
Similarly, structural studies using a combination of X-ray absorption spectroscopy and 
density functional theory analysis (Streltsov et al. 2008) demonstrated that the structure 
of the Aβ high-affinity Cu2+ binding site is consistent with the hypothesis that the 
formation of dityrosine-linked dimers found in AD (Naylor et al. 2008) could result 
from the redox activity of the metal ion bound to Aβ.  
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Figure 5-5: Structural model of Aß40 fibrils that constructed using ssNMR (Paravastu et al. 2008). 
Tyrosine residues at position 10 are located at the end of β-sheet core and available to form dityrosne 
links. The model was regenerated using PyMol (DeLano 2002) 
 
The TEM images of oxidised Aβ42 fibrils revealed some shorter fibrils (Figure 5-4) and 
this could be due to protein fragmentation induced by oxidative modification following 
oxidation condition of Cu2+/ H2O2.  
 
Yoburn et al. applied four different oxidative conditions to compare the relative 
efficiency of dityrosine formation in soluble and fibrillar Aβ40. However, the results 
showed that both the HRP/H2O2 and Cu2+/H2O2 conditions led to the production of 
more dityrosine crosslinks in fibrillar Aβ40 than in soluble Aβ40, explaining that 
tyrosine residues are orientated within the fibre to favor dityrosine formation. It was 
suggested that these crosslinks might serve to stabilise the fibrillar state (Yoburn et al. 
2003). 
 
 Aβ42 fibrils formation induced by dityrosine crosslinks formation 5.2.1.2
Many recent studies have demonstrated that soluble Aβ oligomers, rather than Aβ 
fibrils, are the most toxic species and that they are disruptive to physiological processes 
involved in learning and memory in AD (Bruggink et al. 2013; Naylor et al. 2008; 
Roychaudhuri et al. 2009; Walsh et al. 2002; Williams et al. 2011). Recently, this has 
been named the oligomeric hypothesis versus the classical amyloid hypothesis (Hardy 
and Selkoe 2002; Klein 2006), and it has been shown that soluble Aβ oligomers could 
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be generated in vitro through covalent crosslinks, i.e. dityrosine (Atwood et al. 2004; 
Barnham et al. 2004; Naylor et al. 2008), which are stable and irreversible, under MCO. 
In order to investigate whether dityrosine crosslinks can be formed by soluble Aβ42, 
freshly solubilised Aβ42 was incubated over three days in the presence or absence of 
Cu2+ and H2O2 in phosphate buffer at pH 7.4. Dityrosine formation was monitored using 
a fluorescence excitation wavelength of 320 nm over three days (Figure 5-6, A and B) 
and confirmed by LC-ESIMS/MS (Figure 5-3, C).  
 
 
Figure 5-6: Monitoring dityrosine and tyrosine fluorescence during Aβ42 assembly. Freshly prepared 
Aβ42 was incubated in the presence of Cu2+/H2O2 in phosphate buffer and monitored by fluorescence 
over three days (A, C) and compared to control Aβ42 (B, D). Dityrosine fluoresence is shown in A) and 
B) and tyrosine fluorescence in C) and D). Dityrosine fluorescence was monitored (Ex.320 nm, Em. 410-
420 nm) and A) oxidised Aβ42 shows a strong signal at 24 h incubation compared to no signal in B) 
control Aβ42 sample. Tyrosine fluorescence (Ex 280 nm, Em 305 nm) was used to follow assembly with 
time. Both conditions show a decrease in fluorescence signal over time for tyrosine, but C) oxidised Aβ42 
shows a significant reduction after 24 h, compared to a slow reduction in tyrosine fluorescence that 
accompanies assembly for D) control Aβ42. E) The intensity at 305 nm is plotted against time to show the 
difference between control and oxidised sample. 
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Fluorescence spectra revealed an increasing dityrosine fluorescence signal with time in 
the Aβ42 sample incubated in the presence of Cu2+ and H2O2 (Figure 5-6, A), whilst no 
such signal was observed in the control sample (Figure 5-6, B). Tyrosine intrinsic 
fluorescence of Aβ has been frequently used to study the metal coordination site (Maiti 
et al. 2008; Syme et al. 2004; Tougu et al. 2008). Tyrosine fluorescence excited at 280 
nm was also monitored to observe changes to tyrosine with oxidation, the tyrosine 
fluorescence signal at 305 nm was observed to the decrease over the incubation time of 
three days (Figure 5-6, C & D). A gradual decrease in tyrosine intensity was observed 
for control fibrils (Figure 5-6, D) and this decrease is thought to correspond to 
involvement of tyrosine residues in Aβ42 fibril assembly (Marshall and Serpell 2009), 
as the tyrosine ring becomes more solvent exposed as assembly and elongation 
progresses and, as a consequence, tyrosine fluorescence signal is quenched. Tyrosine 
fluorescence spectra revealed a very significant loss of tyrosine signal concurrent with 
the increase in dityrosine signal in the oxidised sample following 24 h incubation 
(Figure 5-6, C) at the same time as a strong dityrosine signal is observed. Comparison 
of the intensity at 305 nm against time shows the slow decrease in tyrosine fluorescence 
for the control sample compared to the rapid reduction after 24 h for the oxidised 
sample. Dityrosine formation appears to occur early in the assembly process consistent 
with dityrosine coupling being present in early oligomeric species. 
 
At time zero, the intensity at 305 nm is lower for the oxidised sample compared to the 
control and this is likely to arise from the quenching of the signal due to the binding or 
involvement of tyrosine in the Cu2+ binding site (Maiti et al. 2008; Tickler et al. 2005). 
Based on absorption spectrscopy data, tyrosine was excluded to be the fourth equatorial 
ligands bound to Cu2+, explaining that Tyr remains close to the Cu2+ centre but not 
tightly bound to Cu2+ (Maiti et al. 2008). Thus, Tyr residue is indirectly involved in the 
binding Cu2+ centre. 
 
Experimental evidence shows that Aβ42 can be soluble and non-amyloidogenic (Dyrks 
et al. 1992), explaining that the aggregation of Aβ42 does not occur spontaneously. 
Also, the transformation of soluble monomeric Aβ42 into an aggregating, 
amyloidogenic state was induced by the addition of metal-catalysed oxidation systems 
that produce free radicals and the aggregation process induced by the radical initiators 
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can be prevented by addition of radical scavengers such as ascorbic acid. This supports 
the role of free radicals in the generation of insoluble aggregating Aβ. Similarly, it was 
showed that noncovalent aggregates of Aβ40 and Aβ42 could be formed by addition of 
Cu2+ (Atwood et al. 1998; Atwood et al. 2000). Dyrks and co-workers demonstrated 
that metal-catalysed oxidation systems induce amino acid oxidation and protein cross-
linking, and these modifications are required to initiate the Aβ42 aggregation process in 
vitro and in AD (Dyrks et al. 1993). Combining our results with others, strongly 
supports the view that dityrosine cross links occur as early events of the Aβ42 assembly 
process and preformed Cu2+-induced aggregates facilitate the formation of covalent 
cross link.  
 
Alternatively, Galeazzi and co-workers demonstrated that in vitro soluble Aβ42 
undergoes tyrosine oxidative modification under peroxidase oxidation, resulting in 
stable dityrosine cross-linked Aβ42 dimers (Galeazzi et al. 1999). Moreover, Aβ16-28, 
which lacks a Tyr10, did not show any detectable peroxidative modifications, indicating 
the peroxidase oxidation specificity towards tyrosine residue and not other residues such 
as His and Met residues. Another study has shown the colocalisation of 
myeloperoxidase with Aβ in senile plaques in AD brain tissue (Reynolds et al. 1999), 
and revealed that myeloperoxidase is the most efficient enzyme among the peroxidases 
to catalyse the formation of dityrosine (Marquez and Dunford 1995). These data taken 
together support the possibility of in vivo dityrosine cross-linked Aβ formation in a 
peroxidase environment as an alternative pathway.  
 
The resulting Aβ42 assemblies were also assessed using TEM (Figure 5-8) and ThT 
fluorescence (Figure 5-7). ThT fluorescence showed an increase following 72 h 
incubation of both control and oxidised Aβ42 confirming formation of fibrils in both 
samples (Figure 5-7). 
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Figure 5-7: Fibril formation was monitored using ThT fluorescence (ex. 450 nm, Em. 485 nm) for freshly 
prepared Aβ42 in the presence or absence of Cu2+/H2O2 for 72 h. 
 
The ThT spectrum for oxidised and control samples shows an increase over the 
incubation time. However, the intensity of the signal from control fibrils is significantly 
higher than from oxidised fibrils. This may arise from the effect of differences in the 
buffer conditions on the ThT signal since electron microscopy does not suggest any 
difference in fibril amounts or morphologies.  
 
To gain further insight into the morphological changes to Aβ42 fibrils induced by 
oxidation, samples were examined using negative stain TEM (Figure 5-8). Aβ42 
immediately following preparation (0 h) showed small globular structures consistent 
with oligomeric species (5−30 nm) (Figure 5-8).  Under oxidation conditions, the 
freshly dissolved Aβ42 oligomers again appeared to have a spherical appearance (5−25 
nm) and these developed into clustered fibrils after 48 h. After incubation for 48 h, 
control fibrils were observed with both flat, striated ribbons and twisted morphologies. 
TEM did not reveal any obvious differences in fibril density between Aβ incubated 
under oxidising and non-oxidising conditions, although the oxidised sample appears to 
show shorter, more laterally associated fibrils, which may be consistent with some 
interfibrillar cross-linking. Time course TEM images for incubation of soluble Aβ with 
and without Cu2+/H2O2, or with just Cu2+ in phosphate buffer pH 7.4, are shown in 
Figure 5-8. 
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Figure 5-8: Time course TEM images for incubation of soluble Aβ with and with out Cu2+/H2O2, and also 
with just Cu2+ in phosphate buffer pH 7.4. Dityrosine was monitored by fluorescence over three days. At 
zero h, Aβ42 shows oligomeric species and fibrils following 24 h incubation with and without Cu2+ 
compared to that resulting from incubation with Cu2+/H2O2, which shows no fibril formation. After 48 h 
of incubation, more matured fibrils were formed in all cases, which are exhibited characteristic 
morphology features of amyloid fibrils of flat, straight with some twisting fibrils. 
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Interestingly, no fibrils were observed in the oxidised fibrils at 24 h by TEM despite a 
very strong signal by dityrosine fluorescence, suggesting presence of dityrosine in 
oligomeric species. 
 
 Probing the stability of Aβ42 - dityrosine cross-linked fibrils 5.2.1.3
Dityrosine cross-linking may lend further stability to the already stable amyloid fibrils 
formed. To investigate this possibility, we compared the stability of oxidised and non- 
oxidised Aβ42 amyloid fibrils. Fibrils were stored at −80 °C for over one year. 
Following thawing, dityrosine content was assessed using fluorescence and oxidised 
fibrils were shown to still contain dityrosine crosslinks after prolonged freezing, whilst 
no dityrosine fluorescence was detected for non-oxidised, frozen fibrils (Figure 5-9, A). 
Both sets of fibrils were examined by electron microscopy, and both contained fibrils 
(Figure 5-9, C and D). Comparison of soluble Aβ42 concentration in the supernatants 
indicated that there was more soluble Aβ in the oxidised samples (Figure 5-9, B). The 
fibril pellets were treated with formic acid to dissolve fibrils and the amount of peptide 
released into the supernatant was compared between the oxidised and non-oxidised 
samples (Figure 5-9, B). The concentration of Aβ found in the supernatant following 
formic acid treatment was very significantly lower in oxidised sample compared to the 
non-oxidised sample (0 versus 14.8 µM), suggesting that the oxidised fibrils were 
resistant to dissolution with the acid (Figure 5-9, B). Electron microscopy revealed that 
the oxidised fibrils were shortened, but remained at a broadly similar concentration 
when compared to amounts prior to oxidation. Those that had not been oxidised were 
narrower and much more difficult to find on the grid (Figure 5-9, C and D). These 
results seem to support the view that the dityrosine cross-linking strengthens the fibrils 
and these fibrils become more resistant to acid dissolution following oxidation. 
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Figure 5-9: Stability of dityrosine cross-linked Aβ42 fibrils that is formed under oxidation condition. A) 
Oxidised and non-oxidised Aβ42 fibrils were examined using dityrosine fluorescence after prolonged 
incubation at - 80 °C showing a strong intensity signal at ~ 410 nm for oxidised but not non-oxidised 
fibrils. B) Formic acid was used to dissolve the fibrils and the concentration of Aβ42 in solution was 
compared before and after formic acid dissolution for oxidised and non-oxidised fibrils. C) Electron 
micrographs of oxidised fibrils before and after formic acid treatment showing that the dityrosine 
crosslinked fibrils are resistant to formic acid. D) Electron micrographs of non-oxidised fibrils before 
and after formic acid treatment showing the fibrils are susceptible to damage by formic acid. Scale bars 
represent 0.2 µm. 
 
 Negative stain TEM immunogold labelling of dityrosine crosslinks 5.2.1.4
In order to examine whether dityrosine crosslinks can be detected within the amyloid 
fibrils and to show the dityrosine distribution, TEM immunogold labelling using a 
dityrosine specific monoclonal antibody was performed. Figure 5-10 shows anti-
dityrosine labelling on Aβ42 fibrils revealing gold distributed close to the fibrils grown 
in an oxidising environment. Control Aβ42 did not label with the dityrosine antibody 
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(Figure 5-10, B). Very strong evidence of dityrosine identity was provided using these 
specific monoclonal dityrosine antibodies. These in vitro findings suggest that 
conditions similar to oxidative stress can promote the formation of dityrosine cross-
links in self-assembling Aβ42 samples resulting in a high density within the fibrils.  
 
 
Figure 5-10:#TEM immunogold labelling of dityrosine in Aβ42 fibrils. 20 µM of Aβ42 oligomers were 
oxidised using Cu2+ ions and hydrogen peroxide. After 72 h of oxidation, the process was quenched by 
adding EDTA, and then the assembled fibrils were immunogold labelled with dityrosine antibody as 
shown in the A, which reveals the high density and localisation of dityrosine cross links (10 nm gold 
particles) in oxidised Aβ42 fibrils compared to non oxidised fibrils B. For clarity bigger images were 
provided, see appendix (vii). 
 
 Copper ion induces soluble Aβ42 aggregation  5.2.1.5
Redox-active metal ions, such as Cu2+ and Fe3+, have been suggested to play a role in 
the pathogenesis of many neurodegenerative disorders, including AD and PD (Bush and 
Curtain (2008). There is a large body of evidence pointing to the importance of 
interactions between redox-active metal ions and proteins in the pathogenesis of many 
diseases (Ali et al. 2003; Huang et al. 2004a; Sarell et al. 2010). Two mechanisms have 
been suggested to explain the abnormalities of these interactions in neural tissue: (a) the 
aggregation of protein mediated by redox-active metal ions; and (b) metal-catalysed 
oxidation reactions (Strozyk and Bush 2006). Metal-protein interactions could result in 
protein misfolding (Drew et al. 2013; Strozyk and Bush 2006; Viles 2012). In order to 
examine whether the assembly of soluble Aβ42 was enhanced by dityrosine cross-link 
formation alone or via the interaction with Cu2+ ions, 20 µM of freshly prepared 
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oligomeric Aβ42 was incubated in the presence or absence of 20 µM Cu2+ only in 
phosphate buffer pH 7.4. Dityrosine fluorescence was monitored over three days and 
showed no significant yield of dityrosine, and the data is supported by the data of other 
studies that revealed that incubation of Aβ with Cu2+ ion does not lead to tyrosine 
oxidation (Jiang et al. 2007; Tougu et al. 2008). Amyloid fibril content was monitored 
over 48 h using a ThT assay combined with TEM. The ThT data show that incubation 
Aβ42 in the presence of Cu2+ ion reduces the ThT fluorescence signal (Figure 5-11, B), 
indicating a less amyloidogenic material, and this is consistent with TEM images that 
show fewer amyloid fibrils after 72 h of incubation of oligomeric Aβ42 in the presence 
of Cu2+ ions (Figure 5-11, F). 
 
 
Figure 5-11: Aβ42 fibrils growth monitored using ThT assay combined with TEM. A) ThT fluorescence of 
Aβ42 fibrils incubated without Cu2+ which show higher ThT intensity compared to that incubated in 
presence of Cu2+(B). TEM images of control Aβ42 oligomers at zero h (C) and after 72 h (D) reveal 
formation of straight, long, and unbranched fibrils. E) TEM image of Aβ42 oligomers at zero h and after 
72 h of incubation with Cu2+ (F), showing that less amount of fibrils were formed consistent with ThT 
fluorescence results. 
 
The data show that incubation of Cu2+ ions with Aβ42 at 1:1 molar ratio results in fewer 
amyloid fibrils (Figure 5-12) and this may be due to the formation of Cu2+ induced 
aggregates, which are unable to convert into amyloid fibrils. These results are in good 
agreement with a previous study (Smith et al. 2007).  
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Figure 5-12: ThT assay revealed that incubation of Aβ42 with Cu2+ ions results in slowed elongation 
rates compared to control. 
 
It has been demonstrated that metal ions such as Cu2+ at very low concentrations are 
required for Aβ40 fibril formation, explaining that solutions depleted of metal ions do 
not form amyloid fibrils and the addition of trace metal ions such as Cu2+ and Zn2+ 
accelerate Aβ40 amyloid formation (Huang et al. 2004b). It is suggested that Aβ-metal 
ion complexes induce amyloid fibril formation through either acting as nuclei or 
inducing structure within the peptide (Dai et al. 2006). Cu2+ ions can also mediate the 
conversion of Aβ42 peptide from amyloid material to a non-amyloidogenic aggregate 
(Smith et al. 2007). Smith and co-workers demonstrated that the switch between the two 
aggregate morphologies is centered at an equimolar Cu2+: peptide ratio, suggesting two 
mutually exclusive aggregation pathways. In a previous study, it has been suggested 
that the formation of His-bridge Cu2+ dimer at Cu2+: peptide ratio of 0.3:1 and above 
can mediate the Cu2+ induced assembly (Smith et al. 2006a). 
 
 Aβ42 is internalised into neuroblastoma cells and becomes dityrosine 5.2.1.6
cross-linked 
In previous work, the Serpell group have shown that freshly prepared Aβ42 can be 
internalised into SH-SY5Y neuroblastoma cells and that it accumulates over 24 h in 
lysosomal compartments (Soura et al. 2012). It was of interest to investigate whether the 
Aβ42 administered to these cells formed dityrosine cross-links during incubation in 
contact with neuroblastoma cells. Cells were treated in an identical way to previous 
experiments (Soura et al. 2012), administered with a final concentration of freshly 
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solubilised 10 µM Aβ42 and incubated for 24 h. Sectioned cells were co-labelled with 
the mouse monoclonal dityrosine antibodies and rabbit polyclonal Aβ antibodies for 
Aβ42. Previously, a monoclonal, conformational specific antibody Nu1, which was 
raised against oligomeric Aβ, was used to detect Aβ (Soura et al. 2012). Alternatively, a 
rabbit polyclonal antibody AB5078P was raised against C-terminus of Aβ42 (1-6) and 
used to detect Aβ in the following experiments. This antibody has been shown to not 
cross react with APP (Agholme et al. 2012) and presumably detect monomeric, 
oligomeric and fibrillar Aβ. For the purpose of this study, secondary antibodies were 5 
nm gold conjugated goat anti-rabbit IgG and 10 nm gold conjugated goat anti-mouse 
IgG, allowing the identification of both Aβ (5 nm) and dityrosine (10 nm) respectively 
in the sectioned cells and the opportunity to detect whether they co-localised. TEM of 
sectioned neuroblastoma cells treated with Aβ42 confirms the appearance of 
internalised Aβ42 concentrated in lysosomal regions (Figure 5-13, A), as shown 
previously (Soura et al., 2012).  
 
 
Figure 5-13: Immunogold labelling TEM showing neuroblastoma cells treated with oligomeric Aβ. A) 
The images reveal dityrosine (10 nm gold particles) and Aβ42 (5 nm gold particles) labelling within the 
lysosomes of treated cells. B) Low level dityrosine labelling was observed within lysosomes in vehicle 
treated, control cells, but no Aβ labelling was observed. C) Cells were observed containing fibrillar Aβ 
labelled for both Aβ (5 nm gold particles) and dityrosine (10 nm gold particles). Inserts show magnified 
images for further clarity, and also bigger images were provided, see appendix (viii). 
1 µm 200 nm 200 nm 
200 nm 100 µm 100 nm 
control A 
C 
B 
Chapter 5 
 
149 
Close examination also showed that dityrosine and Aβ42 were co-localised together 
inside the lysosomes (Figure 5-13, A). Examination of control cells showed some 
labelling of dityrosine within lyosomes, but no co-localisation with Aβ labelling (Figure 
5-13, B). These findings may indicate the importance of dityrosine cross-links in the 
internalisation of Aβ. Further investigation revealed the presence of fibrillar Aβ42 
around (Figure 5-14) and within the cells, where the fibrils exhibited clear co-
localisation of dityrosine and Aβ (Figure 5-13, C, Figure 5-14). This suggests that Aβ is 
crosslinked both inside and outside of the neuroblastoma cells. Occasionally 
extracellular Aβ was observed to be entering the cells at the plasma membrane (Figure 
5-14) and again showed co-localisation of Aβ and dityrosine labelling. Taken together, 
these results suggest that the externally administered Aβ42 becomes oxidised during 
incubation in the cellular environment and that dityrosine cross-linked oligomers (and 
possibly fibrils) can be internalised into lysosomes. 
 
 
Figure 5-14: Electron micrographs of sections of Aβ42 treated neuroblastoma cells showing immunogold 
labelling of Aβ (5nm) and dityrosine (10 nm gold particles). The images reveal colabelled fibrils outside 
and also inside the cells. 
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 The presence of dityrosine within amyloid plaques in AD brain 5.2.2
We have established that Aβ42 is able to undergo oxidation leading to formation of 
dityrosine cross-links in vitro and in a cellular environment. To determine the possible 
physiological relevance of dityrosine formation in the Aβ accumulation in AD brain, 
immunogold labelling TEM was carried out to detect any co-localisation of Aβ and 
dityrosine in AD brain and compared to age matched control brain. Previously, 
dityrosine has been detected and quantified in AD brain (Hensley et al. 1998). Using 
HPLC with electrochemical array detector (HPLC-ECD), dityrosine was quantified in 
four regions of the AD brain (Hensley et al. 1998). It was reported that dityrosine levels 
were elevated significantly in the hippocampus and neocortical regions of the AD brain. 
However, no previous study has successfully detected dityrosine in plaques, and no 
cellular localisation study of dityrosine in human brain has been reported before. 
Immunogold labelling using anti-dityrosine antibody was performed on brain sections 
taken from AD and control patients (Table 2-2), which revealed high density of 
dityrosine within amyloid plaques in AD brain sections (Figure 5-15, A). Double 
immunogold labelling TEM was also used to confirm that the amyloid plaques labelled 
with the anti-Aβ antibody as well as anti-dityrosine (Figure 5-15, B). These results 
show the high density and the cellular localisation of dityrosine within plaques (Figure 
5-15), suggesting a potentially important role for dityrosine in amyloid accumulation in 
amyloid plaques. For clarity and to easily distinguish between the two different gold 
particles, the image was analysed using in house software written in Matlab as shown in 
Figure 5-15, C. The immunogold particles analysis revealed two different sizes 
corresponding to dityrosine (red dot) and Aβ (blue dot).  A control was performed using 
an irrelevant antibody (to hair cell antigen) at identical an IgG concentration and 
showed virtually no labelling (<<1 gold particles/micron) compared to the serial section 
showing dityrosine/Aβ labelling of the same plaque in (Appendix ix a and b 
respectively) (showing 100 gold particles/µm2). 
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Figure 5-15: Immunogold labelling TEM within amyloid plaques from AD brains. A) Shows single 
labelling using the dityrosine antibody only and reveals very dense labelling of the amyloid plaques. B) 
Double labelling with anti-Aβ (5 nm gold particles) and anti-dityrosine (10 nm gold particles) reveals 
colocalisation within amyloid plaques. C) Shows the 10 nm labelling for dityrosine highlighted in red and 
5 nm labelling for Aβ in blue. Immunogold particle counting and size analyses were performed using in 
house software written in Matlab by Dr Morris. Inserts show magnified images for further clarity. 
 
In brain, tyrosine can be oxidised by peroxidases such as myeloperoxidase (Heinecke et 
al. 1993; Heinecke 2002; Leeuwenburgh et al. 1997b) and also by free radicals 
(Huggins et al. 1993; Ischiropoulos and Al-Mehdi 1995). Hydroxyl radicals, which are 
generated according to Fenton chemistry in both mitochondria and lysosomes, can 
attack tyrosine residues, leading to tyrosyl radical formation. In turn, a tyrosyl radical 
could be coupled to give dityrosine or attack the lipids, causing lipid peroxidation 
(Savenkova et al. 1994). Dityrosine is a covalent, irreversible and stable cross-link, and 
also showed high resistance to hydrolysis by proteases (Atwood et al. 2004; Giulivi and 
Davies 1994). Therefore, it represents a good contributor to amyloid plaque formation. 
 
Oxidised and non-oxidised Aβ peptides were separated by SDS-PAGE (Figure 5-16) 
and analysed by densitometry (data and analysis provided by Dr. Tom Williams). Aβ42 
dimer of molecular mass of 9 kDa was observed after ten minutes of oxidation as shown 
in Figure 5-16, whilst non-oxidised Aβ42 did not exhibit a strong dimer band and shows 
SDS separation similar to that observed elsewhere (Bitan et al. 2003).   
2 µm 0.2 µm 0.5 µm 
A 
1 µm 100 nm 
B C 
Chapter 5 
 
152 
 
 
Figure 5-16: Oxidised and non-oxidised Aβ42 were separated and analysed using SDS-PAGE/sliver 
staining. Dimeric Aβ42 was observed only in oxidised Aβ42 compared with unoxidised Aβ42 that 
produced monomeric and trimeric isomers.   
 
The Aβ42 dimer of 9 kDa that formed under oxidative condition corresponding to 
expected dityrosine cross-linked dimeric Aβ42 and strongly support the formation of 
dityrosine cross-linked oligomers of Aβ in small oligomeric species. 
 
Photo-induced cross-linking of unmodified protein (PICUP) chemistry was used to 
cross-link Aβ42. As a result, Aβ42 oligomers were formed and detected using SDS-
PAGE (Bitan et al. 2003). It has been found that uncross-linked Aβ42 produced 
predominantly two bands, a monomer band and a broad trimer band (Bitan et al. 2003), 
explaining that the trimer band was found to be induced by SDS. However, an 
analogous trimer band was not observed after cross-linking of Aβ42 using PICUP 
method.  
 
Water-soluble oligomers of Aβ were isolated and quantified in the cerebral cortex of 
normal and AD brains (Kuo et al. 1996). Interestingly, the levels of these oligomers 
were markedly elevated in AD brain compared to normal brain. Later on, stable Aβ42 
dimer and trimer were purified from neuritic and vascular amyloid deposits and using 
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size exclusion chromatography in the presence of 80% formic acid or 5 M guanidine 
thiocyanate pH 7.4, the molecular mass of Aβ dimer and trimer were determined and 
found at 9 and 13.5 kDa respectively (Roher et al. 1996). The toxicity of the purified 
Aβ42 dimers was tested on rat cultured neurons and exhibited toxicity only in the 
presence of microglia, which has been shown to release free radicals (Roher et al. 
1996). 
 
Consistent with our data, dimeric Aβ42 that has been purified from neuritic amyloid 
plaques could correspond to dityrosine cross-linked Aβ dimer observed by SDS-PAGE. 
We suggest that dityrosine cross-linked Aβ plays an essential role in the pathogenesis of 
AD and may represent the early building blocks that may initiate the formation of 
insoluble Aβ fibrils.  
 
 Lipofuscin formation could be moderated by dityrosine crosslinks  5.2.3
Lipofuscin is considered to be a biomarker of aging and the age-dependent 
accumulation of lipofuscin in the nervous system of individuals has made possible the 
reliable estimation of absolute age (Gray and Woulfe 2005; Szweda et al. 2003). 
However, it has been reported that amyloid-containing Alzheimer neurons contain a 
large amount of lipofuscin and lysosomal protease enzymes (Adamec et al. 2000), 
suggesting that the accumulation of Aβ may contribute to lipofuscin formation under 
oxidative stress conditions. Probing the contribution of oxidative stress on the tyrosine 
residue in Aβ will help to raise our understanding of the mechanism underlying the 
increased lipofuscin accumulation in AD. 
 
In order to establish whether oxidised Aβ42 is found in lipofuscin pigments in AD 
brains, immunogold labelling for dityrosine and Aβ42 in lipofuscin of AD and control 
age matched brains was carried out. Single immunogold labelling of dityrosine was 
observed in the lipofuscin granules of a control age-matched human brain (Figure 5-17), 
A & B). TEM micrographs of lipofuscin in age-matched controls show dityrosine 
labelling, indicating the possibility of dityrosine contribution in lipofuscin formation. 
Interestingly, TEM immunogold labelling of dityrosine in lipofuscin of AD brain 
reveals two different labelling areas, low-density dityrosine labelling (Figure 5-17, C) 
and high density dityrosine labelling (Figure 5-17, D), indicating different levels of 
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oxidative stress may have occurred and leading to a variety of dityrosine content that 
accumulates in lipofuscin. Additionally, it could be due to a variety of proteins that 
contribute to lipofuscin accumulation. The quantification and counting analysis of 
immunogold particles show significantly more dityrosine labelling in AD brain 
compared to age-matched control (Figure 5-17, E). 
 
 
Figure 5-17: Immungold electron microscopy of lipofuscin in AD brain compared to age matched 
controls. Micrographs reveal single labelling for dityrosine at low levels in lipofuscin in control brains 
(A, B) and high levels in AD brain (C, D). Quantification shows significantly more dityrosine labelling in 
AD brain compared to age matched controls (E). 
 
These results are in good agreement with a previous study using immunohistochemical 
detection (Kato et al. 1998), which showed dityrosine in the lipofuscin granules of the 
pyramidal neurons in control age-matched brain. However, here we find that 
comparison of AD and age-matched controls revealed a significant increase in density 
of dityrosine labelling in lipofuscin in AD brains, compared to that in control (Figure 
5-17). These results are in agreement with the capacity of oxidative stress to induce 
protein modifications resulting in the formation of intralysosomal lipofuscin. 
 
To examine the co-localisation of dityrosine and Aβ within lipofuscin pigments and to 
determine whether dityrosine resulted from the oxidative modification of Aβ, 
immunogold co-labelling for dityrosine and Aβ in lipofuscin of AD and control age 
matched brains was carried out. TEM immunogold co-labelling of dityrosine and Aβ in 
AD brain reveals some colocalisation within lipofuscin (Figure 5-18), although some 
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areas showed low levels of Aβ labelling. These results may indicate that dityrosine 
cross-links could be generated from oxidation of various proteins that contain tyrosine 
residues.  
 
 
Figure 5-18: Immunogold labelling TEM of lipofuscin in AD brains. Double labelling with anti-Aβ (5 
nm) and anti-dityrosine (15 nm) reveals colocalisation within lipofuscin.#The images reveal two different 
areas of labelling, one shows delocalisation of dityrosine and Aβ as marked with circles, and the second 
area shows colocalisation of dityrosine and Aβ as marked with rectangles, indicating that dityrosine 
crosslinks can produce from various proteins that accumulate to form lipofuscin.  
  
The protease resistant feature of dityrosine that has been reported in many studies 
(Amado et al. 1984; Atwood et al. 2004; Giulivi and Davies 1994) supports the view 
that dityrosine can associate with lipofuscin formation.  
 
It is important to keep in mind that the number of AD brain samples that we have tested 
is not enough to confirm the elevation of dityrosine levels in lipofuscin in AD brain, as 
other data collected by a project student did not show a significant increase in the 
dityrosine level in lipofuscin in the AD brain. Further investigations are needed to gain 
a better understanding of the role of dityrosine in lipofuscin accumulation and also to 
verify whether the dityrosine level undergo any elevation upon AD progress or not. On 
the other hand, dityrosine is markedly increased in lipofuscin in healthy control 
individuals along with age progress and this is consistent with other results that used 
immunohistochemical technique to assess dityrosine level in lipofuscin of healthy aged 
matched individuals (Kato et al. 1998). 
 
Both lipofuscin and plaques could form as a result of oxidative stress effects, these 
findings point to a relationship between dityrosine and amyloid accumulation in the AD 
brain and support strongly the hypothesis of dityrosine contribution to AD pathogenesis.  
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 Dityrosine as a biomarker of oxidative stress in AD 5.2.4
Given our results showing that there are dityrosine cross-linked amyloid fibrils 
deposited in AD brains and that neuroblastoma cells incubated with Aβ42 also show 
cross-linked Aβ42, we were interested to see if dityrosine cross-linked Aβ could be 
identified in cerebrospinal fluid and could therefore be a useful biomarker for AD.  
   
Here, TEM immunogold labelling for dityrosine was used to detect dityrosine and gain 
a general view of protein oxidation represented by dityrosine in CSF of AD and healthy 
age-matched control subjects. TEM immunogold colabelling-negative staining of CSF 
reveals a higher density of dityrosine and Aβ labelling in CSF taken from three AD 
patients (Table 2-3) (Figure 5-19, A) compared to age matched controls (Figure 5-19, 
B). Overall there was a much higher density of labelling for both Aβ and dityrosine in 
the AD CSF compared to controls, highlighting the presence of Aβ and also showing 
the increased level of dityrosine cross-linked proteins in CSF from AD. In the CSF from 
AD patients, two different areas of labelling were observed: those with low-density co-
localisation, and others showing high-density co-localisation of dityrosine and Aβ 
indicating that the Aβ found in the CSF may contain dityrosine cross-links, but also that 
other tyrosine containing proteins are cross-linked in the CSF from AD. More TEM 
images of negatively stained CSF from other AD patients and age-matched control are 
presented in the appendix (x). 
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Figure 5-19: Immunogold labelling TEM/negatively stain of cerebrospinal fluid from AD pateints and 
age matched controls. A) A higher density of dityrosine (labelled with 15 nm) and Aβ (labelled with 5 nm) 
labelling was observed for CSF from an AD patient  (top images) compared to b) age matched control. In 
CSF of AD patients, we can identify two different areas of labelling, low-density co-localisation (), and 
high density co-localisation () of dityrosine and Aβ. Inserts show magnified images for further clarity. 
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 Overall(discussion(((5.3
Results presented here have shown that dityrosine cross-links form in preformed Aβ42 
fibrils and in oligomeric Aβ incubated under oxidising conditions in the presence of 
Cu2+ and H2O2. It has been shown previously that 1:1 Cu2+: Aβ molar ratios and above 
are the most efficient ratios to generate dityrosine cross-links (Smith et al. 2007), 
demonstrating that Cu2+: Aβ molar ratio is a critical factor in controlling the aggregation 
state of Aβ42. Moreover, it has been shown that both non-aged and aged Aβ42-Cu2+ 
complexes at molar ratio of 1:1 are neurotoxic, whilst Aβ42-Cu2+ complexes prepared 
at sub and supra-equimolar ratios were nontoxic to neuronal cells (Smith et al. 2006a; 
Smith et al. 2007). Aβ peptide can coordinate with Cu2+ to give Aβ-Cu2+ complexes 
(Atwood et al. 2000; Syme et al. 2004), which are redox-active. In turn, these 
complexes show the ability to induce ROS formation, resulting in oxidative stress 
(Huang et al. 1999a; Smith et al. 2006a). Cu2+ ions coordinate to Aβ via the three 
histidine residues His6, His13, and His14 and potentially Tyr10 as shown in Figure 5-1 
(Atwood et al. 1998; Curtain et al. 2001; Maiti et al. 2008; Tickler et al. 2005) and 
produce SDS-resistant oligomers (Atwood et al. 2004). 
 
Clioquinol is a potent Cu/Zn chelator and has been shown to significantly reduce Aβ 
amyloid deposition in an AβPP transgenic mouse (Cherny et al. 2001) and has shown 
some efficacy in human AD subjects (Ritchie et al. 2003). These studies have been 
taken to suggest that Cu2+ plays a very significant role in Aβ deposition in AD and 
could imply that dityrosine formation can stabilise deposits. 
 
Here, cell culture experiments show that conditions amenable to Aβ dityrosine cross-
linking are also present in a cellular environment and that dityrosine containing Aβ is 
found around cells and internalised into cells both in lysosomes and occasionally as 
internalised fibrils. Previously, Serpell and coworkers (Soura et al. 2012) showed that 
internalised oligomeric Aβ42 leads to accumulation of autophagosomes containing Aβ. 
Considerable evidence supports the view that intralysosomal Aβ accumulation can 
induce neuronal death, and that the oligomers and fibrils can be stabilised by dityrosine 
cross-linking (Gouras et al. 2005; Yu et al. 2005; Zheng et al. 2006).  Studies using 
Aβ42 with the Tyr10 substituted for alanine mutant showed significantly reduced H2O2 
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production and prevented toxicity to primary cortical neurons supporting the view that 
dityrosine cross-linking may be important in mediating oligomer toxicity (Barnham et 
al. 2004).  Here, electron micrographs show the internalisation of dityrosine cross-
linked Aβ fibrillar material into the cytoplasm (Figure 5-14) and into lysosomes (Figure 
5-13). The oligomeric Aβ may be stabilised by covalent cross-links. 
 
Oxidative stress has been widely implicated in AD pathogenesis. Sources of ROS, such 
as H2O2, superoxide anion, and hydroxyl radicals, can be formed from different in vivo 
sources (e.g. oxidation, photochemical, and enzymatic reactions) although mitochondria 
represent the main in vivo source of ROS formation (Chance et al. 1979; Loschen et al. 
1971). At the same time, mitochondria are the main target of ROS attack (Harman 
2002), resulting in the formation of peroxidised, undegradable macromolecules. H2O2 
can easily diffuse into lysosomes and react with iron ions that are released from the 
degradation of different metalloproteins during their intralysosomal degradation. The 
interaction of hydrogen peroxide with iron ions results in the formation of the highly 
reactive hydroxyl radicals. The latter could attack intralysosomal macromolecules, such 
as Aβ, causing cross-linking of these materials. The oxidative modification especially 
cross-linking of autophagocytosed material, is the most probable cause of non-
degradability of these materials. The excessive accumulation of these non-digested 
materials could result in endosomal/lysosomal leakage and as a consequences acid 
hydrolase enzymes will be released, ultimately leading to cell death (Zheng et al. 2006); 
(Ditaranto et al. 2001; Yang et al. 1998). Recently, Murakami and Shimizu have 
clarified the role of cytoplasmic superoxide radical as a possible contributing factor to 
intracellular Aβ oligomerisation in AD (Murakami and Shimizu 2012). They 
demonstrated using a human amyloid precursor protein transgenic AD mouse model 
that lacking SOD1 can accelerate Aβ oligomerisation and also resulted in memory loss, 
neuro-inflammation, tau phosphorylation, and synaptic loss. This highlights the 
importance of cytoplasmic superoxide radicals in the pathogenesis of AD, explaining 
that excessive free radicals in the cytosol could result in conformational changes of 
intracellular Aβ (Murakami et al. 2010). Supporting the previous result, it is reported 
that the levels of SOD1 were markedly lower in human AD patients compared with 
non-AD subjects (Murakami et al. 2011). On the other hand, it has been reported that 
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interaction of intracellular Aβ with SOD1 decreases the activity of SOD1 (Yoon et al. 
2009). 
 
 It has also been suggested that intraneuronal Aβ oligomers cause neuronal death by 
activating endoplasmic reticulum stress, endosomal/lysosomal leakage and 
mitochondria dysfunction (Umeda et al. 2011); (Misonou et al. 2000). Kurz et al. have 
highlighted a close relation between lysosomes and mitochondria, explaining that 
accumulation of iron inside mitochondria will result in lysosomal iron loading as a 
consequence of degradation of mitochondria by lysosomal enzymes (Kurz et al. 2008). 
Moreover, normal production of H2O2 by mitochondria results in oxidative stress, 
which will labilise lysosomes and further oxidative stress could result from degradation 
of mitochondria by lysosomal enzymes.  
 
We have shown that amyloid plaques in AD brain tissue show extensive dityrosine 
cross-linking and this may suggest that these highly stable, insoluble deposits are 
stabilised by covalent cross-linking, resulting in a resistance to degradation. Therefore, 
the existence of dityrosine may be relevant in AD pathology. Friedrich et al. (Friedrich 
et al. 2010) have shown that Aβ internalised to cultured cells can accumulate and 
assemble resulting in eventual cell death and thus they suggest that the formation of 
amyloid plaques might arise from accumulated intracellular Aβ. Therefore, there may 
be a pathway from the lysosomal/autophagsosome accumulation of dityrosine cross-
linked Aβ that we have observed in neuroblastoma cells, to the eventual deposition as 
amyloid plaques composed of dityrosine cross-linked Aβ observed here in AD tissue.  
 
Interestingly, our preliminary data shows significant increased dityrosine levels in 
lipofuscin in brain tissue of AD patient compared to healthy aged matched control 
(Figure 5-17), and that may reflect the important role that is played by oxidative stress 
in lipofuscin and plaque formation and subsequently AD pathogenesis. It has been 
found that the level of lipofuscin is markedly elevated in AD brain tissue, thus it is 
important to understand the mechanism by which lipofuscin is produced and 
accumulates in brain tissue.   
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It has been suggested that intraneuronal lipofuscin is intrinsically harmful to neuronal 
cells (Double et al. 2008). Alternatively, Giaccone et al. discussed the role of lipofuscin 
in the pathogenesis of AD, and proposed that lipofuscin could be harmful to neuronal 
cells after its release into the extracellular space (Giaccone et al. 2011). However, they 
reported that lipofuscin contains both Aβ and its precursor and suggested that upon its 
release into the extracelluar space it may serve as a source of Aβ oligomers for a 
prolonged period. Results presented here support this hypothesis, showing that 
lipofuscin in AD brain contains both Aβ and dityrosine. 
 
A few studies have previously attempted to quantify dityrosine in cerebrospinal fluid.  
Techniques including HPLC with fluorescence detection, HPLC with electrochemical 
array detection (HPLC-ECD) or fluorescence detection, and liquid chromatography 
with triple quadrapole mass spectrometric detection have been applied to quantify 
dityrosine concentrations in CSF sample from both healthy and disease affected 
subjects (Abdelrahim et al. 1997; Ahmed et al. 2005; Hensley et al. 1998). However, the 
results of these studies have been conflicting, perhaps due to differences in sample 
handling and preparation before measuring. Quantitative screening of protein glycation, 
oxidation and nitration adducts in CSF of AD and healthy age-matched subjects have 
been taken to suggest that dityrosine concentration does not change in AD patients with 
respect to control subjects (Ahmed et al. 2005). By contrast, earlier studies using 
electrochemical detection showed that dityrosine concentration was elevated markedly 
in CSF of AD patients (Hensley et al. 1998). 
 
Our results have revealed very strong evidence for the presence of both Aβ and 
dityrosine in the CSF from AD patients. Both Aβ and dityrosine are very rarely 
observed in CSF from age-matched controls. Therefore, we suggest that dityrosine 
cross-linked Aβ could represent a potential biomarker for AD. 
 
It has been illustrated that, at equimolar or Cu2+:Aβ molar ratios > 0.3 (Curtain et al. 
2001; Smith et al. 2006a) , Aβ coordinates a Cu2+ ion and a His bridge forms between 
Cu2+ ions. This His bridge has a marked effect on the formaion of dityrosine adduct, 
explaining why elimination of the His bridge formation by methylation of the imidazole 
side chain of the His at either the π or τ position inhibits dityrosine formation 
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significantly. This His bridge can play a significant role in the formation of dityrosine 
cross-linking by bringing two tyrosine residues in to close approximation and facilitates 
dityrosine cross-link formation (Smith et al. 2006a). 
 
 
Figure 5-20: Graphic abstract explaining the role of dityrosine cross-link in the pathogenesis of AD. 
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 Conclusion((5.4
At equimolar ratio of Cu2+ and Aβ42, Cu2+ can catalyse tyrosine oxidation by H2O2, 
leading to dityrosine cross-link generation and the latter can cause Aβ misfolding, 
resulting in Aβ assembly into oligomers and subsequently into amyloid fibres. It is 
possible that dityrosine cross-links stabilise Aβ fibres once formed.  
 
Here we present a comprehensive study of in vivo and in vitro dityrosine cross-linking 
associated with Aβ. We have revealed the presence of dityrosine cross-links in amyloid 
plaques in human AD brain, and also in CSF, and identified significant relationships 
between dityrosine cross-links and amyloid deposit formation. The in vitro and in vivo 
results presented here reveal that oligomeric Aβ can undergo oxidative modification in a 
cellular environment, resulting in cross-linked Aβ through dityrosine, followed by 
intralysosomal Aβ accumulation that could lead to lysosomal leakage and cell death. 
Our results show significant accumulation of dityrosine crosslinked Aβ in amyloid 
plaques, implying a role in stabilisation of these insoluble deposits. We have also 
proposed a potential new biomarker for AD in CSF, which contains elevated dityrosine 
cross-linked proteins as well as elevated dityrosine cross-linked Aβ. Our preliminary 
findings show that dityrosine cross-links were increased in lipofuscin in AD brain, 
indicating the important role played by dityrosine cross-links in the accumulation of 
lipofuoscin in higher levels in AD compared to control subjects.  
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6 Results and Discussion 
Aggregation(of(α-syn induced by Cu2+-catalysed oxidation as a 
potential mechanism of Lewy body production 
 
 Introduction(6.1
PD is the second most common neurodegenerative disease after AD in humans. 
Recently, it has been proposed that intermediate forms of self-assembled α-syn are the 
main pathogenic species (Celej et al. 2012; Wright et al. 2009). Oxidative stress has also 
been implicated in the pathogenesis of a number of neurodegenerative diseases, 
including AD and PD (Moreira et al. 2007; Zhou et al. 2008). Similar to Aβ, dityrosine 
cross-links can also be formed in vitro via MCO of α-syn under physiological 
conditions (Cole et al. 2005; Paik et al. 2000), and have been identified as biomarkers of 
oxidative stress in an MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) mouse 
model of PD (Pennathur et al. 1999a; Pennathur et al. 1999b). Studying the influence of 
dityrosine cross-links in the α-syn conformation and during fibrillogenesis would 
provide insights into the importance of oxidative modification of tyrosine residues in 
the pathogenesis of PD. In this chapter, the ability of the Cu2+ ion to promote the 
formation of in vitro dityrosine cross-linked α-syn was explored and the effect of the 
Cu2+ ion on α-syn fibrillogenesis and conformation was investigated. The role of 
dityrosine as a covalent cross-linker was revealed using a number of techniques 
including fluorescence spectroscopy, HPLC, LC-ESIMS/MS, SDS-PAGE, TEM, 
XRFD and CD. 
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 Results(and(discussion(6.2
 Cu2+-catalysed oxidation of α-syn enhances dityrosine cross-link formation 6.2.1
Formation of dityrosine cross-linked α-syn was enhanced by incubation of 50 µM 
recombinant α-syn with 50 µM Cu2+/ 1.25 mM H2O2 in 20 mM HEPES buffer pH 7.4 
(Figure 6-1, A). Controls were prepared by incubating 50 µM recombinant α-syn in 
buffer alone and with buffer supplemented with 50 µM Cu2+ (Figure 6-1 B and C 
respectively). The mixtures were incubated for 24 h at 37 °C with agitation of 400 rpm. 
The incubation of α-syn with Cu2+/H2O2 leads to rapid loss of the intrinsic tyrosine 
fluorescence signal at a wavelength of 305 nm using an excitation wavelength of 280 
nm, as seen in Figure 6-1, A. Concomitant with the decrease in tyrosine signal, there 
was an enhancement in fluorescence emission intensity at wavelength of 410 nm, 
indicating dityrosine formation (Figure 6-1, A). 
 
 
Figure 6-1: Enhanced dityrosine cross-linked α-syn in the presence of Cu2+/H2O2. 50 µM of monomeric 
α-syn was incubated for 24 h with Cu2+/H2O2 at 37 °C and agitation 400 rpm (A). After one h of 
incubation, the tyrosine fluorescence signal was reduced with simultaneous appearance of a new signal 
at 410 nm, typical of the dityrosine fluorophore. No dityrosine fluorescence signal was obtained over 24 
h of incubation of α-syn in HEPES buffer alone (B), and with 50 µM Cu2+ (C). 
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The assignment of the fluorescence to dityrosine was further confirmed using an 
excitation wavelength of 320 nm and emission at 410 nm as seen in the inset of Figure 
6-1, similar to data in Figure 3-9, and also supported by published data obtained at a 
similar pH (Borsarelli et al. 2012). In addition, LC-ESIMS/MS, which was acquired 
using MRM mode, was used to further confirm the identity of the resulting dityrosine 
cross-link (Figure 6-2). As described previously in chapter 3, the detection of the 
dityrosine was achieved using the most intense ion reaction of m/z: 361.1→315. 50 µM 
of α-syn was oxidised under metal-catalysed oxidation for 24 h, and the reaction was 
quenched using EDTA. The oxidised peptide was desalted, concentrated and hydrolysed 
under acidic conditions as described in the method’s chapter (2.4.8). The mass 
chromatogram of α-syn hydrolysate revealed a peak with retention time of 5.8 min, 
which corresponds to that of authentic dityrosine (Figure 6-2). 
 
 
Figure 6-2: LC-ESIMS/MS (MRM) chromatograms showing the presence of dityrosine in the α-syn 
hydrolysate, which was obtained by acidic hydrolysis of the oxidised α-syn. The oxidised α-syn was 
obtained by oxidation of (50 µM) monomeric α-syn for 24 h under Cu2+/H2O2 conditions.  
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Incubation of 50 µM α-syn in both Cu2+-depleted and Cu2+-containing buffer revealed 
the remarkable appearance of a fluorescence peak around 410 − 420 nm after 7 days of 
incubation (Figure 6-3), indicating the possible involvement of dityrosine cross-links in 
the mechanism underlying the α-syn aggregation and accumulation in PD. At early time 
points (0-6 days), only the typical tyrosine fluorescence signal at 305 nm was observed, 
and interestingly after 7 days of incubation in both Cu2+-depleted and Cu2+-containing 
buffer, a typical dityrosine fluorescence signal at 410 − 420 nm was observed (Figure 
6-3, A and B respectively).  
 
 
Figure 6-3: Dityrosine formation upon α-syn incubation in HEPES buffer only (A) and with Cu2+ (B). 
Incubation of 50 µM α-syn in both Cu2+-depleted and Cu2+-containing buffer revealed remarkable 
appearance of dityrosine signal at 410 - 420 nm after 7 days of incubation.  
 
Previous work shows that Cu2+ ions play a vital role in α-syn aggregation and 
fibrillogenesis (Lucas and Lee 2010; Rasia et al. 2005; Uversky et al. 2001; Wang et al. 
2010). Preliminary ThT results showed that the ThT signal was significantly enhanced 
after 13 days of α-syn incubation with 50 µM Cu2+ applying 1:1 molar ratio (Figure 
6-4, A). The dityrosine and ThT fluorescence data showed an increased intensity after 7 
days incubation both with and without Cu2+. This may indicate an important role of 
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MCO in initiating the α-syn fibrillogenesis process in vitro, and perhaps also in vivo. It 
is important to mention that the provided α-syn, which is used in this study, was of high 
purity and does not show any cysteine mis-incorporation to tyrosine at position 136, 
which has been observed for about 20% of human α-syn expressed in Escherichia coli 
(Masuda et al. 2006). It has been reported that α-syn mutant Y125W/Y133F/Y136F had 
showed the same physical properties, including the ability to form fibrils, as wild type 
α-syn (Kaylor et al. 2005), reflecting the important role played by Y39 in the α-syn 
fibrillation. A dityrosine fluorescence signal at 410 nm was observed for the mentioned 
mutant α-syn after 125 h of incubation in only phosphate buffer pH 7.4 with stirring at 
37 ºC, explaining that the dityrosine cross-links were intermolecular as there is only one 
Tyr at position 39 and also it formed only in the soluble late oligomers (Kaylor et al. 
2005). Although both α- and β-syn contain four similarly placed tyrosine residues in the 
C terminus, they display differing abilities to aggregate and, unlike α-syn, β-syn is not 
found in the Lewy bodies in PD (Biere et al. 2000; Jakes et al. 1994; Spillantini et al. 
1997). It has been revealed that in vitro exposure of α-syn to nitrating agents resulted in 
the formation of stable dityrosine cross-linking (Souza et al. 2000). In contrast, β-syn 
does not form stable dityrosine crosslinks after exposure to nitrating agents, despite the 
presence of all four conserved tyrosine residues (Souza et al. 2000). This may reflect the 
importance of dityrosine cross-link formation to enhance α-syn aggregation and its 
pathological role in PD. 
 
It has been shown that dityrosine forms in α-syn fibrils that have been aged in the 
absence and presence of Cu2+ in an aerobic environment, whilst α-syn aged 
anaerobically did not show any dityrosine formation (Lucas et al. 2010). Furthermore, 
incubation of α-syn in solutions that contain methionine and/or EDTA, which help to 
prevent or reduce the level of protein oxidation, led to lengthened lag times for fibril 
nucleation (Krishnan et al. 2003). Gathering our results with others indicates that Cu2+ 
ions strongly promote the oxidation of α-syn, resulting in dityrosine cross-linked α-syn 
formation. Also, it has been found that seeding α-syn with dityrosine cross-linked 
dimers accelerates α-syn fibrillogenesis, suggesting that the critical rate-limiting step in 
the nucleation of α-syn fibrils is the formation of dimeric species, dityrosine cross-
linked, and their accumulation (Krishnan et al. 2003). Current results are in good 
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agreement with other published data (Krishnan et al. 2003; Lucas et al. 2010; Souza et 
al. 2000), and support the notion that dityrosine cross-linked α-syn oligomers can serve 
as a seed in the α-syn fibrillogenesis process. Interestingly, it has been showed that 
stable α-syn polymers can be generated using nitrating agents and these polymers were 
highly stabilised due to the formation of dityrosine cross-link (Souza et al. 2000). 
 
To examine whether Cu2+-enhanced α-syn fibrils have a β-sheet conformation, a 
combination of CD and ThT fluorescence were used to compare the control with Cu2+-
enhanced α-syn fibrils. The CD spectra of both α-syn incubated under control (i.e. 
without Cu2+) and Cu2+-containing buffer conditions did not display a β-sheet structure 
(Figure 6-4, D and E), which typically has a positive and a negative peak at ~ 196 nm 
and ~ 216 nm respectively. Instead the CD spectra are consistent with random coil 
conformation (minimum at 195 nm). In contrast, ThT fluorescence spectrum and TEM 
micrographs of Cu2+-enhanced α-syn showed fibril formation (Figure 6-4, A and C). 
These CD results may arise from only the soluble α-syn species that remain in solution 
in the buffer whilst fibrils were precipitated, leading to the surprising lack of β-sheet 
signal by CD. Moreover, it could be that the β-sheet CD signal was masked by the 
signal raised from random coil conformation, which is reported to be much stronger 
than β-sheet. 
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Figure 6-4: Cu2+ ion accelerates α-syn fibrillogenesis.! Preliminary results showed that the ThT signal 
was slightly enhanced after 13 days of α-syn incubation with 50 µM Cu2+(A) and this agreed with 
corresponding TEM micrographs which showed formation of α-syn oligomers in absence of Cu2+ (B) 
compared those incubated with Cu2+ (C). The Cu2+-enhanced assemblies display characteristic fibril 
morphology by negative stain TEM, by contrast spherical aggregation was observed under control 
condition that corresponds to protofibrils species of α-syn (B). CD spectra of both α-syn fibrils obtained 
in buffer only (D) and Cu2+-enhanced fibrils (E) revealed a random coil structure that did not change 
over the incubation time. 
 
TEM micrographs of Cu2+-enhanced α-syn fibrils revealed the formation of relatively 
uniform, mostly unbranched, and often twisted fibrils (Figure 6-4, C), whereas 
incubation of α-syn under control conditions for 13 days resulted in α-syn protofibril 
formation (Figure 6-4, B), indicating that the formation of α-syn fibrils is significantly 
promoted upon incubation with Cu2+. This finding is in good agreement with previously 
published data that revealed that various metal ions accelerate α-syn fibrillogenesis 
(Uversky et al. 2001). Moreover it has been revealed that Cu2+ is the most effective ion 
for inducing α-syn oligomerisation (Paik et al. 1999).  
 
Because the α-syn has four tyrosine residues in its sequence located at 39, 125, 133, 136 
(Figure 6-5), this raises the possibility that α-syn oxidation can lead to the formation of 
intra and inter dityrosine cross-links.  
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Figure 6-5: Amino acid sequence of human α-syn showing the positions of tyrosine residues at 39, 125, 
133, and 136 respectively that are highlighted in blue. 
 
In order to characterise which of these tyrosine residues is responsible for the cross-
linking formation, HPLC chromatograms of α-syn that had been incubated for 6 h under 
both control and oxidative conditions were obtained. A C-4 Phenomenex (150X4.6 
mm) column was used for HPLC analysis, and α-syn was monitored detecting 
absorbance at 226 nm. The HPLC chromatogram of non-oxidised α-syn showed a 
major single peak with a retention time of 9.73 min and maximum absorbance at 226 
nm (Figure 6-6, A), indicating the presence of monomeric species of α-syn. The HPLC 
analysis of oxidised α-syn showed the HPLC profile in Figure 6-6, B. The HPLC 
chromatogram of oxidised α-syn showed many peaks with retention times between 7.2 
– 9.9 min; consequently this makes the comparison of oxidised and non-oxidised α-syn 
more challenging. Also, the resolution of the peaks that were obtained from oxidised α-
syn is very poor, making the fraction collection process difficult. However, the peaks 
with retention time range of 7.17 – 8.38 min and 8.78 – 9.98 min were collected and 
labelled fraction 1 and fraction 2 in the figure (Figure 6.6), and then analysed for 
dityrosine presence using fluorescence spectrophotometry. The fluorescence spectra 
revealed the appearance of a signal at 410 nm, indicating the presence of dityrosine in 
fraction 2, whilst fraction 1 did not give a dityrosine fluorescence signal.  
 
  
     1 MDVFMKGLSK  AKEGVVAAAE KTKQGVAEAA  GKTKEGVLYV  GSKTKEGVVH  
    51 GVATVAEKTK  EQVTNVGGAV VTGVTAVAQK  TVEGAGSIAA  ATGFVKKDQL  
   101 GKNEEGATQE  GILEDMPVDP  DNEAYEMPSE  EGYQDYEPEA  
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Figure 6-6: HPLC chromatograms showing the profile of oxidised α-syn oligomers. Non-oxidised (A) 
and oxidised (B) α-syn samples were injected into C–4 Phenomenex (150 X 4.6mm) column with a flow 
rate was 1 ml/min. 0.1% TFA in water used as solvent A and 0.085% TFA in acetonitrile used as solvent 
B. α-syn monitored using UV detector at wavelength of 226 nm. 
 
As demonstrated previously, the fluorescence data (Figure 6-1, A) showed that 
incubating α-syn under oxidation conditions rapidly induces dityrosine cross-linkages 
in α-syn and 1 h was enough to observe a dityrosine signal with high intensity. 
Oxidation of α-syn at early time points was examined and analysed by SDS gel 
electrophoresis and visualised by Coomassie blue and silver staining (Figure 6-7), and 
showed formation of a dimer after 1 h incubation under oxidation and increasing the 
oxidation time to 5 h resulted in greater yield of dimer, which is covalently cross-linked 
through tyrosine-tyrosine coupling. Also, large SDS resistant aggregates that are 
incapable of entering the gel matrix were observed in all cases, as visualised by silver 
staining, and this could be due to the presence of these aggregates in the stock solution 
of α-syn that was used to prepare the desired concentrations and the centrifuging speed 
was not enough to remove them. Although the fluorescence data showed rapid 
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formation of dityrosine cross-links with high intensity, SDS analysis displayed the 
presence of high levels of monomeric α-syn with a molecular weight of 14.5 kDa, 
suggesting that dityrosine cross-linking was more likely intra-α-syn rather than inter-α-
syn. Interestingly, SDS analysis revealed an appearance of two adjacent bands after 1 h 
of oxidation (Figure 6-7), and this could be explained by the formation of two structural 
forms of dimeric α-syn with different mobilities within the gel. SDS represents one of 
the compounds that are used as a membrane mimetic (Hunter et al. 2005). Recently, it 
has been found that α-syn can adopt an α-helical conformation in micelles of SDS 
(Zibaee 2005), suggesting that the dimeric α-syn species found here may be comprised 
of two different structural isoforms, i.e. α-helical and another undetermined form, 
which could be an unfolded form. 
 
 
Figure 6-7: SDS-PAGE analysis of α-syn samples as a function of the time of oxidation. 100 µM of 
purified recombinant human α-syn was oxidised under Cu2+/H2O2 conditions in 20 mM HEPES buffer, 
pH 7.4, at 37 °C with agitation of 400 rpm. Aliquots were removed at time intervals indicated and EDTA 
was added to quench the oxidation process. SDS-sample buffer added to the samples and then boiled for 
5 min at 100 °C, and 10 µl of the boiled sample loaded on 15% Tris-glycine gel. The figure shows the 
appearance of a new band with molecular weight about 30 kDa after 1 h of oxidation that became more 
obvious at 5 h of oxidation indicating the presence of a dimer with time. 
 
 Identification of dityrosine cross-linked α-syn dimer using LC-MS 6.2.2
To investigate which tyrosine residue(s) may be evolved in the formation of dityrosine 
cross-links, both intact oxidised and non-oxidised α-syn were analysed using nanoLC-
MS (Figure 6-8). 
 
55  
45  
36  
 
 
 
 
 
14.2  
29  
24  
20  
116 
97  
66  
Oxidised alpha-synuclein 
M
ol
ec
ul
ar
 W
ei
gh
t (
K
D
a)
 200 
Marker Control 
Marker  
0 h 
15 min 
30 min 
1 h 
5 h 
20 h 
20 h 
Oxidised Alpha-synuclein  
Control  
   
 
   36 
  
   29  
 
 
 
14.2  
M
ol
ec
ul
ar
 W
ei
gh
t (
K
D
a)
 
45 
55 
66 
116 
  97 
200 
20 h 
20 h 
5 h 
1 h 
30 min 
15 min 
0 h 
Chapter 6 
 
174 
 
Figure 6-8: NanoLC-MS analysis of intact non-oxidised α-syn. 1 pmole/µl of human recombinant α-syn 
prepared in 0.1% formic acid and then analysed by LTQ orbitrap hybrid FT mass spectrometer. The 
mass spectrum confirms the identification of the α-syn with the expected mass of 14451.219. 
 
Non-oxidised α-syn (1 pmole/µl of human recombinant α-syn prepared in 0.1% formic 
acid) was initially used to optimise the nanoLC-MS conditions using a LTQ orbitrap 
hybrid FT mass spectrometer connected to nanoLC. The mass spectrum revealed the 
identity of the analysed α-syn and the molecular mass of α-syn was estimated to be m/z 
(M+H+) 14451.256 and this is consistent with the calculated m/z (M+H+) 14451.219 
with precision of 2.6 ppm. The determined primary amino acid sequence (Figure 6-8) 
was identical with the expected and known sequence of human α-syn (Lucas and Lee 
2010; Lucas et al. 2010). To determine the formation of dityrosine cross-linked α-syn 
dimer, 1 µl aliquot from the α-syn oxidation mixture was injected into nanoLC-MS, and 
the analysis was performed using the same conditions that were used to identify the 
non-oxidised α-syn. Unfortunately, it was not possible to detect the α-syn dimer as the 
signal of monomeric α-syn masked the α-syn dimer signal. The high proportion of 
monomeric compared to dimeric α-syn dominated the mass spectrum and as a result 
high signal suppression was observed. These data are consistent with that shown from 
SDS-PAGE, which revealed a higher concentration of monomeric α-syn compared with 
α-syn dimer (Figure 6-7). However, many nanoLC-MS attempts were carried out to 
resolve this problem and to get better resolution, but all of the trials failed to separate 
the oxidised α-syn mixture. 
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Coupling of SDS-PAGE with mass spectrometry has been widely used to characterise 
the post-translational modifications of proteins (Burlingame et al. 1996), and also in 
protein identification using database searching algorithms (Cohen and Chait 1997). 
However, nanoLC-MS/MS mapping enabled the determination of a detailed oxidative 
modification for oxidised α-syn. The oxidised α-syn mixture was successfully separated 
by SDS-PAGE as demonstrated above (Figure 6-7), and this resolved the problem 
arising from poor resolution in the LC column and in turn the bad yield in mass 
spectrometry analysis. In order to gain better insight into the nature of oxidative 
modification of α-syn catalysed by Cu2+ ions, oxidised α-syn mixture was first 
separated using SDS-PAGE (Figure 6-7), followed by in gel trypsin digestion for the 
separated bands. Finally, the extracted peptide fragments were analysed by LTQ 
orbitrap hybrid FT mass spectrometry. To identify the α-syn peptides, the Mascot 
search engine was used and the search results revealed 100% sequence recovery of α-
syn (monomeric) and 89% of α-syn (dimeric) (Figure 6-9 A and B, respectively). 
 
 
Figure 6-9:Identification of tryptic peptides of α-syn using Mascot database search engine. Mascot 
search results of α-syn digested from the monomeric band (A), and from dimeric band (B).  
 
Interestingly, two regions were not mapped, corresponding to 7GLSKAK12 and 
35EGVLYVGSK43 in the α-syn dimer peptides (Figure 6-9, B). The second region 
contained Y39, and one explanation for the absence of this sequence from all the mass 
spectrometry data is that Y39 is oxidised and as a result a dityrosine cross-link was 
formed. As dityrosine exhibits high protease resistance, the mentioned peptide fragment 
was not released and instead a dimeric form of the 35EGVLYVGSK43 peptide is 
released, indicating the involvement of Y39 to form homo dimer α-syn. This proposal 
Matched peptides shown in Bold Red 
  
     1 MDVFMKGLSK  AKEGVVAAAE KTKQGVAEAA  GKTKEGVLYV  GSKTKEGVVH  
    51 GVATVAEKTK  EQVTNVGGAV VTGVTAVAQK  TVEGAGSIAA  ATGFVKKDQL  
   101 GKNEEGATQE  GILEDMPVDP  DNEAYEMPSE  EGYQDYEPEA  
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was confirmed by the appearance of a peak at m/z 1179.6127 and identified to be a 
dimer peptide of (33TKEGVLYVGSK43) as shown in Figure 6-10. 
 
 
Figure 6-10: NanoLC-MS/MS chromatogram (A) of tryptic digested α-syn dimer that extracted from 
electrophoresis gel. Mass spectrum (B) showing the appearance of a peak at m/z 1179.6127 that 
corresponds to the dimer of the peptide with sequence of (33TKEGVLYVGSK43). 
 
The involvement of Y39 in the formation of hetero dimer, i.e. Y39-Y125, Y39-Y133 or 
Y136, was also analysed and showed no evidence of formation of these peptide links. 
Furthermore, the Mascot data showed the presence of the regions that contained Y125, 
Y133, and Y136 in both monomeric and dimeric α-syn that indicates that α-syn dimer 
results from crosslinking between Y39 from two molecules to form a dimer. 
 
Quenched hydrogen/deuterium exchange NMR spectroscopy has been used to study the 
structure of α-syn in its amyloid state and identified five β-strands within the fibril core, 
comprising residues 35–96 and termed aSβ1, aSβ2, aSβ3, aSβ4 and aSβ5 (Vilar et al. 
2008). Tyrosine at position 39 was involved in the formation of aSβ1, while tyrosine 
residues at 125, 133, and 136 did not contribute towards the formation of any β-strand. 
Recently, the first region aSβ1, consisting of 37VLYVGSKT44 was studied using XRFD 
and it was found that at high concentrations the peptide forms nanotubular cross-β 
assemblies (Morris et al. 2013a). Interestingly, the proposed structural model of these 
nanotubes revealed that peptide packing and inter-sheet Tyr interactions were involved 
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to stabilise the tape width (Figure 6-11) (Morris et al. 2013a). Also, the model shows 
that the orientation of the phenol groups of Tyr residues is in agreement with the 
formation of inter-sheet dityrosine cross-links, however, it is important to keep in mind 
this may be not true in full length α-syn. 
 
 
Figure 6-11: The structural model of aSß1 showing the peptide packing within the fibrils and revealed 
that inter-sheet Tyr interactions were involved to stabilise the tape width. The model was constructed 
based on XRFD analysis. Adapted from (Morris et al. 2013a).  
 
Recently, dityrosine cross-linked α-syn oligomers have been formed by PICUP using 
tris(bipyridine) ruthenium(II) chloride complex as a photosensitiser and these oligomers 
exhibited high toxicity effects on differentiated neuronal-like SH-SY5Y cells, indicating 
the importance of the tyrosine residue oxidative modification in the etiology of PD 
(Borsarelli et al. 2012). Interestingly, using western blot, they showed no intramolecular 
dityrosine formation in the monomeric band of α-syn and this could be due to the 
specificity of the PICUP method used to induce dityrosine formation, or the sensitivity 
of immunochemistry assay. The photo-enhanced α-syn dimer was cross-linked via Y39-
Y39 to give homo dimer peptide and Y39-Y125, Y133 and Y136 to give hetero dimer 
peptide (Borsarelli et al. 2012). The mass spectrometry data in our hands revealed no 
such hetero dimer peptide formation and could be interpreted as due to the variation in 
the specificity of the oxidation conditions used to induce the dityrosine formation in α-
syn.  
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 α-syn fibrillogenesis and conformation upon incubation with Cu2+ ions 6.2.3
Figure 6-3 reveals that incubation of recombinant human α-syn monomers in both the 
absence and presence of Cu2+ ions generate dityrosine cross-links, and that in the case 
of the presence of Cu2+ ions, fibril formation was accelerated. In order to gain insights 
into the role played by Cu2+ ions and to probe both structural and morphological 
developments of the generated α-syn fibrils, further studies were carried out using 100 
and 400 µM α-syn incubated with 100 and 400 µM Cu2+ respectively. The samples 
were then analysed over two weeks using ThT fluorescence, TEM, and CD (Figure 
6-12). After one week of incubation, α-syn fibrils formed when incubated in the 
presence of Cu2+, whereas no α-syn fibrils were detected by TEM or ThT fluorescence 
in the sample incubated under control conditions, as shown in Figure 6-12. ThT 
fluorescence spectra of Cu2+-induced α-syn fibrils revealed a significant increase in 
intensity over the two week incubation period (Figure 6-12, E), revealing α-syn fibril 
formation after seven days of incubation, and this was further confirmed by observation 
of fibrils in TEM images (Figure 6-12, D), which showed formation of α-syn fibrils that 
are of a similar appearance to those formed using 50 µM Cu2+ (Figure 6-4, C). This 
contrasted with the α-syn that was incubated in buffer only, which showed no evidence 
of fibril formation using both TEM and ThT (Figure 6-12, A and B respectively). 
Interestingly, after two weeks of incubation, TEM micrographs of Cu2+-induced α-syn 
fibrils showed distinct morphological changes (Figure 6-12, D), with more dense, short 
fibrils formed, with needle-like structures. In contrast, α-syn fibrils formed under 
control condition are similar to those previously seen in other studies (Celej et al. 2012; 
Serpell et al. 2000a; Wright et al. 2009), which showed a uniform, long and unbranched 
morphology, with some twisting fibrils (Figure 6-12, A). Fewer fibrils were observed 
compared with those formed under the Cu2+-containing buffer. To investigate whether 
α-syn fibrils aged under the Cu2+-containing buffer underwent a conformational 
development over time, CD spectra were acquired and revealed that after two weeks of 
incubation assembled α-syn fibrils still have a random coil structure (Figure 6-12, F), 
and a similar conformation was observed for those aged under control condition (Figure 
6-12, C). However, a noticeable decrease in the CD signal at ~ 200 nm was observed for 
those aged with Cu2+ ions  (Figure 6-12, F), indicating the presence of less soluble α-
syn with random coil structure compared to those aged under control conditions. 
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Figure 6-12: 100 µM of monomeric human α-syn incubated in the absence and presence of 100 µM 
Cu2+in 20 mM HEPES buffer, pH 7.4 at 37 ºC with agitation of 400 rpm. Assembled α-syn fibrils 
analysed for their growth and structure using ThT, TEM, and CD. TEM micrographs of α-syn fibrils that 
formed from incubation of α-syn monomers in HEPES buffer only (A) and in Cu2+-containing buffer (D), 
showing that the presence of Cu2+ accelerates the fibril formation. The growth of α-syn fibrils was also 
monitored using ThT fluorescence in presence (E) and absence (B) of Cu2+. CD spectra of α-syn were 
recorded upon incubation in HEPES buffer only (C) and in Cu2+-containing buffer (F) and revealed a 
random coil structure in both cases. 
 
It has been shown that α-syn fibril growth is concentration dependent (Serpell et al. 
2000a), where α-syn fibril growth and conformation were assayed using many 
techniques, including CD, ThT fluorescence, TEM and XRFD. In this current study, 
fibrillar α-syn was obtained by incubation of 400 µM monomeric recombinant human 
α-syn in the absence or presence of 400 µM Cu2+ using 20 mM HEPES buffer, pH 7.4 
with agitation at 450 rpm and a temperature of 37 ºC. Both ThT fluorescence data and 
TEM images confirmed α-syn fibril formation under control and Cu2+-containing buffer 
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conditions after 120 h of incubation (Figure 6-13), and again revealed that incubation 
with Cu2+ markedly accelerates fibril formation (Figure 6-13, C). A secondary structure 
measurement of Cu2+-induced α-syn fibrils by CD reveals no significant conformational 
change over the incubation period (Figure 6-13, D), but, in contrast, the CD spectra 
from control α-syn fibrils showed a transition from the unfolded conformation, which is 
characterised by a maximum negative ellipticity at ~ 200 nm, to a β-sheet conformation 
with a minimum at ~ 218 nm (Figure 6-13, B). 
 
 
Figure 6-13: Cu2+ ions affect α-syn fibril growth and structure. Addition of Cu2+ ions to the monomeric 
α-syn enhanced fibril growth as shown in ThT spectra (C). Cu2+-depleted solution of α-syn shows less 
fibril content (A). However, TEM images reveal no significant morphological changes over incubation of 
α-syn with Cu2+, but more fibrils were formed upon incubation. The CD spectra of α-syn fibrils grown in 
20 mM HEPES buffer, pH 7.4 with 450 rpm agitation show a conversion from random coil to ß sheet 
structure after 96 h of incubation (B), whereas α-syn fibrils grown in Cu2+-containing buffer did not show 
this conversion (D), although a significant decline at ~ 200 nm band was obtained after 96 h of 
incubation. 
 
To verify that the samples contained the expected cross-β amyloid fibrils, XRFD 
patterns were collected for both α-syn fibrils incubated with Cu2+ ions and those which 
assembled without Cu2+ ions following a desalting process by centrifuging for 30 mins 
at 20,000 g and 4 ºC (see 2.4.12). The XRFD patterns showed the expected cross-β 
conformation, the characteristic shared feature of both amyloid and amyloid-like fibrils 
0"
50"
100"
150"
200"
250"
300"
350"
460" 480" 500" 520" 540" 560" 580" 600"
In
te
ns
ity
((a
.u
.)(
Wavelength((nm)(
0(h( 24(h( 120(h(
0.5 µm 
0"
50"
100"
150"
200"
250"
300"
350"
460" 480" 500" 520" 540" 560" 580" 600"
In
te
ns
ity
(a
.u
.)(
Wavelength((nm)(
0(h( 24(h( 120(h(
0.5 µm 
!"###$
!%###$
!&###$
!'###$
!(###$
!)###$
#$
)###$
(###$
'###$
&###$
%###$
)*#$ (##$ ((#$ (&#$ ("#$ (*#$ '##$
!"
#$
%&'
(%)
*+
,-
%.
/
0-
%*
/
12
+#
!3
%
456+2+7,89%)7/3%
#$+$ &*$+$ ,"$+$
!"###$
!%###$
!&###$
!'###$
!(###$
!)###$
#$
)###$
)*#$ (##$ ((#$ (&#$ ("#$ (*#$ '##$
!"
#$
%&'
(%)
*+
,-
%.
/
0-
%*
/
12
+#
!3
%
456+2+7,89%)7/3%
"%9% :;%9% <$%9%
A 
D 
B 
C 
Chapter 6 
 
181 
(Conway et al. 2000; Serpell et al. 1999; Sunde et al. 1997), for both Cu2+-enhanced α-
syn fibrils (Figure 6-14, B) and control α-syn fibrils (Figure 6-14, A). Meridional 
reflections at 4.76 and 2.4 Å were observed in patterns from fibrils assembled under 
both control (i.e. without Cu2+) and Cu2+-containing conditions. Moreover, a set of 
reflections at ~ 8.1, 9.5 and 19.4 Å were observed on the equator, similar to those 
reported in a previous study (Serpell et al. 2000a), confirming the formation of α-syn 
fibrils with cross-β structure. However, the XRFD for Cu2+-enhanced α-syn fibrils 
(Figure 6-14, B) revealed a new reflection at ~ 35 Å and also showed more intense 
reflections attributable to the formation of more aligned fibrils compared to those 
assemblies incubated under control conditions. TEM micrographs revealed a higher 
density of Cu2+-enhanced α-syn fibrils that also appeared to have a more ordered, rigid 
appearance (Figure 6-13, C). This provided more evidence that the Cu2+ ion plays a 
vital role in accelerating α-syn fibril formation and may affect the final structure. 
 
 
Figure 6-14: X-ray fibre diffraction patterns of α-syn fibrils showing cross-β structure. X-ray fibre 
diffraction patterns were collected for α-syn fibrils formed by incubation of 400 µM recombinant α-syn 
monomer in 20 mM HEPES buffer, pH 7.4 alone (A) and in 20 mM HEPES containing 400!µM Cu2+ (B).  
 
The cross-β diffraction pattern was first shown for insect silk (Geddes et al. 1968), and 
it demonstrated that the cross-β reflections consist of a meridional reflection at ~ 4.7 Å 
corresponding to the inter-chain spacing, and an equatorial reflection located in the 5 - 
10 Å region, which represents the spacing between the β-sheets. This distance is 
dependent upon the size of the side chains (Figure 6-15). The assembly properties and 
secondary structure features of recombinant α-syn have been assessed using XRFD, CD 
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and electron diffraction (Serpell et al. 2000a), which showed that α-syn assemblies 
display a cross-β conformation characteristic of amyloids. It is clear from the XRFD 
pattern of Cu2+-enhanced α-syn fibrils (Figure 6-13, C) that those fibrils showed a 
cross-β conformation contrasted to their CD spectra that revealed a random coil 
structure corresponding to the negative band at ~ 200 nm (Figure 6-13, D). However, 
the decline in the 200 nm signal observed upon incubation time would suggest that 
those fibrils precipitated out of the buffer and the CD was recorded just for the buffer-
soluble α-syn aggregates.  
 
 
Figure 6-15: Schematic diagram illustrating the X-ray fibril diffraction analysis. Provided by Prof. 
Louise Serpell. 
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 Conclusion(6.3
PD is the second most common neurodegenerative disease after AD among the ageing 
human population (Tanner and Goldman 1996). Copper has been found to decrease in 
the substantia nigra and increase in the CSF of PD patients (Barnham and Bush 2008; 
Pall et al. 1987). A large body of data shows that α-syn is a metalloprotein and can bind 
Cu2+ and that Cu2+ can promote α-syn aggregation efficiently (Ahmad et al. 2012; 
Binolfi et al. 2006; Rasia et al. 2005). In addition, a role was suggested for Cu2+ in the 
catalysis of oxidative oligomerisation and subsequent α-syn aggregation in the presence 
of H2O2 (Paik et al. 2000). Oxidative stress is implicated in the pathogenesis of PD. 
Oxidative modification of tyrosine residues plays a vital role in the α-syn aggregation 
via protein cross-linking. In this chapter, in vitro dityrosine cross-linked α-syn, which is 
formed through coupling of two tyrosyl radicals, was formed under oxidative stress 
conditions of Cu2+/H2O2, which are more physiologically relevant than other conditions 
used to oxidise the α-syn, such as PICUP. The covalently cross-linked dimer was 
isolated and characterised to contain dityrosine. The mass spectrometry analysis showed 
that dityrosine dimer was formed via the coupling of Y39-Y39 to give homo dimer 
peptide. Incubation of α-syn in both Cu2+-depleted and Cu2+-containing buffer revealed 
a remarkable appearance of dityrosine signal at 410 − 420nm, indicating the possible 
involvement of dityrosine cross-links in the mechanism underlying α-syn aggregation 
and accumulation in PD. The suggested role played by these dityrosine oligomers in the 
aggregation and fibrillogenesis of α-syn is explained in the schematic diagram below, 
and it is proposed that dityrosine cross-linked α-syn dimers could serve as nuclei to 
initiate the polymerisation of α-syn monomers resulting in α-syn fibril formation 
(Figure 6-16). 
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Figure 6-16: Schematic of a proposed mechanism explaining the suggested role of dityrosine cross-linked 
α-syn dimers in the fibrillation of α-syn. Fibrillation of α-syn was demonstrated as a nucleation- 
dependent process (Fernandez et al. 2004). In vitro, at high concentrations of α-syn, the non-covalent 
aggregates provide seeds to initiate the polymerisation of α-syn to form fibrils as shown in path A. By 
contrast, at low concentration of α-syn these non-covalent oligomers become less available and thus the 
fibrillation of α-syn takes longer to develop. Formation of covalent oligomers represents an alternative 
mechanism (path B) that may be important at low concentrations. These covalent oligomers are 
represented by Y39-Y39 coupling, which is formed as a consequence of oxidative stress, could represent 
the toxic forms of α-syn, and also serve as a nucleus for α-syn fibrillation. 
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7 Discussion and Future work 
The work presented here describes the importance of oxidative modification of tyrosine 
residues to form dityrosine cross-links in a range of amyloidogenic peptides/proteins 
from naturally derived to designer, and eventually establishes the role of dityrosine 
cross-links in the pathogenesis of AD and PD. It has been revealed that oxidative stress 
may play a vital role in the pathogenesis of many neurodegenerative diseases including 
AD and PD. High levels of oxidative stress can be produced as a consequence of metal-
protein interactions leading to protein misfolding and cross link formation. Increasing 
evidence points to the pivotal role of the Cu2+ ion in Aβ and α-syn misfolding and 
aggregation. However, no previous comprehensive in vitro and in vivo study has been 
carried out to establish the role played by dityrosine cross-links in amyloid fibril 
formation and to explain the link between dityrosine cross-links and misfolding of 
amyloidogenic proteins, such as Aβ and α-syn, leading to amyloid assembly. The 
research aims here were firstly, synthesis of dityrosine as a standard for comparison, as 
it is commercially not available. Secondly, testing the Cu2+/H2O2 oxidation system 
using two short peptides as model system, which can provide more information about 
the nature of oxidative modification under Cu2+/H2O2 oxidation system. Finally, in vitro 
and in vivo investigation of dityrosine cross-links in Aβ and α-syn examined the affects 
on fibril stability and morphology providing more details to enhance our understanding 
of the putative role played by dityrosine cross-links in Aβ and α-syn misfolding and 
subsequently in the pathogenesis of AD and PD. Furthermore, the work included testing 
the possibility of using dityrosine cross-linked Aβ as a biomarker of oxidative stress in 
AD and to detect the early stages of AD. 
 
In this work, authentic dityrosine was synthesised chemically and enzymatically and 
identified using different analytical techniques including RP-HPLC, mass spectrometry, 
fluorescence spectrophotometry, and NMR spectroscopy. Later on it was used in the 
rest of our study as a standard. Moreover, LC-ESIMS/MS method using MRM mode, 
which has high sensitivity and selectivity, was used in order to detect dityrosine cross-
linking in samples of interest. 
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A fine balance of conditions will be required for optimising the production of dityrosine 
cross-links. In the current study, the oxidative modification of two short peptides, 
HYFNIF and VIYKI, using Cu2+/H2O2 oxidation system was explored, and also the 
morphological and conformational changes of these amyloid fibrils over the oxidation 
process was studied. Both HYFNIF and VIYKI serve as useful and worthwhile model 
systems to examine the ability of Cu2+/H2O2 to induce tyrosine residue modifications 
and to form dityrosine cross-links. Both HYFNIF and VIYKI have been previously 
structurally characterised using many biophysical techniques (Morris et al. 2013b), and 
therefore provide excellent starting point for further study. The results and conclusions 
drawn demonstrate how these models can provide a wealth of information on what 
drives the formation of dityrosine cross-links. Many factors can significantly affect the 
oxidation process using Cu2+/H2O2 and the most important are buffer composition and 
pH. Phosphate buffer appears to be more suited for the oxidation than HEPES, and this 
can be explained in context of Cu2+/ peptide complex stability. It has been found that 
Cu2+ions can form more stable complexes in HEPES buffer (Tougu et al. 2008), and 
this can affect the free radical generation. The pH of the oxidation environment has a 
strong influence on the dityrosine production and this is due to the net peptide charge. It 
is important to generate a neutral or negatively charged peptide to facilitate the 
coordination with Cu2+ ions. At pH 7.4, HYFNIF and VIYKI peptide have more neutral 
net charge (0.1 and 0.8 respectively) than that in water (1.2 for HYFNIF and 1.1 for 
VIYKI), where the pH is more acidic (the pI of HYFNIF and VIYKI fibrils are 8.0 and 
10.3 respectively). As a result, Cu2+-peptide complexes can be easily generated at pH 
7.4, subsequently these complexes can catalyse the tyrosine cross-linking and that may 
explain why a lower dityrosine yield was obtained at acidic pH in water compared to 
more efficient dityrosine formation at pH 7.4. 
 
The presence of dityrosine in oxidised fibrils was confirmed using LC-ESIMS/MS 
following acid hydrolysis of the oxidised VIYKI and HYFNIF fibrils. It appears that 
once dityrosine cross-links form they do not revert back to monomers, indicating that 
they are very stable. Several studies reported that dityrosine exhibits protease resistance, 
supporting our results that the dityrosine cross-link is stable (Amado et al. 1984; Giulivi 
and Davies 1994). 
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The results showed that VIYKI fibrils have a greater ability than HYFNIF fibrils to 
oxidise and produce dityrosine cross-links, and also demonstrated that the preorganised 
fibrils can enhance dityrosine formation by bringing two tyrosine residues close enough 
to cross-link covalently. The results are in good agreement with XRFD models of 
HYFNIF and VIYKI fibrils from a previous study (Morris et al. 2013b), which revealed 
that phenolic groups of the tyrosine residues in VIYKI fibrils are packing closely 
together (Figure 4-19) and become close in proximity that allows tyrosine cross-linking 
to be more favorable (Morris et al. 2013b). In contrast, the structural model of HYFNIF 
fibrils revealed that side chain of tyrosine residues are organised away from each other 
(Figure 4-19) and as a consequence, dityrosine formation was more restricted. Although 
the CD and TEM data of the oxidised fibrils revealed interesting structural and 
morphological changes upon the oxidation processes, no dityrosine characteristic signal 
was observed in CD.  
 
Both Aβ and α-syn can undergo modification to yield species that are toxic and also 
these modifications can facilitate the conversion of Aβ and α-syn from non-
amyloidogenic to an amyloidogenic state. The fundamental questions are; what is the 
identity of the toxic species and what is the mechanism that underlies the formation of 
amyloid fibrils? These questions can be possibly answered through the oxidative 
modification of Aβ and α-syn that leads to protein cross-linking.  
 
The in vitro experimental model presented here can help to understand the early events 
leading to chemical, structural and conformational modifications before the conversion 
of soluble Aβ and α-syn to insoluble amyloid fibrils and eventually the formation of 
senile plaques in AD and Lewy bodies in PD respectively. In turn, this could help to 
design a new inhibitor (e.g. antioxidant) for Aβ and α-syn deposition process and 
identify a potential biomarker for early AD and PD. Herein, we have explored the role 
of Cu2+ ions in the formation of dityrosine cross-links in Aβ and α-syn using many 
different techniques, including fluorescence spectrophotometry, HPLC, mass 
spectrometry, transmission electron microscopy, immunogold labelling, and CD. 
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In chapter 5, I present a comprehensive study of in vivo and in vitro dityrosine cross-
linking associated with Aβ. We have revealed for the first time the presence of 
dityrosine cross-links in amyloid plaques in human AD brain, and also in CSF, and 
identified significant relationships between dityrosine cross-links and amyloid deposit 
formation. The in vitro and in vivo results presented here reveal that oligomeric Aβ can 
undergo oxidative modifications in a cellular environment, resulting in cross-linked Aβ 
through dityrosine followed by intralysosomal Aβ accumulation that could lead to 
lysosomal leakage and cell death. Our results show the significant accumulation of 
dityrosine crosslinked Aβ in amyloid plaques, implying a role in stabilisation of these 
insoluble deposits. This hypothesis was confirmed in vitro by testing the stability of Aβ 
fibrils induced under Cu2+/H2O2 conditions and showed higher stability compared with 
that formed in control conditions. We have also shown a potential biomarker for AD in 
CSF, which contains elevated dityrosine crosslinked proteins as well as elevated 
dityrosine crosslinked Aβ. Our preliminary findings show that dityrosine crosslinks 
were increased in lipofuscin in AD brain, indicating the important role played by 
dityrosine crosslinks in the accumulation of lipofuoscin in higher levels in AD 
compared to control subjects. Also, our results have revealed very strong evidence for 
the presence of both Aβ and dityrosine in CSF from AD patients and both Aβ and 
dityrosine are very rarely observed in CSF from age-matched controls. Therefore, we 
suggest that this could represent a potential biomarker for AD. A few studies have 
previously attempted to quantify dityrosine in cerebrospinal fluid. Techniques including 
HPLC with fluorescence detection, HPLC with electrochemical array detection (HPLC-
ECD) or fluorescence detection, and liquid chromatography with triple quadrapole mass 
spectrometric detection (LC-MS/MS) have been applied to quantify dityrosine 
concentrations in CSF sample from both healthy and disease affected subjects 
(Abdelrahim et al. 1997; Ahmed et al. 2005; Hensley et al. 1998). However, the results 
of these studies have been conflicting, perhaps due to differences in sample handling 
and preparation before measuring. Quantitative screening of protein glycation, oxidation 
and nitration adducts in CSF of AD and healthy age-matched subjects have been taken 
to suggest that dityrosine concentration does not change in AD patients with respect to 
control subjects (Ahmed et al. 2005). By contrast, earlier studies using electrochemical 
detection showed that dityrosine concentration was elevated markedly in CSF of AD 
patients (Hensley et al. 1998). 
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The plausibility of dityrosine cross-linking has been illustrated as a possible mechanism 
for the formation of Aβ aggregates (Atwood et al. 2004), thus dityrosine would be 
highly localised with Aβ at plaque sites. Many studies focused on measuring the 
dityrosine levels in whole brain section in AD, and their results conflicted. While some 
showed elevated dityrosine levels in AD affected brain (Hensley et al. 1998), others 
failed to show any significant elevation (Bucknall 2006). Plaques represent only a small 
proportion of whole AD affected brain, so dityrosine cross-linked protein in whole brain 
might not be measurably elevated. In this work, we have revealed a novel observation 
of the presence of dityrosine cross-links in amyloid plaques in human AD brain. This 
observation provides strong evidence of implying of dityrosine in the Aβ aggregation 
and subsequently plaque formation in the brain of AD patients. 
 
The ability of the Cu2+ ion to promote the formation of in vitro dityrosine cross-linked 
α-syn was explored and the effect on α-syn fibrillogenesis and conformation that is 
induced by the Cu2+ ion was investigated. The role of dityrosine as a covalent cross-
linker was revealed using a number of techniques including fluorescence spectroscopy, 
HPLC, LC-ESIMS/MS, SDS-PAGE, TEM, XRFD and CD. In vitro dityrosine cross-
linked α-syn, which formed through coupling of two tyrosyl radicals, was formed under 
oxidative stress condition of Cu2+/H2O2. The covalently cross-linked dimer was isolated 
by SDS-PAGE and characterised by nanoLC-MS/MS following tryptic digestion to be 
dityrosine. The mass analysis showed that dityrosine dimer was formed via the coupling 
of Y39-Y39 to give a homo dimer peptide. Incubation of α-syn in both Cu2+-depleted 
and Cu2+-containing buffers revealed the remarkable appearance of a dityrosine signal 
at 410 − 420 nm, indicating the possible involvement of dityrosine cross-links in the 
mechanism underlying the α-syn aggregation and accumulation in PD. α-syn 
fibrillogenesis is a nucleus dependent process. Thus the dityrosine cross-linked α-syn 
dimers can serve as nuclei to initiate the polymerisation of α-syn monomers resulting in 
α-syn fibril formation. This hypothesis is supported by finding that dityrosine cross-
linked α-syn dimer formation is the critical rate-limiting step for α-synuclein 
fibrillogenesis in PD (Krishnan et al. 2003). 
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For a long time, it was believed that insoluble Aβ fibrillar deposition found in 
extracellular amyloid plaques initiated the neurodegenerative cascades of AD. However, 
a recent view is that prefibrillar soluble oligomeric Aβ species are the key intermediates 
in AD-related the observed synaptic disorder (Caughey and Lansbury 2003; Klein 
2006). Various amyloidogenic proteins, such as Aβ and α-syn, can produce toxic 
soluble oligomers, proposing that soluble oligomeric species are the general key factors 
in various amyloidosis diseases such as AD and PD (Haass and Selkoe 2007; Kayed et 
al. 2003; Sorgjerd et al. 2008). However, both Aβ and α-syn oligomers can be formed 
through interactions between two tyrosine residues to form dityrosine cross-links and 
this may represent one of the pathways by which stable oligomers are generated. 
 
Further work in the area of dityrosine cross-linked Aβ  measurement in the AD brain 
using LC-MS/MS should focus on extracted plaques rather than whole brain tissues and 
measurement of the dityrosine levels. Isolation and identification of dityrosine cross-
linked Aβ using various techniques such as western blot or mass spectrometry would 
further confirm our results, however, it is important to keep in mind that the plaque 
isolation process can affect the chemical and biochemical structure of plaques and that 
in turn could affect analysis of the samples. On the other hand, the immunogold-
labelling procedure reduces the possibility of artifacts from the isolation procedure and 
enables the examination of the in vivo dityrosine cross-linked species as they are, to 
provide a clearer, more physiologically relevant view. Further toxicity studies with early 
stage oligomeric species and fibrils that may provide a better understanding about the 
identity of the toxic species. Testing some compounds that inhibit the dityrosine cross-
link formation using a model AD or PD would give more a clear view about the 
importance of dityrosine cross-linking in the etiology of neurodegenerative diseases. 
The potential use of dityrosine as a biomarker of oxidative stress in AD and PD remains 
unresolved, but work is currently aiming to confirm this using immunogold labelling 
quantification, particularly in early cases of AD and also would surely bring us closer to 
confirming that by quantification using LC-MS. In addition, it would be ideal to 
estimate the limit of detection for dityrosine using LC-MS. 
 
 
 
Chapter 7 
 
191 
Although many studies demonstrated that dityrosine cross-linked α-syn species reduce 
the yield of amyloid fibrils (Borsarelli et al. 2012; Ruf et al. 2008), dityrosine formation 
has been described to be the critical rate-limiting step in α-syn fibrillogenesis (Krishnan 
et al. 2003). These results appear to be in conflict and this could be interpreted by the 
variation of the in vitro oxidative stress conditions that have been used to form the 
dityrosine cross-link. Also, there are many factors that can affect the lag duration such 
as α-syn concentration, buffer composition and pH, and temperature (Fink 2006; Lee et 
al. 2007a; Roberti et al. 2009). In order to gain better understanding of the relationship 
between dityrosine oligomer formation and α-syn fibrillogenesis, it would be ideal to 
use in vitro oxidative stress conditions that mimic the in vivo conditions. Also, it would 
be very important to detect dityrosine cross-linked α-syn in vivo using a similar method 
we have used for dityrosine cross-linked Aβ in brain and CSF samples of AD, and also 
try to isolate it from Lewy bodies in PD. 
 
More structural measurement, e.g. LD, can be applied to discover whether dityrosine 
has a unique LD signal and consequently enhance our understanding of the structural 
role for dityrosine as a cross-linker in the protein. Moreover, more precise details could 
be gained by using a pure dityrosine cross-linked peptide. As dityrosine is intrinsically 
fluorescent, more evidence can be gained using confocal microscopy about whether the 
dityrosine can be intra- or inter fibrils. Thereby dityrosine cross-linked protein could 
potentially be monitored in the cell using confocal microscopy. 
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Appendix 
i. 1H%NMR%spectrum%of%34iodo4L4tyrosine%derivative%
 
 
ii. 13C%NMR%spectrum%of%34iodo4L4tyrosine%derivative%
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Appendix 228 
iii. 1H%NMR%spectrum%of%protected%dityrosine%
 
 
 
iv. 13C%NMR%spectrum%of%protected%dityrosine%
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Appendix 229 
v. 1%H%NMR%spectrum%of%diiodo%diacetyl%dityrosine%
 
 
 
vi. 13%C%NMR%spectrum%of%diiodo%diacetyl%dityrosine%
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Appendix 230 
vii. TEM%immunogold%labelling%of%dityrosine%in%oxidised%Aβ42%fibrils%
 
 
 
 
 
 
 
 
 
 
 
 
0.2 µm 
0.2 µm 0.2 µm 
100 nm 
Appendix 231 
viii. Immunogold%labelling%TEM%imagesshowing%showing%neuroblastoma%
cells%treated%with%oligomeric%Aβ%
 
ix. TEM%image%of%negative%immunogold%labelling%control%
 
 
100 µm 
100 nm 
Appendix 232 
x. Immunogold%labelling%TEM%images%of%dityrosine%in%CSF%
 
 
 
 
0.2 µm 
0.2 µm 0.2 µm 0.2 µm 100 nm 
0.2 µm 0.2 µm 0.2 µm 0.2 µm 
CSF from AD affected patient 
CSF from age matched control 
